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Summary 
 
Neuronal death is induced by a series of pathogeneses in different 
neurodegenerative diseases, and one of them, which has been widely 
accepted previously, is the overload of intracellular calcium (Ca2+) in 
neurones. This study has investigated ryanodine receptor (RyR) on the 
endoplasmic reticulum (ER) and several potassium (K+) channels which 
might be neuroprotective, such as the large conductance Ca2+-activated 
K+ channel (BK) and adenosine-5’-triphosphate (ATP)-sensitive K+ 
channel, in both neuronal and astrocytoma cell lines. The reverse 
transcription (RT)-polymerase chain react (PCR) results in this Thesis 
show that the messages of RyR, BK channel and ATP-sensitive K+ 
channel (KATP) exist at the messenger ribonucleic acid (RNA) level in 
those cell lines. And, the expression of RyRIII message was found 
being increased in SH-SY5Y cells but decreased in NTERA-2 cells after 
differentiation. The BK channel was confirmed as functional in SH-
SY5Y cells with patch clamp recording. Cell insults which increase 
intracellular Ca2+ ([Ca2+]i), such as cobalt (II) chloride (CoCl2), hydrogen 
peroxide (H2O2), beta-amyloid (Aβ1-42) and glutamate, were found to 
reduce cell number in those cell lines in cell proliferation MTS [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt] assays, and the cells with higher expression of 
RyRIII message were more sensitive to CoCl2 and H2O2 insults. In cell 
proliferation assays testing RyR or K+ channel modulators in the 
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presence of insults, it has been found that generic blockade of RyR or 
K+ channel might be neuroprotective, and the activation of RyR or BK 
channel and the blockade of KATP channel may aggravate the insults. 
Selective blockade of RyRI and RyRII cannot protect the cells, which 
probably indicates that RyRIII is the key target in neuroprotection. 
Activators of the KATP channel cannot protect the cells at a low dose of 
CoCl2 but might be protective at a high dose, although cromakalim was 
an exception. Hence, blockade of RyRIII and the BK channel, and 
activation of the KATP channel, could be possible neuroprotective 
strategies. Future study should measure [Ca2+]i and cell apoptosis 
through Ca2+ imaging and fluorescence-activated cell sorting (FACS) 
respectively, and design selective a RyRIII blocker. 
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1. Introduction 
 
Neurodegeneration is the progressive loss of structure and/or function of 
neurones, including the death of neurones. Most of the neurodegenerative 
diseases are related to the damage or loss of brain tissues, or related to the 
dysfunction of neurones. For example, Parkinson’s disease (PD), which is a 
movement disorder, is contributed by the loss of dopaminergic neurones in the 
substantial nigra and the degeneration of monoaminergic neurones in the brain 
stem and basal ganglia (Stutzmann and Mattson, 2011). Alzheimer’s disease 
(AD), which is a progressive deterioration in a broad range of cognitive 
functions including language, personality, visual-spatial abilities, and 
characteristically, memory (Arispe et al., 2007, Kagan et al., 2002), is caused 
by the shrinkage and dysfunction of brain tissues, such as hippocampal 
neurones (Mattson and Kater, 1989). Huntington disease (HD), which is a 
genetic disease contributed by a disorder of gene, is also found with 
dysfunction of brain areas like striatum, cortical structures (Mattson and 
Magnus, 2006) and limbic system (Mattson, 2003). Stroke, which is caused by 
a clot formed in a cerebral blood vessel, has been found to cause dysfunction of 
neurones because of the high energy demand and results in neurone death 
(MacDonald et al., 2006). Finally amyotrophic lateral sclerosis (ALS) is also 
related to neurodegeneration linked to peripheral neuropathies (Fernyhough 
and Calcutt, 2010), although it is not a brain disorder. 
 
Neurodegenerative diseases are widely spread nowadays. According to a report 
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from the World Health Organisation (WHO), the prevalence rate of stroke is 
ranging from 5 to 10 per 1,000 population and it is estimated that 5.5 million 
subjects die from stroke every year (Prilipko, 2004). In Europe, the number of 
persons with stroke, including extension, has been estimated as 8.2 million in 
2010, the number in UK being estimated as 947 thousand by then (Gustavsson 
et al., 2011). The prevalence of dementia has been estimated as 18 – 25 million 
subjects in 2000 and 50% - 75% of them are AD cases which is the commonest 
pathology in dementia. The prevalence of dementia including AD is age-
dependent and doubles with every five-year increment in age from 1% for 60 – 
64 years old group to 45% for those aged 95 years or over (Prilipko, 2004). 
There were more than 6.3 million dementia subjects in Europe by 2010 and 
738 thousand of them exist in the UK (Gustavsson et al., 2011). WHO has 
estimated the incidence of PD as between 16 – 19 per 100,000 people per year 
and the crude prevalence is 160 per 100,000 people per year (Prilipko, 2004). 
The prevalence of PD in Europe is estimated as 1.2 million subjects, while 110 
thousand of them are in UK (Gustavsson et al., 2011). 
 
The cost for neurodegenerative diseases cannot be neglected neither. The 
average cost of stroke was €7,775 per patient in Europe and was €8,967 in UK 
in 2010 (Gustavsson et al., 2011), which means the total cost was about 64 
billion Euros all over the Europe including about 8.5 billion Euros in UK. The 
average cost for dementia was about 17 thousand Euros per patient in Europe 
and was about 30 thousand Euros in UK in 2010 (Gustavsson et al., 2011), 
which means the total cost was about 107 billion Euros all over Europe 
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including about 22 billion Euros in UK. The average cost of PD was about 11 
thousand Euros per patient in Europe and was 21.5 thousand Euros in UK in 
2010 (Gustavsson et al., 2011), which means the total cost was about 13 billion 
Euros all over Europe including about 2.4 billion Euros in UK. The total cost 
for stroke, PD and dementia, although not all of the neurodegenerative diseases 
are included, would be about 180 billion Euros over Europe. According to the 
WHO report on the primary method of financing neurological care, 59% are 
based on social insurance, 33% are tax-based, and 8% are out of pocket in 
Europe (Prilipko, 2004). That means, the burden on neurodegenerative diseases 
in Europe would be more than 165 billion Euros to the governments and 
society and would be nearly thousand Euros to each individual patient. 
 
Considering the wide prevalence of neurodegenerative diseases and the huge 
cost to the government, society and patients themselves, it is essential to find a 
way to prevent or treat these diseases. Since most of the neurodegenerative 
diseases are related to the dysfunction of neurones or loss of brain tissues, 
which progresses to neuronal death, this Thesis is focussed on “the cellular 
basis of neurodegeneration” and establishes neuronal insult models to find 
possible targets for a neuroprotective purpose, such as the ryanodine receptor 
(RyR) and potassium (K
+
) channels. 
 
1.1 Cell death and calcium 
 
Neurones are excitable cells that rapidly communicate electrical signals in a 
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precise spatio-temporal manner. Calcium (Ca
2+
) is a major intracellular 
messenger that mediates many of the physiological responses to chemical and 
electrical stimulation. Hence, the influx of Ca
2+
 through channels is a critical 
signal for the release of neurotransmitters from presynaptic terminals and for 
the responses of the postsynaptic neurone (Mattson, 2007). Unfortunately such 
an influx, if excessive, may eventually cause cell death. Ca
2+
 activates calpains 
and caspases, which are forms of cysteine proteases that degrade a variety of 
substrates (Mattson, 2007, Nixon, 2003). They can also induce oxidative stress 
(Mattson, 2007, Lafon-Cazal et al., 1993), and finally can trigger apoptosis 
which is a form of programmed cell death (Ankarcrona et al., 1995, Mattson, 
2007). 
 
Intracellular Ca
2+
 ([Ca
2+
]i) overload caused by Ca
2+
 influx has been implicated 
in several neurodegenerative diseases, such as ischemic stroke, ALS, PD, AD 
(Stutzmann and Mattson, 2011) and HD (Mattson, 2007). In normal neurones, 
large amounts of energy need to be spent to maintain the homeostasis of ion 
gradients, and Ca
2+
-ATPases on the cell membrane and the endoplasmic 
reticulum (ER) membrane are one of the major adenosine-5’-triphosphate 
(ATP) sinks (Mattson, 2007) and the ER is a large intracellular Ca
2+
 pool. 
 
In stroke, compromised blood flow in vascular damage results in a massive 
release of glutamate which can activate the N-Methyl-D-aspartate (NMDA) 
receptor. The activation of the NMDA receptor can cause a rise in [Ca
2+
]i 
(MacDonald et al., 2006). In addition, membrane associated oxidative stress 
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can impair the function of glutamate transporters, and promote membrane 
depolarization and Ca
2+
 influx through NMDA receptors (Mattson, 2007). 
 
In ALS patients, the Ca
2+
 content in motor neurones is significantly increased 
(Mattson, 2007), and such an increase has been linked with a Copper (Cu)/Zinc 
(Zn)-superoxide dismutase (SOD) mutation and with the death of motor 
neurones (Kruman et al., 1999). 
 
PD has been linked with the death of dopaminergic neurones (Stutzmann and 
Mattson, 2011) and dopamine is a widely accepted treatment for PD. 
Furthermore, previous studies have suggested that the death of dopaminergic 
neurones is contributed by mitochondrial stress, with a possible role of 
perturbed [Ca
2+
]i homeostasis downstream of the mitochondrial alterations 
(Mattson et al., 2008). Previous experiments have also found that PD cybrids 
(mitochondrially transformed cells) recovered from a carbachol-induced 
increase in cytosolic Ca
2+
 53% more slowly than controls (Sheehan et al., 
1997). 
 
For HD, it has been proposed in previous studies that a polyglutamine 
expansion would modify huntingtin to mutant huntingtin fragmentation, and 
the latter could be switched to huntingtin oligomers through polyglutamine 
expansion and/or the increasing of ferrous (Fe
2+
), copper I (Cu
+
) or hydrogen 
peroxide (H2O2). The huntingtin oligomers may then increase [Ca
2+
]i and cause 
cell damage or death (Mattson and Magnus, 2006). Ca
2+
-stabilizing agents 
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which can prevent [Ca
2+
]i overload have therefore been proposed as a possible 
treatment for HD (Mattson and Magnus, 2006). 
 
AD is a chronic, fatal, neurodegenerative disease which causes progressive 
deterioration in a broad range of cognitive functions including language, 
personality, visual-spatial abilities, and characteristically, memory (Arispe et 
al., 2007, Kagan et al., 2002). In the research on AD, a lot of attention has been 
paid to the role of Ca
2+
. Some studies on brain tissue from AD patients have 
revealed that alterations in cellular Ca
2+
 homeostasis contribute to the cell 
death. Further, previous studies have reported that the amount of free and 
protein bound Ca
2+
, and the activity of Ca
2+
-independent proteases, are 
increased in neurones containing neurofibrillary tangles as compared with 
tangle-free neurones in brain tissue from AD patients (Mattson, 2007, Nixon, 
2003). The Ca
2+
 entering through putative Ca
2+
 channels formed by β-amyloid 
(Aβ) stemming from amyoid precursor protein (APP) may be one possible 
pathogenesis of [Ca
2+
]i overload (Alarcón et al., 2006), and, certainly a Ca
2+
 
current through an Aβ channel has been recorded with electrophysiological 
techniques previously (Jang et al., 2010).  
 
To summarise those studies mentioned above, it may be important to consider 
that [Ca
2+
]i overload plays an important role in neuronal death and in most, if 
not all, of the neurodegenerative diseases. However, the source of the [Ca
2+
]i 
rise might not be from solely the outside of the cell, but may also be derived 
from an intracellular store. As soon as Ca
2+
 has entered the cells, either through 
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an NMDA receptor channel or Aβ, the increased [Ca2+]i binds with the 
receptors on the ER, which is known as an intracellular Ca
2+
 pool, and actives 
the Ca
2+
 channels on ER. This causes more Ca
2+
 to be released from ER and 
the [Ca
2+
]i is further increased (Berridge, 2010). Importantly, this pathway is 
called Ca
2+
 induced Ca
2+
 release (CICR) path. In neurones, like many other 
cells, apoptosis would be activated by the increased [Ca
2+
]i and cell death 
would follow. Fig. 1.1 outlines Ca
2+
 signalling and the CICR pathway on the 
ER. 
 
 
Figure 1.1 [Ca
2+
]i signals and activation of cell death (Berridge, 2010) 
 
The CICR system (see Fig. 1.1) has a key well understood physiological 
function also in skeletal muscle and cardiac muscle by triggering release of 
further Ca
2+
 from the muscle sarcoplasmic reticulum (Endo, 1977). In neurones, 
other studies have pointed out that any rise in [Ca
2+
]i may not solely result in 
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inducing cell apoptosis, but might somehow be protective. Although it has 
been mentioned above that neuronal death in ischemic stroke is contributed by 
the Ca
2+
 release from ER, another study has claimed that when neurones are 
exposed to a mild brief ischemia they can be more resistant to a more severe 
ischemic stroke (Calabrese et al., 2007). However, this result does not fit well 
with a Ca
2+
 hypothesis of neuronal death. The possible reason is that ER Ca
2+
 
release can stimulate NF-κB, which is a transcription factor. The activation of 
NF-κB can down-regulate NMDA current and inhibit Ca2+ release via inositol 
1,4,5-trisphosphate (IP3) receptor (Stutzmann and Mattson, 2011). That means, 
the brief ischemia, which can increase [Ca
2+
]i, might not necessarily be 
protective, but just temporally down-regulate NMDA receptor and prolong 
further increasing of [Ca
2+
]i. 
 
1.2 Intracellular Ca2+ and ER 
 
As introduced before, in most of the models of neurodegeneration mimicking 
stroke, PD, ALS, HD and AD, neuronal death or dysfunction is caused by, or 
related to an increase of [Ca
2+
]i, even if the pathologies of [Ca
2+
]i increase are 
different. The ER plays an important role in [Ca
2+
]i homeostasis. Thus, some 
ER Ca
2+
 release mechanisms are going to be briefly introduced here since ER 
is known as an important intracellular Ca
2+
 pool. 
 
1.2.1 Inositol 1,4,5-trisphosphate receptor 
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IP3 receptor (IP3R) is a Ca
2+
 channel located on the ER membrane. There are 3 
mammalian subtypes of IP3R (Stutzmann and Mattson, 2011). IP3R1 is a 
tetramer of four subunits, and, for each subunit, the amino terminal is the IP3 
binding domain, the carboxyl terminal is the channel-forming domain, and the 
middle part is a modulatory domain. The other two subtypes of IP3R have 
similar amino acid sequence with IP3R1 with a homology of 70.5% for IP3R2 
and a homology of 64.6% for IP3R3 (Bezprozvanny, 2005). 
 
IP3R is a cation-selective channel gated by IP3 (Bezprozvanny, 2005). When 
there is limited intracellular [IP3], few receptors bind IP3 and localized small 
Ca
2+
 signals are generated by Ca
2+
 released through a single IP3R channel. 
When there is intermediate intracellular [IP3], coordinated openings of several 
channels within a group is triggered by Ca
2+
 release from one channel 
stimulating gating of nearby channels through CICR process. When there is 
high intracellular [IP3], global propagating Ca
2+
 signals can be evoked and the 
Ca
2+
 released at one cluster can trigger Ca
2+
 release at adjacent clusters by 
CICR (Parker et al., 1996). According to previous measurements of Ca
2+
 
current magnitude through RyR [< 0.5 pico ampere (pA)], and considering that 
the relative magnitudes of Ca
2+
 currents through IP3R and RyR can be 
estimated to be about 2.85, the Ca
2+
 current through an IP3R channel under 
physiological ionic conditions is predicted to be 0.1 – 0.2 pA (Foskett et al., 
2007). 
 
The reason that the cycles of Ca
2+
 release exist is that IP3R is a CICR channel, 
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and can be activated by not only IP3, but also intracellular Ca
2+
. Under low 
[Ca
2+
]i [about 50 nano moles (nM)] in the environment, the activity of IP3R 
channel is very low (Foskett et al., 2007). As the [Ca
2+
]i is increased from 100 
nM, the IP3R channel activity can also be increased until [Ca
2+
]i is 1 micro 
mole (μM), and the maximum opening probability (Po) of IP3R is estimated as 
about 0.8. Interestingly, channel Po stays at the maximum level over a wide 
range of [Ca
2+
]i until about 10 – 20 μM. When the [Ca
2+
]i is further raised 
above 20 μM, the IP3R channel is inhibited (Foskett et al., 2007, Mak et al., 
1998). Hence, in the cycles of Ca
2+
 release mentioned above, high intracellular 
[IP3] stimulates the IP3R channel and releases Ca
2+
, and increased [Ca
2+
]i 
actives the IP3R and continues the Ca
2+
 release thereafter. Although Ca
2+
 can 
modulate the Po of the IP3R channel, Ca
2+
 cannot independently active IP3R 
channel in the absence of IP3 (Stutzmann and Mattson, 2011). Besides the 
intracellular Ca
2+
, the IP3R channel can be modulated by luminal Ca
2+
 also. 
IP3R activity can be inhibited by luminal Ca
2+
, and the channel can be rapidly 
inactivated by high luminal Ca
2+
 after it is activated by IP3 (Foskett et al., 
2007). 
 
In addition to intracellular and luminal Ca
2+
, IP3R can be modulated by ATP 
and pharmacological modulators. ATP [< milli mole (mM)] can active IP3R1, 
and adenophostin A (nM) actives IP3R1 and IP3R2. Heparin [microgram per 
millilitre (μg/mL)] and decavanadate (μM) also inhibit all 3 subtypes of IP3R, 
while xestospongin C (μM) and caffeine (mM) can inhibit IP3R1 only 
(Alexander et al., 2009). 
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Previous studies have linked IP3R channel with some neurodegenerative 
diseases. In ischemic stroke, Ca
2+
 release through the IP3R channel is enhanced 
(Stutzmann and Mattson, 2011). In AD, presenilin (PS) 1 actives IP3R to 
release more luminal Ca
2+
 and increase [Ca
2+
]i (Berridge, 2010). 
 
1.2.2 Ryanodine receptor 
 
RyR is another important Ca
2+
 release channel on the ER membrane 
(Stutzmann et al., 2006a). The name of “ryanodine receptor” is given because 
it is sensitive to a plant alkaloid ryanodine (Sorrentino, 1995), which is found 
in the South American plant Ryania speciosa (Flacourtiaceae) (Rogers et al., 
1948). The chemical structure of ryanodine is shown in Fig. 1.2. 
 
There are three isoforms of RyR found so far: RyRI, RyRII and RyRIII. They 
are distributed in many different organs, tissues or cells (Giannini et al., 1995). 
However, generally speaking, RyRI is mostly found in skeletal muscle, RyRII 
is usually found in cardiac muscle, and RyRIII is widely found in neurones 
(Vanterpool et al., 2006, Manunta, 2000). Thus, they are named skeletal type 
(sRyR), cardiac type (cRyR) and brain type (bRyR) respectively in some 
papers (Hakamata et al., 1992, Furuichi et al., 1994). The amino acid and 
mRNA sequences of human RyRs have been studied before (Bhat and Ma, 
2002, Yamaguchi et al., 2004, Tilgen et al., 2001, Pugh et al., 2005), and the 
degree of homology on amino acid is quite high. It is 67% between RyRI and 
RyRII, is 66% between RyRI and RyRIII and is 70% between RyRII and 
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RyRIII (Manunta, 2000). 
 
 
 
 
Fig. 1.2 Ryania speciosa and ryanodine. Left hand panel: ryania speciosa; right top: 
ryania speciosa; and right bottom: chemical structure of ryanodine. 
 
The three-dimensional of RyRIII is shown in Fig. 1.3. 
 
Previous work with the RyRI has shown that the three-dimensional structure of 
RyRI is similar to that of RyRIII shown above (Samsó et al., 2005). The 
differences between RyRI and RyRII, and even the selective RyRII binding 
areas, have been studied and described in 1990s (Manunta, 2000, Sorrentino, 
1995). But, the differences between RyRIII and the other two isoforms have 
not been completely revealed yet. 
 
RyR, like the IP3R, is a CICR channel on the ER. It is a high-conductance but 
relatively nonspecific cation channel [about 100 – 150 pico siemens (pS) for 
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Fig. 1.3 Three-dimensional structure of RyRIII (Sharma et al., 2000). a: RyRIII in 
open buffer. Open buffer favours the open state of RyR channel and contains 400 mM 
sodium chloride (NaCl), 20 mM 1,4-piperazinediethanesulfonic acid (PIPES) (pH = 
7.2), 5 mM Na2AMP, 2 mM dithiothreitol, 0.2 mM calcium chloride (CaCl2), 0.1 mM 
ethylene glycol tetraacetic acid (EGTA), 0.6% 3-[(3-
cholamidoprophl)dimethylammonio]-1-propanesulfonic acid [CHAPS, weight to 
volume (w/v)], 0.3% soybean phospholipid and 1 μg/mL leupeptin. And b: RyRIII in 
closed buffer. Closed buffer contains 400 mM NaCl, 20 mM PIPES, 2 mM 
dithiothreitol, 0.1 mM EGTA, 1% CHAPS (w/v) and 1 μg/mL leupeptin. This buffer 
favours the closed state of RyR channel. Scale bar is 100 angstrom (Å). The left panel 
shows the cytoplasmic view, the central panel shows the face interacting with 
junctional face membrane, and the right panel shows the interaction of transmembrane 
assembly (TA) with the cytoplasmic assembly. All the numbers show the domains 
which have been studied previously. 
 
Ca
2+
], which is therefore quite different from IP3R (Stutzmann and Mattson, 
2011). The three isoforms of RyR have different sensitivities to intracellular 
Ca
2+
 (RyRI > RyRII > RyRIII). All of the three isoforms can be activated by 
low concentrations of intracellular Ca
2+
 (μM) to release luminal Ca2+ and can 
be inhibited by high [Ca
2+
]i (Alexander et al., 2009). Ca
2+
 release through RyRI 
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can achieve maximal release at about 5 μM [Ca2+]i and can be inhibited by 
intracellular Ca
2+
 at several hundred μM (Alexander et al., 2009) to low mM 
range (Stutzmann and Mattson, 2011). The RyRII and RyRIII require higher 
[Ca
2+
]i for inhibition, requiring about 1 mM (Alexander et al., 2009) to 10 mM 
(Stutzmann and Mattson, 2011) or above. The RyR can also be modulated by 
luminal Ca
2+
 and high luminal Ca
2+
 levels increase its responsiveness to some 
cytosolic agonists (Stutzmann and Mattson, 2011). In addition, in a transgenic 
(KM670/671NL + V717F) mouse model, importantly, enhanced expression of 
RyR and increased [Ca
2+
]i have been reported, but the [Ca
2+
]i is similar to 
control in the transgenic model with silenced RyRIII (Supnet et al., 2006). This 
result suggests that [Ca
2+
]i cannot be markedly increased without the existence 
of RyR, even in the transgenic AD model. 
 
In addition to both intracellular and luminal Ca
2+
, RyR can also be modulated 
by ATP, calmodulin, cytosolic magnesium (Mg
2+
) and some pharmacological 
modulators. Cytosolic ATP (mM) can active RyR while Mg
2+
 (mM) can inhibit 
it (Stutzmann and Mattson, 2011). Calmodulin at low [Ca
2+
]i level actives 
RyRI and RyRIII. Ryanodine (nM – μM) and caffeine (mM) can active all the 
three isoforms of RyR, and suramin (μM) can active RyRI and RyRII. 
Ruthenium red inhibits all the three isoforms of RyR, ryanodine (> 100 μM) 
and procaine block RyRI and RyRII only, and dantrolene blocks RyRI and 
RyRIII only (Alexander et al., 2009). 
 
Intriguingly, previous studies have related the dysfunction of RyR to several 
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neurodegenerative diseases. Ca
2+
 release through RyR is enhanced in ischemic 
stroke (Stutzmann and Mattson, 2011), and the study on a transgenic AD 
mouse model (KM670/671NL + V717F), which has been mentioned above, 
has revealed that both RyR expression and Ca
2+
 release are enhanced in the 
transgenic model comparing with the control (Supnet et al., 2006). Some 
studies even claim that RyR induced Ca
2+
 release in the ER may be crucially 
involved in the formation of the pathological hallmarks of AD (Kelliher et al., 
1999). 
 
1.2.3 Other considerations 
 
Besides IP3R and RyR, there are other relevant targets on the ER which could 
either modulate Ca
2+
 release from ER directly, or modulate IP3R or RyR. These 
include PS, Ca
2+
 homeostasis modulator 1 (CALHM1) and the sarcoplasmic-
endoplasmic reticulum Ca
2+
 ATPase (SERCA). 
 
There are two types of PS, PS1 and PS2. PS has been widely studied in AD 
research since it can cleave APP to generate Aβ (Stutzmann and Mattson, 
2011). Previous studies have also found that PS, either wild type or mutant, can 
increase the intracellular Ca
2+
 level and can enhance IP3-evoked Ca
2+
 responses. 
PS can also increase the open probability of (EC50 = 7 nM) and the Ca
2+
 release 
current from the RyR channel (Rybalchenko et al., 2008). In addition, PS itself 
may constitute a Ca
2+
 leak channel to release luminal Ca
2+
 (Berridge, 2010, 
Stutzmann and Mattson, 2011, Tu et al., 2006). Besides the release from 
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luminal Ca
2+
, PS can also increase [Ca
2+
]i by enhancing Ca
2+
 entry from 
extracellular sources (Lessard et al., 2005). In addition to modulating 
intracellular Ca
2+
, PS increases potassium (K
+
) current in hippocampal 
neurones, an action which may be related to neuronal apoptosis (Zhang et al., 
2004). 
 
CALHM1 is a novel Ca
2+
 channel localised to both the ER and plasma 
membrane (Stutzmann and Mattson, 2011). A previous study has proposed that 
CALHM1 is an essential component of a previously uncharacterised Ca
2+
 
channel that controls both Aβ level and [Ca2+]i, both of which are related to AD 
(Dreses-Werringloer et al., 2008), and, luminal Ca
2+
 can be released from 
CALHM1 (Berridge, 2010). However, the link between CALHM1 and AD is 
still arguable and some other studies have shown no support for CALHM1’s 
role in AD. This is reviewed in Stutzmann and Mattson (2011). 
 
In addition to those luminal Ca
2+
 release channels mentioned above, IP3R, RyR, 
PS and CALHM1, there is a Ca
2+
 influx pump, SERCA, on the ER membrane. 
It pumps cytosolic Ca
2+
 into the ER using energy derived from ATP hydrolysis. 
There are three (SERCA1, SERCA2 and SERCA3) different proteins, and they 
can be further divided to 7 isoforms (SERCA1a, SERCA1b, SERCA2a, 
SERCA2b, SERCA3a, SERCA3b and SERCA3c). SERCA2b and SERCA3 
are expressed in nomuscle tissues, SERCA2b particularly is expressed in brain 
(Stutzmann and Mattson, 2011). Previously it has been shown that the activity 
of SERCA2b to pump Ca
2+
 into ER can be enhanced by higher expression of 
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PS1, which means that high expression of PS1 would accelerate cytosolic Ca
2+
 
clearance (Green et al., 2008). This result does not suggest a neuroprotective 
effect of PS1, since the enhanced activity of SERCA may not balance the 
increased activity of IP3R and the Ca
2+
 leak through PS1 itself (Berridge, 2010). 
 
1.3 Neuronal insult 
 
Since this thesis is focused on the cellular basis of neurodegeneration, several 
cell insult models, which can result in neuronal death and may be highly 
relevant to neuronal degenerative diseases, have been considered. These are 
now described in turn. 
 
1.3.1 β-amyloid 
 
Aβ is thought to be the main pathogenesis of AD (Zahradnίková and Palade, 
1993). Some studies of the channel hypothesis claim that the Aβ peptides are 
the major constituents of senile plaques found in the brain (Plant et al., 2003), 
especially in the hippocampal regions (Mattson and Kater, 1989), of AD 
patients. They accumulate in plaques in the brain, form ion channels, and 
actually damage and/or kill neurones (Alarcón et al., 2006, Kagan et al., 2002, 
Kelliher et al., 1999, Lin et al., 2001). Such a channel forming ability of Aβ 
peptides was first demonstrated in lipid bilayers in 1993 (Arispe et al., 2007, 
Kagan et al., 2002) and the 3D structure of the Aβ ion channel was reviewed in 
2007 (Lal et al., 2007). Other studies have shown that Aβ peptides can insert 
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into the plasma membranes of target cells, transport ions such as Ca
2+
, and 
mediate cytotoxicity in a manner consistent with channel formation (Kagan et 
al., 2002). Further, patch clamping has also confirmed that the Aβ channel is 
existent and functional (Jang et al., 2010). 
 
However, neurones must maintain ionic gradients and membrane potential to 
function properly in their signalling role, and even small decrements in 
membrane potential can alter firing properties and lead to significant brain 
dysfunction. In particular, neurones need to maintain [Ca
2+
]i low (~ 100 nM), 
hence the Ca
2+
 entering into neurones from Aβ channels will potentially trigger 
apoptosis or at least modify signalling function (Kagan et al., 2002). 
 
 
Fig. 1.4 Aβ peptides and its actions on cells (Arispe et al., 2007) 
 
Fig. 1.4 shows the principal of Aβ channel. The APP is a form of 
transmembrane protein, and can generate Aβ following the activity of a 
specific enzyme (Kelliher et al., 1999). Most Aβ remains in the medium in a 
non-toxic and non-aggregated state. But, in the AD brain, the Aβ plaques can 
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form neuritic plaques, soluble oligomers and ion channels in cells. Such a 
channel will allow ions, such as Ca
2+
, and neurotoxins to enter into, and will 
cause neurofibrillary tangles (Arispe et al., 2007). 
 
In addition to the Ca
2+
 channel formation approach, Aβ can also modulate 
acetylcholine (ACh) release in brain neurones. ACh dysregulation has been 
linked to AD and other dementias in previous studies. The activity of the ACh 
synthesizing enzyme choline acetyltransferase is reduced in the neocortex of 
AD brain, and reduced ACh release and loss of cholinergic neurones occurs in 
the basal forebrain region in AD brains (Kar, 2002). Importantly, a 
fluorescence test on SK-N-MC cells (a human neuroepithelioma cell line) has 
found that Aβ1-42 can bind with the α7 nicotinic ACh receptor with high 
affinity and can reduce cell viability at a concentration of nM (Wang et al., 
2000). Another in vitro study with rat hippocampal slices has shown that 10 
nM Aβ can inhibit ACh release in 2 hours (h) (Kar et al., 1998), and, such an 
inhibitory effect is more significant in the aged cognitively-impaired rats than 
it is in the aged cognitively-unimpaired rats or young adult rats (Vaucher et al., 
2001). These effects may also underlie the toxic effect of Aβ in neurones, 
however whether intracellular Ca
2+
 changes are involved in these actions is still 
unknown. 
 
1.3.2 Hypoxia mimicked by cobalt (II) chloride 
 
Hypoxia is a widely used model in cardiac disease studies and it has a major 
role in the pathogenesis of cardiac dysfunction (Bautista et al., 2009). Hypoxia 
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has also been found to promote chondrogenesis in stem cells (Kanichai et al., 
2008). In those models, hypoxia is linked with ischemia, and hypoxia/ischemia 
can lead to the modulation of some bioactive lipid messengers such as 
eicosanoids whose synthesis is highly regulated in reperfusion as well (Bazan 
et al., 2002). Clearly, ischemia is a key pathogenesis of ischemic stroke and, 
besides stroke, hypoxia has been implicated in several other brain disorders or 
neurodegenerative diseases too, or even has been used as a model for those 
studies. For example, hypoxia has been used as a model to induce generalized 
seizure to study the role of potassium channels (Yamada et al., 2001). And, 
hypoxia is also an important contributor to the onset and progression of AD 
(Bazan et al., 2002). 
 
In addition to having been considered as a model of a range of diseases, 
hypoxia directly modulates [Ca
2+
]i. Previous work believes that the modulation 
of Ca
2+
 by IP3R is based on hypoxia preconditioning in hippocampal neurones 
(Bickler et al., 2009). 
 
Cobalt (II) chloride (CoCl2) has been used as a hypoxia mimetic model in 
previous studies (Gasperi et al., 2010, Bautista et al., 2009), and in neurones, 
CoCl2 can increase the generation of Aβ by up-regulating the expression of 
APP as well as the expression of β-secretase and γ-secretase (Zhu et al., 2009). 
As described above, Aβ is the key pathogenesis factor for neurones in AD and 
is an obvious neuronal insult model. 
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1.3.3 Oxidative stress induced by hydrogen peroxide 
 
Oxidative stress has been found to be increased in the aged brain, and aging is 
obviously related to a range of neurodegenerative diseases or brain disorders 
such as stroke and AD (Floyd and Hensley, 2002). Besides, oxidative stress is 
allegedly involved in ALS as well since an increased level of Ca
2+
, and 
oxyradicals are found in spinal cord motor neurones in ALS patients (Kruman 
et al., 1999). Furthermore, some other studies believe that oxidative stress is 
also involved in PD (Egea et al., 2007). In cells oxidative stress is essentially 
an insult to mitochondria and causes mitochondrial dysfunction (Lin and Beal, 
2006). 
 
H2O2 has been utilised effectively as an oxidative stress insult model for 
cellular based studies before. Hence, the cell death with H2O2 has been tested 
with a mouse hippocampal cell line (Ishimura et al., 2008), and, there is 
evidence to suggest that H2O2 is not an oxidative stress insult only in 
neurodegeneration, but also can modulate [Ca
2+
]i directly (Krebs et al., 2007). 
A similar study has been done with cardiac cell lines to investigate the effect of 
H2O2 on gating Ca
2+
 release channel and to link this release with the function 
of the RyR (Boraso and Williams, 1994). 
 
1.3.4 Glutamate 
 
Glutamate has often been studied in previous studies researching of 
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neurodegeneration since it can bind with, and activate the NMDA receptor, 
which is a Ca
2+
 influx channel. 
 
Glutamate has therefore been used as an insult in neuronal cell lines, and 
glutamate induces neurodegeneration for example in hippocampal neurones 
(Mattson, 1989). It can directly induce neuronal death and direct the cells to 
apoptosis based on the modification of mitochondrial functions (Ankarcrona et 
al., 1995), and can also induce neuronal death by deregulation of [Ca
2+
]i and 
has been used as an ischemia model (Dolga et al., 2011). This effect could be 
due in part to the activation of NMDA receptor since the latter can induce Ca
2+
 
signals (Alford et al., 1993, Makarewicz et al., 2003). In addition, stimulation 
of the NMDA receptor can produce superoxide (O
·-
) which is toxic to cells, and 
is linked with ALS (Lafon-Cazal et al., 1993). Amazingly experimental results 
have shown that 1 mM glutamate can induce APP secretion in 30 minutes 
(Jolly-Tornetta et al., 1998). 
 
In addition, glutamate is involved in, and linked with the other insults. Previous 
studies conclude that glutamate (1 mM) and the activation of NMDA receptor 
are essential in the cell death in a hypoxia mimetic model,  although this same 
study has also indicated that 1 mM glutamate alone is not toxic to neurones if 
hypoxia is absent (Rootwelt et al., 1998). There are even some studies that 
have challenged the idea of a toxic effect of glutamate by suggesting that the 
activation of CICR channel, such as IP3R, can be inhibited by glutamate (Kato 
and Rubel, 1999). 
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1.4 Possible neuroprotective targets studied in this thesis 
 
As introduced above, the CICR channel plays an important role in luminal Ca
2+
 
release and in [Ca
2+
]i homeostasis. Hence, the CICR channels could be selected 
as a potential target for research on neuroprotection. As will be seen, this thesis 
focuses on RyR, which is a CICR channel on the ER. In addition, dysfunction 
of the K
+
 channel and involvement of ATP has been mentioned above in some 
cases of neurodegeneration and neuronal death. Hence several types of K
+
 
channels are also considered here, given their possible roles in neuroprotection. 
 
1.4.1 Ryanodine receptor 
 
As introduced above, earlier studies have pointed out that RyR is implicated in 
luminal Ca
2+
 release (Stutzmann et al., 2006a),  and it is well known as a Ca
2+
-
regulating protein on the ER membrane. Hence its blockade could potentially 
protect neurones against excitotoxic injury (Mattson, 2007). 
 
But why the RyR rather than the other important CICR channel IP3R? This is 
based on a consideration of selectivity. [Ca
2+
]i overload and CICR are likely 
factors in neurodegeneration, but do play a physiological role in skeletal and 
cardiac muscles. Hence, if selected for a neuroprotective strategy, possible side 
effects on other targets or tissues other than neurones are expected. In this case, 
it is preferred to pick a target located in neurones only, rather than one widely 
spread in other organs or tissues. The distributions of three isoforms of RyR 
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have been investigated in previous studies, and RyRIII is the only isoform 
which is mainly located in brain neurones (Sorrentino, 1995). However 
importantly there is little difference in the distribution of the three IP3R 
subtypes. 
 
Equally the RyRIII target is a better target than the SERCA. Although the 
distribution of different subtypes of SERCA are different, and only SERCA2b 
is mainly distributed in brain, there are few pharmacology modulators available 
for SERCA thus far. In addition, the effect of SERCA on [Ca
2+
]i modulation is 
smaller than the effects of RyR or IP3R, although SERCA does play a positive 
role in reducing [Ca
2+
]i. (Green et al., 2008, Berridge, 2010). 
 
As introduced in Section 1.2.2, there are several pharmacological RyR 
modulators available. This study proposes to test the effect of those modulators 
on models of neuronal insult to see whether RyR blockade, particularly the 
blockade of RyRIII rather than the other two isoforms, would be 
neuroprotective or not. 
 
1.4.2 Potassium channel 
 
As introduced above, there are three potential cell insults to be used in this 
study, Aβ, hypoxia and oxidative stress. All of these can increase [Ca2+]i and 
induce neuronal death. However, besides the issue of [Ca
2+
]i, K
+
 channel 
activity may play a role in those cell insults. A previous study has found that 
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platelets from AD patients have a modified activity in a K
+
 channel (Silva et al., 
1998), and, a mathematical model has also shown that any Aβ-mediated block 
of the K
+
 current could result in increased intracellular Ca
2+
 levels and hence 
increased membrane excitability (Good and Murphy, 1996). However, there 
are some other contrasting studies claiming the opposite. For example, one 
study in 1998 has shown that tetraethylammonium (TEA), which is a K
+
 
channel blocker, can reduce the neuronal death from a Aβ insult (Yu et al., 
1998). 
 
So, there remains the big question whether activation or blockade of K
+
 
channels would be neuroprotective. Several K
+
 channels which have been 
studied before, such as the large conductance Ca
2+
 activated K
+
 channel (BK), 
ATP-sensitive K
+
 channel (KATP) and the voltage-gated K
+
 channel (Kv), are 
therefore introduced here. 
 
1.4.2.1 Large conductance Ca
2+
-activated K
+
 channel 
 
Some studies have claimed that the activation of BK channel is neuroprotective. 
In an in vivo BK
-/-
 mouse model (homozygous mice lacking the BKα subunit), 
transient focal cerebral ischemia induced by middle cerebral artery occlusion 
produced larger infarct volume and higher post-ischemia mortality than the 
wild type counterpart, and NMDA-induced neurotoxicity was found to be 
larger than in the wild type counterpart when NMDA is injected intracerebrally 
(Liao et al., 2010). In an in vitro model of rat hippocampal tissue, electrically-
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induced glutamate release was reduced by a selective BK opener (Gribkoff et 
al., 2001). For the possible neuroprotective function of the BK channel, one 
review in 2006 has proposed that the activation of BK channel results in 
hyperpolarization of membrane potential which will close voltage-gated Ca
2+
 
channels, reduce Ca
2+
 entry and diminish Ca
2+
 (Burg et al., 2006). In addition 
to consideration at the cell membrane, one study on guinea pig ventricular cells 
has suggested that the activation of mitochondrial BK channels can cause 
mitochondrial K
+
 uptake, and that such an uptake can protect the heart against 
ischemic injury and infarction (Xu et al., 2002). 
 
In contrast, some other studies have highlighted the opposite effect of BK 
channel activation. The review mentioned above (Burg et al., 2006) has also 
pointed out that the activation of BK channels can enhance transmembrane K
+
 
efflux which can cause cell shrinkage, [Ca
2+
]i increase and finally cell 
apoptosis. One study on cardiomyocytes has claimed that the interference of 
the BK β1 subunit mRNA increases cardiomyocyte resistance to ischemia 
(Bautista et al., 2009). 
 
So whether BK channel activation is neuroprotective, or not, is still uncertain. 
Therefore, the BK channel is investigated in this Thesis to ascertain its role, if 
any. 
 
The BK is a channel with an α subunit and four similar or different β subunits. 
The α subunit is the main and essential part of BK and its silence would render 
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the whole channel nonfunctional. The expression of different β subunits is 
variable in different areas. β1 is primarily expressed in smooth muscle, hair 
cells, and some neurones, β2 is found in ovary and endocrine tissue, β3 is 
found in testis, and β4 is the most abundant β subunit in the brain. The BK 
channel with different β subunits may have different properties and processes 
different functions. (Orio et al., 2002). 
 
The topography of the BK channel is shown in Fig. 1.5. 
 
 
Fig. 1.5 BK α and β subunit topography (Orio et al., 2002). 
 
1.4.2.2 ATP-sensitive K
+
 channel 
 
Some previous studies have proposed that the activation of KATP channel can 
protect neurones. One in vivo study on the Kir6.2 knocked out mouse model 
has found that the neurones were severely damaged after focal cerebral 
ischemia induced by middle cerebral artery occlusion, whereas few injured 
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neurones were found in the wild type counterparts (Sun et al., 2006). Another 
study on a Kir6.2 mutant mouse model has also found that the activity of 
substantia nigra pars reticulate neurones, which plays an important role in the 
control of seizures, was enhanced during hypoxia, while the activity of the 
same neurones in normal mice was inactivated by the opening of the 
postsynaptic KATP channel (Yamada et al., 2001). Similar neuronal activity has 
been found in the normal mice when tolbutamide, which is a KATP channel 
blocker, was applied (Yamada and Inagaki, 2005). In addition, another study 
on rat hippocampal cells has found that diazoxide (a KATP opener) treatment of 
neurones reduces neuronal death from insults of Aβ25-35 or hypoxia induced by 
ferrous sulphate (FeSO4) (Goodman and Mattson, 1996). Also, data from mice 
administrated diazoxide has shown that the infarct volume in the brain under 
cerebral ischemia was reduced (Liu et al., 2002). 
 
In contrast, other studies have claimed the opposite. One study on mammalian 
central neurones has shown cell apoptosis induced by cromakalim, a KATP 
opener, in electron micrographs (Yu et al., 1997), and another study in rat 
hippocampal neurones has found that 5-hydroxydecanoate, a mitochondrial 
KATP blocker, can increase cell survival from glutamate or staurosporine insult 
(Liu et al., 2003). In addition to neurones, another study on rat preadipocytes 
has found that diazoxide can reduce the relative cell number, while the KATP 
channel blocker glibenclamide can increase cell number, in MTT assays (Wang 
et al., 2007). For a possible mechanism, it was believed that K
+
 efflux from 
mitochondria can cause mitochondrial membrane depolarization, cyt c release, 
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and induce subsequent extrusion of cytosolic K
+
 via a K
+
 channel on the cell 
membrane (Burg et al., 2006). 
 
Since it is still unclear what the role of KATP is in neuronal death, it is also 
investigated here in those cellular insult models introduced above (see Section 
1.3). 
 
A functional KATP channel is constructed from four inward rectifier (Kir) 
subunits and four sulphonylurea receptor (SUR) subunits (Burg et al., 2006). 
Although the ion-conducting structure of KATP channel exists in the Kir 
subunits (Ho et al., 1993), SUR subunits are also essential for KATP channel 
function, since SUR subunits represent the ATP binding area. There are several 
inward rectifier K
+
 channels found so far (Kir1 to Kir7), but only Kir6 is found 
to be ATP sensitive (Alexander et al., 2009), hence it is named the KATP 
channel. There are two subtypes of KATP channel, Kir6.1 and Kir6.2, and there 
are three different SUR thus far, SUR1, SUR2A and SUR2B (Alexander et al., 
2009). The proposed topography of the KATP channel is shown in Fig. 1.6. 
 
1.4.2.3 Voltage-gated K
+
 channel 
 
Besides the BK and KATP channels, attention has also been paid to voltage-
gated K
+
 channels in studies on neurodegeneration. One previous study has 
found that there are two missense mutations on the 19q13 gene which is the 
causative gene in a Filipino adult-onset ataxia pedigree and a French 
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Fig. 1.6 Membrane topography of Kir channel. “α” shows the pore-forming subunit, 
and “P” shows the area of the pore. (Burg et al., 2006) 
 
childhood-onset ataxia pedigree, and both of them can alter Kv3.3 channel 
(KCNC3) function (Waters et al., 2006). It has also been found that the Kv3.4 
(KCNC4) channel subunit is up-regulated in the early stages of AD (Angulo et 
al., 2004). 
 
The Kv channel is composed by homo- or hetero-tetramers of α subunits with 
regulatory β subunits. The pore is located in the α subunit which has six 
transmembrane domains (Burg et al., 2006). There are 12 subfamilies of Kv 
channel found so far (Alexander et al., 2009). This study concentrates on the 
two subtypes mentioned above, i.e. Kv3.3 and Kv3.4, which belong to the Kv3 
subfamily. The topography of the Kv channel is shown in Fig. 1.7. 
 
1.5 Models of Neurodegeneration 
 
To study neurodegenerative disease, different sorts of models have been used 
in previous research work, including in vivo animal models, animal tissue slice, 
primary cultures, cell lines and some other models such as bilayer or liposome 
to mimic the cell membrane. Some of these examples are discussed below.  
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Fig. 1.7 Kv channel topography. “P” shows the region of the pore and “V” shows the 
voltage sensor area. (Burg et al., 2006) 
 
1.5.1 In vivo animal models 
 
Animal models are widely used in the studies of neurodegeneration. A 
transgenic (KM670/671NL + V717F) mouse model was used to investigate the 
expression of RyRIII, Ca
2+
 signalling and K
+
 channel expression (Supnet et al., 
2006, Coles et al., 2008). APP transgenic mice (V717F or APPsw) have been 
used to investigate the deposition of Aβ and local toxicity in brain parenchyma 
and cerebral blood vessels (Holtzman, 2004). A YAC128 HD transgenic mouse 
model was employed to test the possible neuroprotective effect of dantrolene 
and improved performance in both beam-walking and gait-walking assays were 
observed (Chen et al., 2011). As introduced above, a BK
-/-
 mouse model with 
middle cerebral artery occlusion or NMDA-induced neurotoxicity treatment 
was used to study the BK channel function by measuring the infarct volume 
and post-ischemia mortality (Liao et al., 2010). Finally a Kir6.2 mutant mouse 
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model with middle cerebral artery occlusion and/or a hypoxia mimetic or 
tolbutamide treatment was used to check the neuronal damage or substantia 
nigra pars reticulate activity (Sun et al., 2006, Yamada et al., 2001, Yamada 
and Inagaki, 2005). 
 
1.5.2 Animal organs, tissues or primary cells 
 
Besides the in vivo experiments undertaken on animal models, in vitro models 
with animal organs or tissues are also widely used in previous studies. 
 
Mouse cortical tissue was used for PCR and western blot studies in an 
investigation of the function of cytosolic N-terminal of PS1 (Rybalchenko et al., 
2008). Cortical slices and neurones were used for a 2-photon Ca
2+
 imaging test 
to distinguish the IP3R- and RyR-mediated Ca
2+
 components (Stutzmann et al., 
2006b). 
 
Bullfrog sympathetic ganglion cells were used to test the role of RyR and BK 
channel in modulation of the action potential (Akita and Kuba, 2000). Primary 
cortical neurones from a triple transgenic mouse model of AD (PS1 mutant 
knock-in mouse with two additional transgenes, APPSWE and tauP301L) were 
selected to study the caffeine induced Ca
2+
 release from intracellular stores 
(Smith et al., 2005). Striatal medium spiny neurones from a YAC128 HD 
mouse model were used to investigate the intracellular Ca
2+
 release triggered 
by caffeine and glutamate (Chen et al., 2011). Finally, astrocytes from RyRIII 
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knock out mice were used to study the RyRIII function in astrocyte migration 
(Matyash et al., 2002). 
 
1.5.3 Cell lines 
 
Cell lines have also been used extensively to study cell death, dysfunction or 
dysregulation of [Ca
2+
]i. 
 
For example, SH-SY5Y is a human neuroblastoma cell line, and it has been 
used to study cell proliferation and the effects of insults such as CoCl2 and Aβ 
(Chong et al., 2007, Hunya et al., 2008). 
 
The NTERA-2 clone D1 (NTERA-2) is a cell line of human Caucasian 
pluripotent embryonal carcinoma. In previous studies, NTERA-2 has been used 
as a cell line to represent “genuine” human neurones, to test the glutamatergic 
regulation of APP (Jolly-Tornetta et al., 1998), to investigate the production of 
Aβ1-40/42 from APP by β-site APP cleaving enzyme (Lee et al., 2003), and to 
study the expression of the mutations in the presenilin (PS) 1 gene, PS1 being 
possibly the major cause of early onset familial AD (Tokuhiro et al., 1998). 
The inhibition and inducement of its proliferation has also been studied (Yao et 
al., 2007), and the properties of the BK channel in this cell line have also been 
studied (Chapman et al., 2007). 
 
MOG-G-UVW is a human brain astrocytoma cell line. Astrocytes were used to 
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study anti-inflammation function and their relevant role in neuronal protection 
(Spillantini, 2011). 
 
In addition to human cell lines, animal cell lines have been used in studies of 
neurodegeneration. For example, rat hippocampal neurones were used to study 
the Ca
2+
 release and sequestration by ryanodine-sensitive stores (Garaschuk et 
al., 1997). 
 
1.5.4 Other models 
 
Most studies previously were performed on either in vivo animal models or in 
vitro organs, isolated tissues, isolated cells or cell lines. Some research has 
utilised other models, such as electrophysiological work on bilayers or 
liposomes. One such study has recorded the activity of the Aβ channel in the 
bilayer (Jang et al., 2010). 
 
The work in the thesis is particularly concerned with neuronal death and 
possible neuroprotective targets in human cells. Therefore, human cell lines 
were preferred rather than in vivo animal models, although the latter sometimes 
can mimic the neurodegenerative disease better than cell lines. The cell lines 
used in this thesis are introduced in Section 2.2. 
 
1.6 Hypotheses 
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Based on previous studies, two hypotheses are proposed here and will be tested 
in the following studies: 
 
a. That there is a role for the RyR channel in paradigms that mimic 
neurodegeneration, and that the blockade of the RyR, especially the 
selective blockade of RyRIII, is neuroprotective. 
 
b. That there are K+ channels, such as the BK channel and KATP channel, 
which are functional in neuronal cell lines, and are involved in neuronal 
protection. 
 
The main objectives of the work presented here are 
 To determine whether there is expression of a RyR message and K+ 
channels in the model cell lines and to determine whether the 
expression of RyRIII message is changed during cell differentiation. 
 To establish a robust and relevant method of inducing cell death using 
oxidative stress, hypoxia, or Aβ. 
 To determine whether there is modified sensitivity to stressors during 
differentiation. 
 To determine whether there is any neuronal protective effect by 
blocking or otherwise modulating RyR, particularly the RyRIII; and 
 To assess whether K+ channel activation or blockade can protect or 
exacerbate respectively the effects of stressors. 
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2. Methods and Materials 
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2. Methods and Materials 
 
In this section, those general methods and materials which are used in many 
parts of this study are introduced. For more specific details, please refer to the 
relevant sections. 
 
2.1 Cell culture 
 
All cells are cultured in culture medium (relevant medium compositions will be 
described below) in 25 square centimetre (cm
2
) or 75 cm
2
 flasks (from Fisher 
Scientific) and incubated in a sterilised incubator (from Sanyo) at 37 centigrade 
(°C) with 5% of carbon dioxide (CO2). Sterilised copper sulphate 
(CuSO4·5H2O) water (H2O) solution was kept in the incubator to maintain the 
humidity and a sterilisation status, and, everything placed in the incubator was 
previously sterilised. Cells are checked under the microscope (Nikon TMS) 
every day, and the contaminated or dead cells (if any) removed from the 
incubator as soon as they were identified. Usually, 3 millilitres (mL) of 
medium was the culture volume in each 25 cm
2
 flask and 9 mL of medium was 
the volume in each 75 cm
2
 flask. The medium was changed every 3 – 4 days, 
or at any other time when the pH was considered too low (the colour of 
medium was turning orange or even yellow). When the cells in the flask were 
80% to 100% confluent, they were split or used for any further experiments 
such as ribonucleic acid (RNA) extraction or cell proliferation assays. Any 
experimental manoeuvres related to cell culture or living cells were performed 
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in a sterilised cabinet (Faster ultrasafe 48 model, from Bioquell) with sterilised 
tools. For sterilisation, all the plastics were autoclaved, all the metal or glass 
utensils were incubated in the oven (from Status) at 180 °C for at least 2 h, all 
the solutions were filtered through 0.2 micrometer (μm) filter membrane (from 
Corning), and all the other items were sprayed with 70% [volume to volume 
(v/v)] ethanol (C2H5OH). 
 
To split the cells in a 25 cm
2
 flask, the first step is to warm the medium, 
phosphate-buffered saline (PBS, pH = 7.4) and ethylenediaminetetraacetic acid 
[EDTA, (HOOCCH2)2NCH2CH2N(CH2COOH)2] / trypsin (0.2% / 0.025%, 
w/v, PBS solution, pH was adjusted to 7.4 – 7.6) in a water bath at 37°C for 
about 15 minutes (min) until the EDTA/trypsin has thawed. Then, the working 
area such as the cabinet (ventilated area) was sprayed and all objects which 
were going to be placed in this area were also sprayed with 70% C2H5OH to 
maintain sterile conditions. Following this, the medium was aspirated from the 
flask containing the cells and 1 mL of 1 × PBS was added into the flask to 
wash the cells. The solution in the flask was swirled to make sure all the cells 
were washed and then the PBS was aspirated from the flask. 500 micro litres 
(μL) of EDTA/trypsin was now added to the flask and the solution gently 
agitated in the flask to make sure every cell might detach, and then the flask 
was placed in the incubator for 3 – 5 min. After the incubation, the flask was 
tapped gently to make sure all the cells would detach, and the cells checked 
under the microscope to see if they were both round and floating. Then, 1 mL 
of culture medium was added to the flask to stop the digestion and the medium 
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containing the cells was thereafter transferred into a 1.5 mL centrifuge tube. It 
was centrifuged at 1,000 revs / minute (r/min) for 3 min (centrifuge is 545C 
model from Eppendorf). The supernatant was aspirated carefully without 
damaging the pellet of cells, and the pellet was resuspended in 1 mL of culture 
medium.  If cells are split from a confluent 75 cm
2
 flask, three times the 
volume of PBS, EDTA/trypsin and culture medium were applied. Then, the 
medium containing cells was split into several new flasks according to need. 
Finally, each new flask had medium made up to 3 mL, and was stored in the 
incubator. 
 
To keep a large stock of living cells, these were frozen at -80 °C (ultra low 
temperature freezer from New Brunswick Scientific) or liquid nitrogen (N2). 
To freeze the cells, a confluent 75 cm
2
 flask of healthy cells was taken and the 
above splitting protocol was followed, until the cell pellet was obtained and the 
supernatant was removed. Then, the cells were resuspended in 4.5 mL of 
freezing medium. Finally, the medium containing the cells was allocated into 9 
freezing tubes by placing 500 μL of the cell suspension into each tube. The 
composition of the freezing medium was foetal bovine serum (FBS) with 15% 
(v/v) of dimethyl sulfoxide (DMSO) and 100 u of penicillin-streptomycin 
mixture (P/S). The cells usually could be kept for roughly 1 month at -80 °C 
and would live for a longer period in the liquid N2 environment (< -196 °C). 
 
All the containers or facilities which were used for living cells were treated 
with Virkon before being discarded. All the pipettes, pipette tips (5 mL, 1 mL, 
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200 μL and 10 μL) and tubes (1.5 mL, 500 μL and 200 μL) used in this work 
are from Eppendorf. The water bath is 750 watt (W) from Grant. 
 
CuSO4·5H2O, C2H5OH and virkon are from Fisher Scientific. PBS (1 ×), P/S 
[10,000 units (u)] and FBS are from Invitrogen. EDTA, trypsin (from bovine 
pancreas), DMSO and sodium hydroxide (NaOH) are from Sigma-Aldrich. 
EDTA is dissolved in 1 mole (M) NaOH (a little 10 M NaOH could be applied 
to make the EDTA to be completely dissolved) as 20% (w/v) for stock. EDTA 
stock, trypsin, FBS, P/S and EDTA/trypsin mixture are stored at -20 °C 
(freezer is from Blomberg). PBS and medium are stored at 4 °C (fridge is from 
Blomberg). The DMSO is light sensitive. 
 
2.2 Cell lines 
 
The following human cell lines are used in this study. 
 
2.2.1 SH-SY5Y 
 
SH-SY5Y is a cell line derived from a human neuroblastoma. It responds to, 
and can be differentiated with retinoic acid (see Section 2.3). It is used here to 
test the existence of BK subunit and the avtivity of the BK channel, to test 
whether there is any change in RyRIII expression during differentiation, and it 
is also used to investigate the response to various insults (before and after 
differentiation), and to BK channel or RyR modulators. 
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The composition of the culture medium is minimum essential medium Eagles 
(EMEM) & nutrient mixture F12 ham (F12) (1 : 1, v/v) with 15% (v/v) of FBS, 
2 mM L-glutamine, 1 × of MEM non-essential amino acid solution (NEAA), 
and 100 u of P/S. The neuronal characteristics are lost with increasing passage 
number (Ross et al., 1983), hence only the SH-SY5Y cells with a passage 
number lower than 22 were used in this study. Thus, a large stock of SH-SY5Y 
cells with lower passage numbers were prepared and stored at either -80 °C or 
in liquid N2. 
 
2.2.2 NTERA-2 clone D1 
 
NTERA-2 clone D1 (NTERA-2) is a cell line of human Caucasian pluripotent 
embryonal carcinoma. It also responds to retinoic acid-induced differentiation 
(Andrews, 1984) (see Section 2.3). The NTERA-2 cell line is used here to test 
for changes in the RyRIII expression during differentiation, and to test its 
response to insults and the RyR modulator ruthenium red. The composition of 
the culture medium is Dulbeceo’s modified Eagle medium (DMEM) with 10% 
(v/v) of FBS and 100 u of P/S. 
 
2.2.3 MOG-G-UVW 
 
MOG-G-UVW is a human astrocytoma cell line. It is used in this thesis to see 
whether there is any K
+
 channel and/or RyRs expression at the mRNA level, 
and to test its response to insult models and BK and RyR modulators. The 
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composition for the culture medium was DMEM & nutrient mixture F10 ham 
(F10) (1 : 1, v/v) with 10% (v/v) of FBS and 100 u of P/S. 
 
2.2.4 N2102Ep clone 2/A6 
 
N2102Ep cell line is a human embryonal carcinoma. It does not response to 
retinoic acid-induced differentiation. So, in this study, the cell line N2102Ep 
was used as the negative control for NTERA-2 differentiation. The 
composition of the culture medium is DMEM with 10% (v/v) of FBS and 100 
u of P/S. 
 
2.2.5 MG-63 
 
MG-63 is a cell line from a human osteosarcoma. In this study, MG-63 cells 
served as a negative control for RyRIII expression. Since it is believed that the 
RyRIII is mainly expressed in brain neurones (see Section 1.2.2), MG63 has 
been used as a negative control to see whether RyRIII message is absent, or is 
at least present at a much lower level than the counterpart neurone. The 
composition of the MG-63 culture medium is DMEM with 5% (v/v) of FBS 
and 100 u of P/S. 
 
All the cells above are from Sigma-Aldrich. DMEM is from Invitrogen. 
EMEM, F10, F12 and NEAA (100 ×) are from Sigma-Aldrich. All the media, 
nutrient mixtures and NEAA were stored at 4 °C. L-glutamine (200 mM) is 
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from PAA Laboratories GmbH and is stored at -20 °C. 
 
2.3 Cell differentiation 
 
The differentiation of SH-SY5Y and NTERA-2 cells is induced by retinoic 
acid. The differentiation medium for each cell line is simply the relevant 
culture medium with 10 μM retinoic acid added. The differentiation period is 1 
week for SH-SY5Y cells (Jämsä et al., 2004), and is 4 weeks for NTERA-2 
cells (Andrews, 1984). Since N2102Ep cells were the negative control for 
NTERA-2 cells differentiation, N2102Ep cells were also treated with 10 μM 
retinoic acid for 4 weeks. 
 
Retinoic acid is light sensitive. Thus, minimum essential checking and medium 
changing was undertaken with cells during the differentiation period. Equally, 
splitting was avoided during the differentiation process. Retinoic acid is from 
Sigma-Aldrich. It was dissolved in DMSO at 10 mM as the stock, and was 
diluted to 10 μM in relevant medium in order to differentiate the cells. Retinoic 
acid stock was stored at -20 °C. The structure of retinoic acid is shown below: 
 
CH3
CH3
CH3
OH
CH3 CH3 O
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2.4 RNA extraction 
 
RNA was extracted from cells in a confluent 75 cm
2
 flask. The medium was 
aspirated and 3 mL of PBS was added to the flask to wash the cells. The PBS 
was then in turn aspirated, 2.5 mL of TRIzol reagent was added to the flask and 
spread over the entire surface to maximise the RNA return. After all the cells 
had detached from the bottom of the flask, the TRIzol solution containing RNA 
was transferred into two of 2 mL tubes by placing 1.25 mL of the TRIzol 
sample into each tube. Then, 250 μL of chloroform (CHCl3) was added into 
each tube, and the tubes were turned over a couple of times. Following this the 
tubes were centrifuged at 14,000 r/min for 10 min at room temperature. The 
pink bottom solution was the CHCl3 phase containing the organic contents 
from TRIzol but without any RNA, and the colourless supernatant was the 
aqueous phase containing the RNA. The colourless supernatant from each tube 
was then transferred into a 1.5 mL tube. 
 
The next step is RNA precipitation. 500 μL of isopropyl alcohol [(CH3)2CHOH] 
was added into each 1.5 mL tube and both tubes were incubated at room 
temperature for about 10 min. Then, the tubes were once again centrifuged at 
14,000 r/min for 10 min at room temperature, whereupon the RNA should form 
visible pellets in the bottom of the tubes. The supernatant was then removed 
carefully without any damage to the RNA pellets, and 500 μL of C2H5OH 
(75%, v/v) was added to each tube. The mixture was vortexed and centrifuged 
at 14,000 r/min at room temperature for 5 min, then, the supernatant was 
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removed carefully again and the tubes were left open at room temperature for 
the remaining C2H5OH to evaporate. Attention should be paid here to prevent 
the samples completely drying out. Finally, 25 μL of nuclease free H2O was 
added to each tube, and the tubes were stored at -80 °C overnight for the RNA 
sample to be rehydrated. All of the above steps were carried in a fume 
cupboard except when washing the cells with PBS and centrifuging. 
 
The third step is the DNAse treatment. This step removes the remaining 
deoxyribonucleic acid (DNA) (Szewczyk et al.) in the RNA sample. The RNA 
sample from both tubes was removed from the -80 °C freezer and combined in 
a 500 μL tube. 5 μL of 10 × DNAseI buffer and 1 μL of rDNAse 1 were added 
to the 50 μL RNA sample. The mixture was then incubated in a thermal cycler 
at 37 °C for 30 min. Following that, 5 μL of DNAse inactivation reagent is 
added to the mixture after a strong vortex. Thereafter, the mixture was 
incubated at room temperature for 2 min and vortexed after each minute. 
Finally, the tube was centrifuged at 10,000 r/min for 2 min at room temperature. 
The RNA sample needed was contained in the supernatant, thus the supernatant 
was transferred into a 200 μL tube for storage. All the reagents were kept in ice 
until required in this step. 
 
The last step is RNA quantification. The RNA sample was diluted 50 times by 
placing 2 μL of it in 98 μL of nuclease free H2O. The concentration of diluted 
RNA sample was then measured with a spectrophotometer, with H2O being the 
blank. Finally, two results were obtained. One was the ratio of absorbance 
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between 260 nano metre (nm) and 280 nm, which represents the level of 
protein contamination. The ratio should be higher than 1.5 for a successful 
RNA extraction. The other reading obtained is the concentration of RNA (w/v) 
in the 50 times diluted sample. It was used to estimate the RNA concentration 
in the original stock, which should be 50 times higher. After preparation, the 
RNA was stored at -80 °C. 
 
TRIzol is from Invitrogen and is stored at 4 °C. CHCl3 and nuclease free H2O 
are from Sigma-Aldrich. (CH3)2CHOH is from Fisher Scientific. The DNAse 
treatment kit (DNAseI buffer, rDNAse 1 and DNAse inactivation reagent) is 
from Ambion and was stored at -20 °C. The PCR workstation (fume cupboard) 
is from Labcaire. The vortex is from Rotamixer. 
 
2.5 Reverse transcription 
 
Reverse transcription (RT) was carried out for those qualifying RNA samples 
in order to prepare the cDNA for future polymerase chain reaction (PCR) or 
quantitative PCR (Q-PCR). To make sure that the PCR or Q-PCR result is 
comparable, the same amount of RNA sample was added in each reaction of 
reverse transcription. Additionally, to test the purity of RNA and to see 
whether there is any possible DNA contamination, a counterpart of no-RT was 
performed for each reaction as a negative control. There was no reverse 
transcriptase, the essential enzyme to transcript the mRNA into cDNA, in the 
no-RT control, and that was essentially the only difference between the no-RT 
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control and the normal reverse transcription reaction mixture. The details of the 
reverse transcription protocol are given below: 
 
Firstly, the same reaction mixtures were prepared in two of 500 μL tubes with 
the following reagents: 
 
Table 2.1 Reagents of RNA mixture 
Reagents Amount to add 
Nuclease free H2O Up to 5.0 μL 
Relevant RNA sample 1 micro gram (μg) 
Random primers (500 μg/mL) 1.0 μL 
 
After preparing the RNA mixtures, they were incubated at 70 °C for 5 min. 
Then, they were chilled in ice immediately for at least 5 min after incubation. 
Thereafter, the following mixtures were prepared for reverse transcription in 
another two 500 μL tubes. 
 
Table 2.2 Reaction mixture for reverse transcription 
Reagents 
Volume to add (μL) 
No-RT Sample 
Nuclease free H2O 7.1 6.1 
RNA mixture 5.0 5.0 
Reaction buffer (5 ×) 4.0 4.0 
Magnesium (II) chloride (MgCl2, 25 mM) 2.4 2.4 
dNTP mix (10 mM each) 1.0 1.0 
Reverse transcriptase - 1.0 
rRNAsin, RNAse inhibitor (40 u/μL) 0.5 0.5 
 
After both the no-RT control and the sample were prepared, they were 
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incubated in a thermocycler (from Perkin Elmer Catus) following the 
programme: 25 °C × 5 min + 42 °C × 1 h + 70 °C × 15 min. The no-RT and 
cDNA products were then stored at -20 °C. 
 
The reverse transcription kit (reaction buffer, MgCl2, dNTPs, reverse 
transcriptase, random primer and RNAsin) and dNTP mix were from Promega 
and were stored at -20 °C. The centrifuge is from MSE Micro Centaur. 
 
2.6 Primer design 
 
As soon as the cDNA was prepared, PCR was performed with relevant primers. 
Before the PCR protocol is introduced below (see Section 2.7), how the 
primers were designed in this study is discussed here. 
 
The appropriate primers should be ideally located in different exons of the 
whole DNA sequence, should contain about 40% of adenine (A) or thymine (T) 
and about 60% of cytosine (C) or guanine (G), and should not match each other 
closely which may result in primer-dimer formation. In this project, the primers 
were designed online on the webpage of Primer III. 
 
Firstly, the whole mRNA sequences of the relevant targets were searched in 
PubMed (http://www.ncbi.nlm.nih.gov/pubmed). The sequences were also 
double checked with blast on PubMed (http://blast.ncbi.nlm.nih.gov/blast.cgi) 
to see whether the mRNA sequences were exactly what were required. The 
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confirmed whole mRNA sequence was then copied and pasted into the website 
of Primer III (http://frodo.wi.mit.edu/primer3). Then certain requirements were 
set for the primer design. In this project, primer size was set around 20 base 
pairs (bp), the annealing temperature was set between 55 °C and 60 °C, and the 
percentage of C and G (GC%) was set at about 60% as mentioned before. The 
primer design programme was run and the suggested primers were listed in 
order of how they match the criteria set. The pair of primers with highest 
priority was selected and examined once more with blast to see whether they 
matched perfectly the sequence to be amplified. The required similarity was set 
as higher than 80% in this work. Finally, the pair of primers was examined on 
the website of Ensembl (http://www.ensembl.org) to see whether they were 
actually located in different exons. 
 
Primers are from Invitrogen. Primers were dissolved in TE buffer (Tris base 
and EDTA, pH = 8.0) at 100 μM for stock and were diluted to 10 μM in 
nuclease free H2O for PCR. Primers were stored at -20 °C. Tris-base [Tris 
(hydroxymethyl) aminomethane, C4H11NO3] is from Fisher Scientific. 
 
2.7 PCR 
 
PCR was used to amplify a certain DNA sequence with the cDNA product 
gained from the reverse transcription reaction. If the target DNA can be 
successfully amplified, it means that there is the relevant message in the 
original mRNA derived from the RNA extraction, and this means in turn that 
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there is the relevant message in the donor cells. 
 
In each PCR reaction, there was always a negative and a positive control. The 
positive control was the amplification of a house keeping gene on the cDNA. 
The purpose of the positive control was a guarantee that all the reagents 
including the cDNA and the PCR conditions were of good quality. In this 
project, β-actin, which is a house keeping gene and expressed in almost all cell 
lines, was selected as a positive control. The negative control was the 
amplification of the house keeping gene in the no-RT sample (see Section 2.5). 
Since no-RT generates no cDNA, this should not respond to any PCR 
amplification, and the PCR result of the negative control should yield no band. 
The purpose of the negative control was a guarantee that all the reagents 
including the cDNA were still purified without any genomic DNA 
contamination. For each PCR reaction, the following mixture (see Table 2.3) 
was prepared in 200 μL tubes. 
 
As soon as the PCR mixtures were prepared, the tubes were placed in the PCR 
thermocycler (from Biometra) and the following PCR amplification 
programme was run: 95 °C × 2min + [95 °C × 30 seconds (s) + annealing 
temperature × 45 s + 72 °C × 1 min] × 30 to 50 cycles + 72 °C × 5 min. The 
annealing temperature and the number of cycles were determined according to 
different target DNA and different primers. A higher annealing temperature 
and/or a larger number of cycles would result in a stronger reaction but less 
specific amplification. The volume of MgCl2 was also optimised. Higher Mg
2+
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concentration would cause a stronger reaction but again less specific 
amplification. These details were optimised in a PCR condition optimisation 
step. The details for PCR condition optimisation is discussed later (see PCR 
condition optimization in Section 3.2.1). The PCR results and products were 
examined using gel electrophoresis (see Section 2.9). 
 
Table 2.3 Reaction mixture for PCR amplification 
Reagents 
Volume to add (μL) 
Negative 
control 
Positive 
control 
Sample 
Nuclease free H2O Up to 12.5 Up to 12.5 Up to 12.5 
Green Go Taq flexi buffer 2.5 2.5 2.5 
MgCl2 (25 mM) 0.25 – 2 0.25 – 2 0.25 – 2 
β-actin primer forward (10 μM) 0.5 0.5 - 
β-actin primer reverse (10 μM) 0.5 0.5 - 
Target primer forward (10 μM) - - 0.5 
Target primer reverse (10 μM) - - 0.5 
No-RT 0.5 - - 
cDNA - 0.5 0.5 
dNTP mix (10 mM each) 0.25 0.25 0.25 
Go Taq DNA polymerase (5 u/μL) 0.0625 0.0625 0.0625 
 
In this thesis, PCR was also performed to amplify a large quantity of those 
target DNA fragments which were already known to exist. The large quantity 
amplification was performed to get a large amount of target DNA fragment for 
sequencing or for Q-PCR. For the large quantity amplification, 4 times the 
volume of each reagent was used for each reaction. 
 
The PCR kit (Green Go Taq flexi buffer, MgCl2 and Go Taq DNA polymerase) 
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is from Promega and is stored at -20 °C. 
 
2.8 Gel electrophoresis 
 
In this project, electrophoresis was used to examine the results of PCR 
amplification, or to separate the large amount of target DNA fragment. 
 
The gel used in this project was 10 milligrams per milliliter (mg/mL) of 
agarose. To prepare a gel, 700 milligrams (mg) [balance: maximum = 400 
grams (g), d = 0.1 g, AND HL-400 model, from Sartorius] of agarose was 
mixed within 70 mL of 1 × TAE buffer in a 100 mL conical flask. 1 × TAE 
buffer is a water solution of 40 mM Tris [(HOCH2)3CNH2] base, 20 mM acetic 
acid (CH3COOH) and 1 mM EDTA. The agarose was not soluble in TAE at 
room temperature, hence, the mixture was heated to boiling with a microwave 
(800 W, E, from LG) and swirled a few times, until the agarose was completely 
dissolved and the mixture was transparent and clear. Then, the flask containing 
boiled agarose solution was cooled down in tap water to about 60 °C before 2.1 
μL of ethidium bromide (EB, 0.003%, v/v) was added. The boiled agarose 
solution containing EB was then poured into an electrophoresis tank which was 
sealed on all four sides. The relevant comb (10 μL one for the testing the 
purified DNA, 20 μL one for normal PCR and 50 μL one for the large amount 
amplification) was loaded on the gel and any visible bubble was removed. The 
comb should go deep into the gel but should not break through it. 
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When the gel was completely cooled, it was solid. The comb was then removed 
gently without damaging the wells on the gel, and the gel placed in the 
electrophoresis tank where the wells were close to the negative electrode. The 
ladder (hyperladder II for 50 – 2,000 bp) and the samples were then added into 
each well respectively. For the 10 μL or 20 μL wells, 5 μL of ladder and 10 μL 
of each sample were added. For the 50 μL wells, 10 μL of ladder and 50 μL of 
each sample were added. Finally, the electrophoresis was run at 100 millvolt 
(mV) for 50 min. 
 
For normal PCR, a photo was taken on the gel in ultraviolet (UV) light. Ideally 
there should be no band for the negative control, and only one band for the 
positive control. Usually, there should be only one band also for the sample 
DNA fragment and the size of it was estimated by comparing it with the ladder. 
If there was more than one band present, the PCR condition was further 
optimised or another pair of primers used. 
 
For the large quantity amplification, the gel was moved onto a UV light to see 
whether the two controls were clean and clear, and to see whether the size of 
target DNA had a correct size of base pairs by comparing the band position 
against the ladder. If the amplification result was acceptable, the band of target 
DNA was cut off and stored in 500 μL tube for DNA purification and future 
sequencing or Q-PCR. 
 
Agarose [gelation temperature 32 – 40 °C and gel strength > 950 gram per 
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square centimetre (g/cm
2
)] and CH3COOH are from Fisher Scientific. EB (10 
mg/mL) was from Bio-Rad and is light sensitive. 
 
2.9 Gel purification 
 
The purified DNA fragment was needed for sequencing and for possible Q-
PCR. In this work, the purpose of the gel purification was to get a high 
concentration of purified target DNA fragment and it was performed after the 
gel slice had been cut from the large quantity PCR amplification. The gel 
extraction kit from Qiagen was applied and the relevant “MinElute gel 
extraction kit protocol” was adopted in this project. 
 
The first step was to dissolve the gel slice. The gel slice was cut under UV light 
with a scalpel which had been sterilised with C2H5OH (70%, v/v). As much as 
possible of the part of gel slice which did not contain DNA and was not bright 
under UV light was removed, but the entire DNA band was left in the cut gel 
slice. The gel slice was weighed and dissolved in 3 volumes [volume to weight 
(v/w)] of buffer QG. Here, 3 volumes means 3 μL for a 1 mg gel slice. Then, 
the mixture was incubated at 50 °C for 10 min or until the gel slice was 
dissolved completely. To help dissolve the gel slice, the tube was vortexed 
every 2 – 3 min during the incubation. When the gel slice was dissolved 
completely, the pH of the solution was checked for its colour. It should be 
yellow like the colour of buffer QG without dissolved agarose. If it was orange 
or violet, up to 10 μL of sodium acetate (CH3COONa) (pH was adjusted to 5.0 
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with CH3COOH) was added to turn the colour yellow. The reason to adjust the 
pH was that the absorption of DNA to the membrane of MinElute column was 
efficient only at pH ≤ 7.5. After that, 1 volume of (CH3)2CHOH was added to 
the solution, and the tube was swirled for a few seconds. Then, the sample was 
transferred into a MinElute spin column which was placed in a 2 mL collection 
tube. Thereafter, the tube containing the column was centrifuged at 13,000 
r/min for 1 min, and the flow-through was discarded. The column was placed 
back into the same collection tube and 500 μL of Buffer QG was added again 
into the spin column. The collection tube containing the spin column was 
centrifuged for 1 min at 13,000 r/min again and the flow-through was 
discarded as well. Finally, the spin column was placed back into the same 
collection tube again. 
 
The following washing procedure step was adopted. 750 μL of buffer PE was 
added into the column and the sample was incubated at room temperature for 5 
min. Then the tube containing the column was centrifuged at 13,000 r/min for 
1 min and the flow-through was discarded. Following that, the spin column 
was placed back into the same collection tube and the tube was centrifuged for 
1 min at 13,000 r/min once again to remove all the buffers. The flow-through 
was then discarded. 
 
The last step was required to elute the DNA. The MinElute spin column was 
transferred into a 1.5 mL tube and 10 μL of buffer EB with C2H5OH was added 
to the centre of the membrane in the spin column. The tube containing the 
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column was incubated at room temperature for 1 min and centrifuged at 13,000 
r/min for 1 min thereafter. The flow-through in the 1.5 mL tube was the 
purified DNA and it was stored at -20 °C. 
 
The purity and quality of the purified DNA was tested with electrophoresis. 3 
μL of the DNA sample was mixed with 1 μL of DNA loading buffer, and the 4 
μL of mixture was run through a gel electrophoresis process as mentioned 
above. If the band was visible, clear and specific under the UV light, the purity 
and quality of the purified DNA was deemed acceptable for future sequencing 
or Q-PCR. 
 
Gel purification kit (buffer QG, PE and EB) was from Qiagen. The scalpel was 
from Swann-Morton. 
 
2.10 Sequencing 
 
Sequencing was used to confirm that the DNA fragment which had been 
amplified by PCR was exactly the one expected. Although the sample is a 
purified DNA fragment, it was still necessary to further amplify it for 
sequencing purposes. To prepare for the PCR amplification, the mixture with 
the following composition (see Table 2.4) was prepared in a 500 μL tube: 
 
Since the highest temperature during the amplification was 96 °C, the purpose 
of adding mineral oil was to avoid any water evaporation during amplification. 
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The volume needed for the purified DNA sample was dependent on its 
concentration. The higher its concentration, the less volume was needed, and 
the volume of H2O was up to the volume used for the purified DNA sample. 
The primers here should be the ones which have been used in previous PCR, 
but either the forward or reverse one can be used in sequencing. 
 
Table 2.4 DNA amplification composition for sequencing 
Reagents Volume to add (μL) 
Mineral oil 40.0 
Nuclease free H2O Up to 50, (~ 3.2) 
Purified DNA fragment ~ 3.0 
Sequencing buffer 1.0 
Primer (4 μM) 0.8 
R R Premix (Big dye) 2.0 
 
After the mixture was prepared, the tube was placed in the thermocycler which 
had been preheated to 96 °C. Then, the following programme was performed: 
96 °C × 2 min + (96 °C × 30 s + 50 °C × 15 s + 60 °C × 4 min) × 25 cycles. 
 
After the amplification programme was finished, all the contents in the tube 
were transferred on a piece of parafilm (from American National Can
TM
). The 
reaction mix, which was the aqueous part, should stay as a bubble distinct from 
the mineral oil, hence, the reaction can be removed from the oil and transferred 
into another 500 μL tube containing 50 μL of 95% (v/v) C2H5OH and 2 μL of 
CH3COONa (pH was adjusted to 4.6 with CH3COOH). The tube was then 
vortexed and incubated at room temperature for 15 min. Following that, it was 
centrifuged at full speed (15,000 r/min) for 20 min and the supernatant which 
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did not contain DNA was carefully aspirated. The pellet might be very small 
and even almost invisible. In such circumstances, a little volume of supernatant 
was left in the tube to avoid any possible damage to the pellet. Subsequently, 
the pellet was washed with 250 μL of 70% C2H5OH, vortexed and centrifuged 
at the same speed again for another 5 min, and the supernatant was discarded in 
the same way. Thereafter, the pellet was rinsed again with another 250 μL of 
70% C2H5OH, and was vortexed and centrifuged at the same speed for 5 min. 
Most of the supernatant was then removed but about 10 μL of it was left at the 
bottom of the tube to cover the pellet. Finally, the sample was sent to the 
sequencing lab to obtain the sequence. This final step was done by the 
sequencing lab in Central Biotechnology Services, School of Medicine, Cardiff 
University. 
 
Since the R R Premix (a dye to make DNA base testable) is light sensitive, the 
R R Premix and any mixture containing it should be covered with foil when 
they were not in the thermocycler or centrifuge. R R Premix was a gift given 
by Dr. Bronwen Evans in School of Medicine, Cardiff University. 
 
CH3COONa buffer was 3 M CH3COONa with pH being adjusted to 4.6 – 5.0 
with CH3COOH. The pH meter was a pH211 model microprocessor pH meter 
and is from Hanna Instruments. Aluminium foil was from Hygex. 
 
2.11 Cell proliferation and assays 
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Cell proliferation was carried out in 96 well plates (from Corning) in the cell 
insult experiments and in studies to test the effect of channel modulators. To 
evaluate the relative cell numbers, MTS assays were used since the reagent can 
combine with the enzyme from living cells and causes absorbance at 490 nm. 
MTS is 3-(4,5-dimethythiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt. The absorbance is proportional to the 
cell number, and so the relative cell number to control reflects, in effect, the 
cell viability in the presence of treatment. 
 
MTS is bioreduced by cells into a formazan product that is soluble in tissue 
culture medium. The conversion of MTS into aqueous, soluble formazan is 
accomplished by dehydrogenase enzymes found in metabolically active cells. 
The quantity of formazan product as measured by the amount of 490 nm 
absorbance is directly proportional to the number of living cells in culture. 
(Barltrop et al., 1991) 
 
Cells were taken out from a flask with EDTA/trypsin (see Section 2.1) and 
seeded in the 96 well plate at a density of 15,000 per well in 100 μL per well of 
relevant culture medium without any drug treatment. After the cells were 
incubated at 37 °C overnight, the medium was aspirated and 100 μL of any 
insult medium, with or without testing drugs was added into each relevant well. 
The insult medium was the culture medium for the relevant cells without FBS. 
Since FBS is essential in cell proliferation, the cells cannot proliferate without 
FBS. Thus, any reduction on cell number here means that the drug tested is 
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killing cells rather than the drug slows down the cell proliferation process. The 
cell sample treated with the insult medium without any test drugs was the 
control and the relative cell number was set as 1. Then the cells were incubated 
at 37 °C for 24 h before 20 μL of MTS & phenazine methosulfate (PMS) (20 : 
1, v/v) mixture was added into each well. The plates were then incubated at 
37 °C for another 2 – 4 hours and the absorbance was read at 490 nm (laser 
plate reader is Sunrise Touchscreen model, from Tecan). 
 
In each experiment there were blank wells prepared for each sample. The blank 
wells were the wells with the same solution mix but with no cells present. The 
absorbance of the blank was subtracted from the absorbance of each relevant 
sample for data analysis. The net absorbance (where the absorbance of the 
relevant blank was subtracted) of each sample was thereafter compared with 
that of control, where the relative cell number was set at 1, and the final ratio 
was the relative cell number of each sample. 
 
Each experiment was repeated in triplicate at least for statistical purposes. For 
the comparison between 2 groups, a t test was performed; and for the 
comparison amongst 3 or more groups, one way analysis of variance (ANOVA) 
with post-hoc test was performed. The confidence interval was set at p < 0.05. 
 
The Cell Titer 96
®
 Aqueous MTS Reagent Powder was from Promega. MTS 
powder is dissolved in PBS as 2 mg/mL. The pH of the MTS solution was 
adjusted to 6.0 – 6.5 and MTS solution was filtered for sterilization. PMS was 
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from Sigma. PMS powder is dissolved in PBS. Both MTS and PMS are light 
sensitive. They were covered with foil and stored at -20 °C. 
 
2.12 Electrophysiology 
 
For the single channel patch clamp recording, about 2,000 cells were seeded on 
the cover slips [diameter = 26 millimetre (mm), from Fisher Scientific] within 
100 µL of culture medium. The cover slips were placed in a 12 well plate 
(from Corning) with 1 cover slip in each well. The plate with cover slips 
containing cells was incubated at 37 ºC for at least 4 h for the cells to be 
completely seeded on the cover slips. Thereafter, 1 mL of culture medium was 
added into each well containing cover slip, and the plate was placed in the 
incubator until ready to be used. 
 
For patching, the cover slip containing cells was removed from the plate and as 
much medium on the cover slip removed as possible. Then, the cover slip was 
fixed in a chamber, topped up with reference buffer, and placed on the 
microscope stage (from Nikon) with 40 × as the objective. The reference 
electrode was filled with the same solution as the bath solution, and the 
recording electrodes were prepared from borosilicate glass capillaries (1.5 mm 
outside diameter and 0.86 mm inside diameter, from Harvard Apparatus) using 
a microelectrode puller (DMZ universal puller from Zeitz-Instruments GmbH) 
and were filled with a relevant patching solution. To prepare the electrode, one 
capillary is pulled and heat-polished to two equal length parts and the outside 
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diameter at the tip is about 1 micrometre (μm). For the patch-clamp recording 
here, sodium (Na
+
) Locke was used as the bath solution and the filling solution 
for the reference electrode, and a high K
+
 solution filled the recording electrode. 
 
A cell with a clean membrane and separated from other cells was selected for 
patching, then the recording electrode was moved into the bath solution. A 
square wave voltage signal was obvious on the oscilloscope screen (OX 722 
model from Metrix) when the recording electrode is in the reference solution. 
Positive pressure was applied as soon as the recording electrode has contacted 
the bath buffer. Then, the recording electrode was advanced gently and slowly 
with a manipulator (from Narishige) until it touched the cell membrane. 
Attention should be paid to this step since the tip of recording electrode is 
extremely easy to break if it touches the cover slip. When the electrode touches 
the cell membrane, the resistance increased and the voltage signal reduced 
correspondingly on the oscilloscope screen. As soon as the recording electrode 
touched the cell membrane, negative pressure was applied to achieve a seal 
with high resistance (giga ohm, GΩ). 
 
Three different configurations of recording were used: cell attached, inside-out, 
and outside-out cell recording. In this project, cell attached was adopted first as 
soon as a good seal was achieved. For a cell attached patching, the electrode is 
attached to the membrane with minimum disturbance to the cell. Any electrical 
current recorded was due to the movement of the ions through the ion channel 
in the “isolated” patch of cell membrane under the pipette. A range of voltages 
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were applied to record the current, and compute the conductance, opening 
probability etc. of channels in the patch. 
 
In addition to cell attached recording, inside-out recording was also performed. 
Hence, the patch of membrane under the electrode was pulled away and 
removed from the rest of the cell membrane. The inside part of the cell 
membrane was then facing the reference solution in the bath. A range of 
voltages was once again applied to record the current, compute the 
conductance, opening probability and so on, from the channel in this 
configuration. 
 
Current data were acquired at different voltages. To acquire the data, a current-
voltage (I-V) converting amplifier headstage (CV 4, from Axon Instruments) 
was fixed on the manipulator holding the recording electrode, and was 
connected to an amplifier. The output signals were amplified by an Axopatch -
1D amplifier and AC-DC AMP (from Axon Instruments and NeuroLog System, 
Digitimer respectively), and then digitised (BNC2110 from National 
Instruments). Then, the data obtained were analysed using WinEDR software 
and two plots were constructed principally to characterise the features of the 
channel being patched. One was the I-V curve, and the slope of the linear 
portion of any trend line gives the conductance, which is an important hallmark 
of any channel. The other plot was the open probability – voltage curve, which 
illustrates whether the opening of the channel is voltage dependent or not. 
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2.13 Drugs solutions 
 
DMEM, EMEM, F10, F12, NEAA and all media were stored at 4 °C, and FBS, 
glutamine, P/S and retinoic acid stock were stored at -20 °C. Retinoic acid is 
light sensitive and was dissolved in DMSO at 10 mM for stock. The 
compositions of media for cell freezing and culture are listed here (see Table 
2.5) 
 
Primers were dissolved in TE buffer at 100 μM for stock and were diluted to 
10 μM in H2O for PCR. Primers were stored at -20 °C. Agarose was dissolved 
in TAE (1×) buffer for electrophoresis. TAE (50 ×) buffer was prepared for 
stock, and was diluted to 1 × in H2O until use. The compositions of TE and 
TAE (50 ×) buffer are listed in Table 2.6. 
 
Table 2.5 Compositions of media (v/v) 
 DMEM DMSO EMEM F10 F12 FBS 
Glutamine 
(200 mM) 
NEAA 
(100 
×) 
P/S 
(10,000 
u) 
Retinoic 
acid (10 
mM) 
Freezing - 15% - - - 84% - - 1% - 
MG-63 94% - - - - 5% - - 1% - 
MOG-G-
UVW 
44.5% - - 44.5% - 10% - - 1% - 
N2102Ep 89% - - - - 10% - - 1% - 
NTERA-2 89% - - - - 10% - - 1% - 
NTERA-2 
differentiation 
88.9% - - - - 10% - - 1% 0.1% 
SH-SY5Y - - 41% - 41% 15% 1% 1% 1% - 
SH-SY5Y 
differentiation 
- - 40.95% - 40.95% 15% 1% 1% 1% 0.1% 
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Table 2.6 Compositions of TE and TAE (50 ×) buffer 
Chemicals TE buffer TAE (50 ×) buffer 
Tris base - 2 M 
Tris hydrogen acid (HCl) 10 mM - 
EDTA 1 mM 50 mM 
CH3COOH - 1 M 
pH  8.0 - 
 
The compositions of Na
+
 Locke and high K
+
 solution for patch-clamp 
recording are listed in Table 2.7. 
 
Table 2.7 Compositions of Na
+
 Locke and high K
+
 solution 
Contents 
Na
+
 Locke (for 
reference) 
High K
+
 solution (for 
recording) 
sodium chloride (NaCl) 150 mM 10 mM 
potassium chloride (KCl) 3 mM 140 mM 
EGTA - 11 mM 
HEPES 10 mM 10 mM 
D-Glucose 10 mM - 
CaCl2 2 mM 1 mM 
MgCl2 2 mM 1 mM 
pH 7.4 7.2 
 
Calcium chloride dehydrate (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), 
NaCl and KCl are from Fisher Scientific, and D-(+)-glucose (C6H12O6), EGTA 
and HEPES (C8H18N2O4S) are from Sigma-Aldrich. 
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3. RyR Expression Determined by PCR and Quantitative PCR 
 
3.1 Introduction 
 
Since previous studies have suggested that RyRIII is the brain type RyR and 
therefore mainly located in the brain and neuronal cells (Furuichi et al., 1994, 
Hakamata et al., 1992), the PCR work in this thesis was undertaken to test the 
presence of the relevant mRNA in the selected neuronal cell model. 
Furthermore, since two of the above cell lines can be differentiated to human 
neurones, Q-PCR was performed to see what the change, if any, in mRNA 
levels is during differentiation. 
 
PCR for RyRs has been carried out previously (Hosoi et al., 2001, Shoshan-
Barmatz et al., 2005, Grievink and Stowell, 2008) and these data have provided 
a starting point for the studies described here. Most of those previous PCR 
experiments have used primers which require annealing temperatures at 54 – 
62 centigrade (°C) for 30 – 40 cycles. Some have used a decreasing annealing 
temperature (Burgos et al., 2005, Hosoi et al., 2001, Shoshan-Barmatz et al., 
2005, Grievink and Stowell, 2008). The extension temperature was different in 
those experiments: 68 °C has been used in some, whereas 72 °C was used in 
the others. 
 
3.2 Materials and methods 
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NTERA-2 and SH-SY5Y cells were differentiated with 10 μM retinoic acid 
treatment for 28 days or 7 days respectively (see Section 2.3). PCR 
amplification of RyRs was performed on the following cell lines: 
undifferentiated SH-SY5Y, differentiated SH-SY5Y, undifferentiated NTERA-
2, differentiated NTERA-2, MOG-G-UVW, N2102Ep and MG-63. The lengths 
of PCR products, the three isoforms of RyR, are based on the primers designed 
and are between 200 bp and 300 bp in this study (see Section 3.3.2). Since the 
main target in this thesis is RyRIII, some of the experiments, such as the 
optimisation of PCR condition and Q-PCR, focused on RyRIII. 
 
3.2.1 Optimisation of PCR conditions 
 
As discussed before (see Section 2.7), the annealing temperature, number of 
cycles and Mg
2+
 concentration ([Mg
2+
]) dictate the quality of PCR and should 
therefore be optimised. Higher annealing temperature, more PCR cycles and 
higher [Mg
2+
] result in a stronger activity but a less specific amplification. So, 
all of these 3 issues have been considered, and optimised for the PCR. In the 
study here, only the PCR condition for RyR amplification was optimised, the 
ones for BK, Kv or KATP channels were following the optimised conditions 
from previous studies in this laboratory (Henney, 2008, Reviriego, 2009, 
Henney et al., 2009). The way to optimise the PCR condition, in this project, 
was to run the PCR and electrophoresis under different conditions and select 
the best one which gives a specific and clear band. 
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The annealing temperature was varied between 55 °C and 60 °C and the [Mg
2+
] 
was varied between 0.75 mM and 1.5 mM for PCR optimisation. These PCRs 
were run with cDNA from N2102Ep cells. The details of the PCR conditions 
which have been trialed are listed below: 
 
Table 3.1 PCR condition optimisation 
Tests 
Factors and levels 
Annealing temperature (°C) Number of cycles [Mg
2+
] (mM) 
1 55 30 1.5 
2 55 40 1.5 
3 55 50 1.5 
4 58 30 0.75 
5 58 30 1.0 
6 58 30 1.25 
7 58 30 1.5 
8 58 40 1.5 
9 60 30 1.5 
 
3.2.2 Q-PCR 
 
Q-PCR is a technique to test the DNA concentration based on the fluorescence, 
and the result can quantitatively reflect the expression of the target DNA. In 
theory, it is to be expected that the DNA amount should double after each cycle 
of PCR. Hence, the principle of Q-PCR is testing the number of cycles needed 
for the amount of target DNA to be amplified to a set amount, and the number 
of cycles needed is defined as the Ct value. The more cycles needed, if the 
efficiency is always the same, the smaller amount of target DNA in the sample, 
and the lower mRNA expression in the original cell line. 
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For the fluorescence, SYBR green was used here and it was contained in the 
SuperMix in the Q-PCR kit. The SuperMix contains Platinum
®
 Taq DNA 
polymerase, SYBR
®
 green I dye, Tris-HCl, KCl, MgCl2 (6mM), 
deoxyguanosine triphosphate (dGTP, 400 μM), deoxyadenosine triphosphate 
(dATP, 400 μM), deoxycytidine triphosphate (dCTP, 400 μM), deoxyuridine 
triphosphate (dUTP, 800 μM), uracil DNA glycosylase (UDG), and stabilizers. 
The composition for the Q-PCR reaction is listed below: 
 
Table 3.2 Q-PCR composition 
Reagents Volume to add (μL) 
Platinum
®
 SYBR
®
 green qPCR SuperMix-UDG 12.5 
Nuclease free H2O Up to 25 
cDNA < 5 
Forward primer (10 μM) 0.5 
Reverse primer (10 μM) 0.5 
ROX reference dye Optional, 0.05 
 
The volume of cDNA was computed as follows. Since the florescence in Q-
PCR is directly proportioned to the concentration of DNA product in a certain 
range, which is called “linearity range”, the volume of cDNA added should 
make the amount of the target DNA in the mix above sit in the linearity range. 
As described above, the cDNA was obtained from the reverse transcription of 1 
μg of RNA, hence, 100 pico grams (pg) to 1 μg of cDNA sample is usually 
used here. The ROX reference dye is optional. It is used to normalize the 
fluorescent reporter signal, and is only used to accompany certain Q-PCR 
instruments. For the primers, since the target DNA for Q-PCR in this work was 
RyRIII, the pair of RyRIII primers, referred to previously, was used here (see 
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Section 3.3.2). 
 
After the above mixture was prepared, they were placed in the Q-PCR 
thermocycler and the following programme was run: 50 °C × 2 min + 95 °C × 
2 min + (95 °C × 15 s + annealing temperature × 30 s + reading) ×40 cycles + 
melting curve. The annealing temperature here was the one which had been 
optimised for the amplified target. The number of cycles was flexible between 
30 to 50 cycles, and the melting curve was applied to find out the melting 
temperature (Tm) of the DNA product. To get the melting curve, the sample 
was heated from 49 °C to 96 °C, which was the whole temperature range of the 
Q-PCR programme (see above). After each 0.2 °C increase of temperature, 
there was 1 s stop for a fluorescence reading. Since every DNA fragment 
would have a specific Tm, the melting curve and Tm result could be used to 
exam the purity of the product. Tm is the peak temperature in melting curve. In 
theory, there should be only one product amplified, and only one Tm obtained 
in each sample. If more than one Tm was obtained in one sample, it was 
possible that the cDNA or the reagents were contaminated. 
 
Besides Tm in the melting curve, efficiency is also an important parameter in 
Q-PCR. As mentioned above, the DNA amount should double after each cycle 
in theory. Efficiency is an indicator of much target DNA has been amplified, 
and a value of 1 means the DNA amount doubles after each cycle. To calculate 
this, the target DNA sample is diluted by different amounts to get a series of 
target DNA samples. The Q-PCR programme is then run on this series of 
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samples and a group of Ct values obtained. Finally, a trend line of Ct value 
against Lg dilution times can be plotted out and the slope of this trend line 
calculated. The Efficiency can then be calculated according to the following 
equation: 
Efficiency =   
 
 
     
 
 - 1. 
Usually the higher the efficiency, the better. For any Q-PCR test, the efficiency 
is acceptable if it is higher than 0.8. More importantly, the efficiency of the 
endogenous control should be comparable with the one of the sample tested. 
 
For quantitative purposes, to compare the RyRIII expression before and after 
differentiation, ΔΔCt method was used for the result analysis and β-actin, 
which is a house keeping gene, was selected as the endogenous control. 
Therefore, in each Q-PCR reaction, the Ct value for β-actin in both 
undifferentiated and differentiated cells was obtained and was defined as Ct,βu 
and Ct,βd respectively. At the same time, the Ct value for RyRIII, which was the 
target gene, could be obtained also and was defined as Ct,Ru and Ct,Rd 
respectively. As soon as the four Ct values were obtained, the calculation was 
carried out in the following way. Firstly, to make sure that the results were able 
to be used for quantitative calculation, the efficiency of the four amplifications, 
both endogenous controls and target DNA in both undifferentiated and 
differentiated cells, should be the same. Besides, the Ct values of endogenous 
control in both undifferentiated and differentiated cells, Ct,βu and Ct,βd, should 
be the same also. Secondly, if Ct,βu and Ct,βd are similar and comparable, two 
ΔCt values, which represent the difference of Ct values between endogenous 
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control and target gene in the same cell line, can be obtained. The ΔCt for 
undifferentiated cells was defined as ΔCt,u = Ct,Ru – Ct,βu, and the ΔCt for 
different cells was ΔCt,d = Ct,Rd – Ct,βd. Thirdly, the ΔΔCt value, which was 
defined as ΔCt,d – ΔCt,u, can be calculated. Finally, the final result   ΔΔ   can 
be calculated to determine what fold increase of RyRIII expression in the 
differentiated cells there is, compared with the undifferentiated counterpart. 
 
3.2.3 Materials and facilities 
 
For RNA extraction, the DNAse kit, including DNAseI buffer (10 ×), rDNAse 
1 and DNAse inactivation reagent, was from Bioline and stored at -20 °C. 
DNAse RNAse free H2O was from Invitrogen. The spectrophotometer (DU730) 
was from Beckman Coulter. 
 
For the RT-PCR and electrophoresis, reverse transcription kit [including 
random primer (500 μg/mL), reaction buffer (5 ×), MgCl2 (25 mM), reverse 
transcriptase and rRNAsin
®
 RNAse inhibitor (40 u/μL)], dNTPs mix (10 mM 
each) and PCR kit [including green Go Taq flexi buffer (5 ×), MgCl2 (25 mM) 
and Go Taq DNA polymerase (5 u/μL)] were from Promega. All primers were 
from Invitrogen. They were dissolved in Tris-EDTA buffer (TE, 10 mM Tris 
and 1 mM EDTA, pH was adjusted to 8.0) as 100 μM for stock and the stocks 
were diluted in nuclease free H2O to 10 μM or 4 μM for PCR or sequencing 
respectively. All the reverse transcription kit, dNTPs mix, PCR kit and primers 
were stored at -20 °C. HyperLadder II (100 lanes, for 50 – 2,000 bp) was from 
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Bioline and was stored at 4 °C. The thermocycler for reverse transcription was 
from Perkin Elmer Cetus, the one for PCR was UNO-Thermoblock from 
Biometra. The electrophoresis tank was from Fisher Scientific and 
electrophoresis power supply was from Apelex. The UV system is a Dual-
Intensity Transilluminator from Genetic Research Instrumentation Ltd, and the 
photography system is an Olympus camera with AlphaDigDoc RT software. 
 
For Q-PCR, the kit, including Platinum
®
 SYBR
®
 Green qPCR SuperMix-UDG, 
ROX reference dye, MgCl2 (50 mM) and bovine serum albumin (20 ×), is from 
Invitrogen and was stored at -20 °C. The thermocycler was an Opticon 2 DNA 
engine from MJ Research, GRII. 
 
For gel purification and sequencing, the Gel purification kit, including Buffer 
QG for solubilisation, Buffer PE for washing and Buffer EB for elution, was 
from Qiangen. DNA loading buffer (5 ×) was from Bioline and was stored at 
4 °C. Both R R Premix (Big Dye) and sequencing buffer were gifts from Dr. 
Bronwen Evans in School of Medicine, Cardiff University, and were stored at -
20 °C. The R R Premix is light sensitive. 
 
3.3 Results 
 
3.3.1 Cell differentiation 
 
NTERA-2 cells were treated with 10 μM retinoic acid for 4 weeks to 
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differentiate to human neurones, and SH-SY5Y cells were treated for 7 days 
for differentiation. The undifferentiated and differentiated cells are shown in 
Fig. 3.1 and Fig. 3.2 respectively. 
 
 
Fig. 3.1 NTERA-2 cell differentiation induced by 10 μM retinoic acid for 4 weeks 
(100 ×). The left hand panel shows what the NTERA-2 cells look like before 
differentiation, and the right hand one shows the morphology of the NTERA-2 cells 
after 4 weeks differentiation. 
 
 
Fig. 3.2 SH-SY5Y cell differentiation induced by 10 μM retinoic acid for 7 days (100 
×). The left hand panel shows how the SH-SY5Y cells look before differentiation, and 
the right hand one shows the morphology of the SH-SY5Y cells after 1 week 
differentiation. 
 
In this study, only the morphology of the cells has been used to evaluate the 
success of cell differentiation. From Figs 3.1 and 3.2, it can be seen that the 
both the differentiated NTERA-2 cells and the differentiated SH-SY5Y cells 
are more spindly than their undifferentiated counterparts respectively. A 
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previous study which has used morphology as the differentiation indicator has 
measured the neurite length (median). It was 4.7 for undifferentiated SH-SY5Y 
cells and was 5.4 after 5 days differentiation (Lovat et al., 1997). The 
difference in neurite length between undifferentiated and differentiated SH-
SY5Y cells in this study is actually more obvious, especially in those cells 
shown in the red square (see Fig. 3.2). Thus, it can be surmised that the cells 
had been differentiated successfully. 
 
3.3.2 Primer design 
 
The primers were designed online as outlined above (see Section 2.5). Among 
those candidate primers, the one expected to produce a product with the higher 
percentage, i.e. closest similarity to the target gene, was selected. 
 
The sequence of primers, as well as relevant information for β-actin, RyRI, 
RyRII and RyRIII are listed below in Table 3.3: 
 
3.3.3 PCR condition optimisation 
 
The results of those experiments are shown in Figs. 3.3 - 3.9. 
 
Comparing Figs. 3.3, 3.4 and 3.6, it can be seen that 40 or 50 cycles are too 
much for the RyRIII amplification. There were multiple bands after 40 or 50 
cycles, whereas the PCR amplification was expected to generate a clear and 
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Table 3.3 Primers for β-actin, RyRI, RyRII and RyRIII (Homo sapiens) 
Primers Gene description Primer sequence 
Product 
size 
PCR conditions 
recommended by 
Primer III 
β-actin 
Forward 
Actin, beta (ACTB), 
mRNA. 1,852 bases 
5’-
cccagccatgtacgttgcta 
126 bp 55 °C, 40 cycles 
Reverse 
5’-
agggcatacccctcgtagatg 
RyRI 
Forward 
Ryanodine receptor 
1 (skeletal) (RyR1), 
transcript variant 1, 
mRNA. 15,391 bases 
5’-
catcagcacgacatgagctt 
241 bp 58 °C, 30 cycles 
Reverse 5’-tgttgctctctttgccattg 
RyRII 
Forward Ryanodine receptor 
2 (cardiac) (RyR2), 
mRNA. 16,365 bases 
5’-
caaccggactcgtcgtattt 
249 bp 58 °C, 30 cycles 
Reverse 5’-ttggctttctctttggctgt 
RyRIII 
Forward Ryanodine receptor 
3 (RyR3), mRNA. 
15,563 bases 
5’-
gaaagtgtgaaacgcagcaa 
211 bp 58 °C, 30 cycles 
Reverse 
5’-
gcaggaagactgctggaaac 
 
 
Fig. 3.3 RyRIII in N2102Ep, 55 °C, 30 cycles, 1.5 mM Mg
2+
. The negative control is 
clear and clean and the positive control (β-actin) is shown as a single clear band, 
which means the cDNA sample qualifies. The RyRIII band is not sufficiently clear. 
 
specific band. 30 cycles were deemed to be the optimum number of cycles for 
RyRIII amplification. Comparing Figs. 3.5 and 3.7, it can be seen that the 
optimum [Mg
2+
] is 1.5 mM, rather than any other concentration. When the 
β-actin     Negative control     RyRIII     Ladder 
300 bp 
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Fig. 3.4 RyRIII in N2102Ep, 55 °C, 40 cycles, 1.5 mM Mg
2+
. The RyRIII band is clear, 
but the band is not specific. 
 
 
 
Fig. 3.5 RyRIII in N2102Ep, 58 °C, 30 cycles. The RyRIII band is clear but unspecific. 
 
 
 
Fig. 3.6 RyRIII in N2102Ep, 55 °C, 50 cycles, 1.5 mM Mg
2+
. The RyRIII band is clear 
but unspecific. There is also a weak band in the negative control, suggesting that 50 
cycles are too many. 
 
 
 
Fig. 3.7 RyRIII in N2102Ep, 58 °C, 30 cycles, 1.5 mM Mg
2+
. The RyRIII band is clear 
and specific, just a little weak. 
 
[Mg
2+
] was 1.25 mM, 1.0 mM or 0.75 mM, there were unexpected bands in the  
β-actin     RyRIII     Negative control     Ladder 
300 bp 
β-actin   0.75 mM Mg2+  1 mM Mg2+   1.25 mM Mg2+   Negative control   Ladder 
300 bp 
β-actin                     RyR III             Negative control            Ladder 
300 bp 
RyRIII      Negative control      Ladder 
300 bp 
RyRIII 
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Fig. 3.8 RyRIII in N2102Ep, 58 °C, 40 cycles, 1.5 mM Mg
2+
. The RyRIII band is clear 
but unspecific. There are bands in the negative control 
 
 
 
Fig. 3.9 RyRIII in N2102Ep, 60 °C, 30 cycles, 1.5 mM Mg
2+
. The RyRIII band is clear 
but unspecific. There are multiple bands in the amplification of RyRIII. 
 
RyRIII amplification as shown in Fig. 3.5. Thus, the optimum [Mg
2+
] after the 
PCR condition optimisation was found to be 1.5 mM. Comparing Figs. 3.3, 3.7 
and 3.9, it is clear that 55 °C was too low an annealing temperature since the 
RyRIII band was not clear, but 60 °C was too high since unspecific 
amplification products were produced. Comparing Figs. 3.7 and 3.8, it can be 
further confirmed that 40 cycles were too many for RyRIII amplification since 
extra bands appeared. Thus, the optimised PCR condition for the RyRIII 
amplification was 58 °C as the annealing temperature, 30 cycles as the number 
of cycles, and 1.5 mM as the [Mg
2+
]. 
  
3.3.4 PCR 
 
300 bp 
300 bp 
β-actin       RyRIII      Negative control      Ladder 
RyRIII    Negative control    Ladder 
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After the PCR conditions were optimised, the PCR was performed on those 
cell lines above. The following PCR results show the RyRs amplification in the 
following cell lines: MG-63, MOG-G-UVW, N2102Ep, undifferentiated 
NTERA-2, differentiated NTERA-2, undifferentiated SH-SY5Y and 
differentiated SH-SY5Y. 
 
 
 
Fig 3.10 RyR isoforms in the MG-63 cell line. 
 
 
 
Fig. 3.11 RyR isoforms in the MOG-G-UVW cell line 
 
 
 
Fig. 3.12 RyR isoforms in the N2102Ep cell line. 
 
1,000 bp 
 
 
300 bp 
Ladder                   RyRI                    RyRII                   RyRIII 
300 bp 
Ladder                       RyRI                       RyRII                       RyRIII 
300 bp 
Ladder             RyRI             RyRII             RyRIII 
Cellular Basis of Neurodegeneration 
 
 
- 82 - 
 
 
 
Fig. 3.13 RyR isoforms in the undifferentiated NTERA-2 cell line 
 
 
 
Fig. 3.14 RyR isoforms in the differentiated NTERA-2 cell line. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.15 RyRIII in SH-SY5Y cell line. 
 
From the data above, it can be seen that there was little RyRIII message in 
MG-63 cells. However, there is RyRIII message in astrocytes, such as MOG-
G-UVW, and the RyRIII band was stronger than for the other two isoforms. In 
NTERA-2 cells, the RyRIII expression was quite strong before the 
differentiation but was weaker after the differentiation. Conversely, the 
opposite was true during the differentiation of SH-SY5Y, since the RyRIII 
expression was stronger in the differentiated ones. The result of PCR indicates 
300 bp 
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the existence of certain messages, but does not measure the expression 
quantitatively. So, Q-PCR was carried out after the band from PCR had been 
confirmed with sequencing. 
 
3.3.5 Sequencing 
 
As soon as the PCR condition had been optimised for RyRIII, large amount 
amplification was performed to generate the high concentration of the DNA 
fragment of RyRIII, in order to check that the sequence of the DNA fragment 
generated could be confirmed as RyRIII. Fig. 3.16 shows a PCR of large 
amount amplification of RyRIII. The cDNA used here was the sample obtained 
from the undifferentiated NTERA-2 cells. 
 
 
Fig. 3.16 Large amount amplification of RyRIII from the undifferentiated NTERA-2 
cell line. 
 
After the bands were cut down under UV light and the gel slices were purified, 
the sequencing process was performed. The result from Central Biotechnology 
Services, School of Medicine, Cardiff University is shown in Fig. 3.17. 
 
From these data, the sequence of this sample is: 
TGAGGGATTGGAACTTTACTCTTCTCCATGGCTATCAGAGATTTTGG
ATAGAAACAGAGGAGTATTCCTTTGAAGAGAAACTAGTACAGGATT 
300 bp 
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Fig. 3.17 Sequencing result of RyRIII 
 
TGGCTAAATCTCCAAAGGTGGAAGAGGAGGAGGAGGAAGAGACAG
AAAAACAACCTGACCCACTACATCAGATCATTCTCTATTTTAGCCGC
CACGCTCTAAAA. 
 
The blast test was run afterwards, and the percentage of the sequence above is 
88% homologous to RyRIII. Thus, it can be confirmed that the product from 
the PCR was RyRIII, and the PCR conditions and primers were legitimate for 
use for Q-PCR, which is a quantitative test of the expression. 
 
3.3.6 Q-PCR 
 
Q-PCR was first performed to test the RyRIII expression during the 
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differentiation of NTERA-2 cells. Fig. 3.18 below shows the fluorescence 
graph of the negative controls and Figs. 3.19, 3.20 show the melting curve of 
negative controls to demonstrate the purity of the cDNA sample. 
 
 
Fig. 3.18 Fluorescence of the negative controls in Q-PCR in the NTERA-2 cell line. 
Note that both two lines are flat and the fluorescence has not increased even after 50 
cycles. 
 
 
Fig. 3.19 The melting curve of negative control in undifferentiated NTERA-2 cells. 
There is no peak appearing in the fluorescence decrease curve, which means that the 
sample is not contaminated. 
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Fig. 3.20 The melting curve of the negative control in differentiated NTERA-2 cells. 
There is no peak in the fluorescence decrease curve, which means that the sample is 
not contaminated. 
 
From Figs. 3.18 – 3.20, it can be concluded that the samples and reagents were 
clean enough and no nuclease contamination existed in the samples. Figs. 3.21 
and 3.22 show the melting curve of the positive control, β-actin which is an 
endogenous control, in both undifferentiated and differentiated NTERA-2 cells 
to demonstrate the purity. 
 
From the Figs. 3.21 and 3.22, it can be concluded that the samples were clean 
and purified, and the PCR conditions were fit for the endogenous control, β-
actin, since only one single product was amplified. Figs. 3.23 and 3.24 
demonstrates the melting curve of RyRIII in both undifferentiated and 
differentiated cells. 
 
From Figs. 3.23 and 3.24, it can be concluded that the samples were clean and  
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Fig. 3.21 The melting curve of the endogenous control in undifferentiated NTERA-2 
cells. There is only a single peak in the fluorescence decrease – temperature curve, 
which means that the purity is acceptable. 
 
 
Fig. 3.22 The melting curve of the endogenous control in differentiated NTERA-2 
cells. There is only a single peak in the fluorescence decrease – temperature curve, 
which means that the purity is acceptable. 
 
purified, and the PCR conditions were fit for the target gene fragment, RyRIII, 
since only one product was amplified. 
 
Before running the Q-PCR to measure RyRIII quantitatively, efficiency of  
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Fig. 3.23 The melting curve of RyRIII in undifferentiated NTERA-2 cells. There is 
only a single peak in the fluorescence decrease – temperature curve, which means that 
the purity is acceptable. 
 
 
Fig. 3.24 The melting curve of RyRIII in differentiated NTERA-2 cells. There is only 
a single peak in the fluorescence decrease – temperature curve, which means that the 
purity is acceptable. 
 
amplification of both endogenous control (β-actin) and target gene (RyRIII) 
was tested. 
 
The slope in Fig. 3.25 for β-actin is 3.024. Efficiency (E) is: 
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Table 3.4 Ct values in β-actin standard curve 
Times of dilution 1 10 10
2
 10
3
 10
4
 10
5
 10
6
 10
7
 10
8
 10
9
 
Ct value 9 18 16 21 23 24 27 31 36 40 
 
 
Fig. 3.25 Standard curve of β-actin 
 
E =   
 
 
     
 
 – 1, 
so 
Eβ-actin =   
 
 
     
 
 - 1 = 1.1 
 
Table 3.5 Ct values in RyRIII standard curve 
Times of dilution 1 10 10
2
 10
3
 10
4
 10
5
 10
6
 10
7
 10
8
 10
9
 
Ct 7 12 15 20 23 28 38 36 38 41 
 
The slope in Fig. 3.26 for RyRIII is 3.952. Efficiency is: 
ERyRIII =   
 
 
     
 
 – 1 = 0.8 
 
Both of the efficiencies are close to 1 and are acceptable for Q-PCR  
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Fig. 3.26 Standard curve of RyRIII 
 
comparison. 
 
Hence, the results, ΔCt, generated from different groups of Q-PCR could be 
used for analysis. The results and analysis are tabulated in Table 3.6, and the 
results are presented in Fig. 3.27. 
 
Table 3.6 Q-PCR results of RyRIII in NTERA-2 cell line 
Duplicate Samples Ct ΔCt ΔΔCt Average, p,         
Experiment 
1 
β-actin, undifferentiated 20.41 
11.61 
5.90 
Average: 5.11 
p < 0.05 
       = 0.0290 
RyRIII, undifferentiated 32.02 
β-actin, differentiated 19.49 
17.51 
RyRIII, differentiated 37.00 
Experiment 
2 
β-actin, undifferentiated 20.74 
14.60 
4.32 
RyRIII, undifferentiated 35.34 
β-actin, differentiated 25.88 
18.92 
RyRIII, differentiated 44.80 
 
From these tables and figures in this section, it may be concluded that the  
y = 3.952x + 8.018 
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Fig. 3.27 Q-PCR result of RyRIII expression during the differentiation of NTERA-2 
cells. It is clear that the relative expression of RyRIII was reduced after differentiation, 
compared with the undifferentiated counterpart. 
 
RyRIII expression was “turned down” during the retinoic acid induced 
differentiation in NTERA-2 cells. 
 
In addition to the NTERA-2 cell line, another neuroblastoma cell line, SH-
SY5Y was also selected for Q-PCR tests of the RyRIII expression change 
during differentiation. 
 
Firstly, the purity of the samples was tested from the Q-PCR of the negative 
control. 
 
From the Figs. 3.28 – 3.30, it can be seen that nothing was amplified in the 
negative control samples of both undifferentiated and differentiated SH-SY5Y 
cells during the Q-PCR, hence, it can be concluded that the sample is clean and  
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Fig. 3.28 Negative control in both undifferentiated and differentiated SH-SY5Y cells. 
It is suggested by the fluorescence curve that nothing was amplified. 
 
 
Fig. 3.29 The melting curve of the negative control in undifferentiated SH-SY5Y cells. 
No peak was observed. 
 
pure enough for further experiments. 
 
In the Figs. 3.31 and 3.32, only one single peak was observed in each graph, 
which means the endogenous control is pure and clean. Two melting curve 
figures for the RyRIII amplification in both undifferentiated and differentiated  
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Fig. 3.30 The melting curve of the negative control in differentiated SH-SY5Y cells. 
No peak was observed. 
 
 
Fig. 3.31 The melting curve of endogenous control, β-actin, in undifferentiated SH-
SY5Y cells. Only one single peak was observed in the curve. 
 
SH-SY5Y cell are shown in Figs. 3.33 and 3.34. 
 
Based on the confirmation of the purity of the samples, Q-PCR was performed 
and repeated in triplicate. The results are tabulated below in Table 3.7 and Fig.  
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Fig. 3.32 The melting curve of endogenous control, β-actin, in differentiated SH-
SY5Y cells. Only one single peak was obtained in the curve. 
 
 
Fig. 3.33 The melting curve of RyRIII in undifferentiated SH-SY5Y cells. Only one 
single peak was observed in the curve. 
 
3.35. 
 
From the Table 3.7 and Fig. 3.35 in this section, it can be observed that the 
RyRIII expression in SH-SY5Y cells was increased after the differentiation  
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Fig. 3.34 The melting curve of RyRIII in differentiated SH-SY5Y cells. Only one 
single peak was observed in the curve. 
 
Table 3.7 Q-PCR results of RyRIII expression in SH-SY5Y cell line 
Triplicate Samples Ct ΔCt ΔΔCt 
Average (standard error), 
  ΔΔ   
Experiment 
1 
β-actin, undifferentiated 22.51 
15.96 
-3.88 
Average: -2.68 (0.735) 
       = 6.41 
p < 0.05 (t test) 
RyRIII, undifferentiated 38.47 
β-actin, differentiated 23.89 
12.08 
RyRIII, differentiated 35.97 
Experiment 
2 
β-actin, undifferentiated 26.07 
20.76 
-2.06 
RyRIII, undifferentiated 46.83 
β-actin, differentiated 22.08 
18.70 
RyRIII, differentiated 40.78 
Experiment 
3 
β-actin, undifferentiated 23.14 
15.64 
-2.01 
RyRIII, undifferentiated 38.78 
β-actin, differentiated 24.51 
13.54 
RyRIII, differentiated 38.05 
 
induced by retinoic acid. 
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Fig. 3.35 The relative expression of RyRIII in SH-SY5Y cells before and after retinoic 
acid induced differentiation. 
 
3.4 Discussion 
 
The principal result here is that in SH-SY5Y cells, which are presumed 
differentiated, there is a significantly higher expression of RyRIII (the opposite 
results in NTERA-2 cells are discussed later on p99-100). It is worth 
considering first the evidence that these cells have become differentiated. 
 
Cell differentiation can be tracked using neuronal markers, however, how 
successful an approach this is, remains arguable. For example, PCR for 
growth-associated-protein 43 (GAP-43) was used as a neuronal marker in 
norepinephrine induced SH-SY5Y differentiation (Laifenfeld et al., 2002). A 
western blot study however has failed to demonstrated any difference of GAP-
43 expression in SH-SY5Y cells before and after retinoic acid induced 
differentiation (Joshi et al., 2007). 
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Besides neuronal markers, other studies accept confirmation of differentiation 
from the morphology of the cells (Lovat et al., 1997). Since cells which 
differentiate to human neurones should have budding synapses, successfully 
differentiated cells should be spindly, while undifferentiated ones remain round. 
Figure 3.36 shows a sample of differentiated SH-SY5Y cells in a previous 
study (Lovat et al., 1997). 
 
   
Fig. 3.36 Retinoic acid induced differentiation of SH-SY5Y cells (Lovat et al., 1997). 
The left hand panel shows the undifferentiated SH-SY5Y cells, and the right hand one 
shows the differentiated ones. The bar is 10 μm. 
 
Some studies use no evaluation, simply following the standard differentiation 
protocol and assumed that the cells were differentiated after the standard 
protocol has been adopted (Tieu et al., 1999). 
 
In this study, a change in morphology was assessed to evaluate whether the 
cells were differentiated or not, although morphology is a subjective indicator 
and is not always easy to accept. For example, in the study above which has 
used morphology to evaluate the differentiation (Lovat et al., 1997), there was 
limited difference in morphology observed between the undifferentiated and 
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differentiated SH-SY5Y cells. But in this study, it was noticed that both the 
differentiated NTERA-2 and the differentiated SH-SY5Y cells were 
characterised by elongated processes in comparison to the undifferentiated 
counterparts. These processes are perhaps indicative of budding synapses. 
 
In the PCR results, it was clear that RyRIII is almost non existent in MG-63 
cells, which are a human osteosarcoma cell line, but exists in MOG-G-UVW, 
N2102Ep, NTERA-2 and SH-SY5Y cells, which are astrocytoma, neuronal 
cells or cells with the potential to be differentiated to neurones. These results 
were consistent with previous studies which suggested that RyRIII is the 
prevalent RyR in the brain. 
 
If RyRIII is believed to be the brain type of ryanodine receptor, the expectation 
might be that there would be a higher expression in the differentiated neurones, 
rather than the undifferentiated or any other cells. However, according to the 
Q-PCR results from NTERA-2 cells reported here, the RyRIII expression was 
decreased after the differentiation, although the morphology suggested that the 
NTERA-2 cells had more processes. The differentiated PCR figures also 
confirmed this finding (see Fig. 3.13 and 3.14). The possible explanation for 
this is that RyRIII does not exist in neurones only, but is also present in some 
other organs and tissues, for example epithelial lung cells (mink) (Sorrentino, 
1995) and germ cells (Giannini et al., 1995). The latter was confirmed in PCR 
investigating RyRs in N2102Ep cell line, which is a non seminomatous germ 
cell carcinoma derived cell line. Fig. 3.12 has shown that RyRIII was highly 
Cellular Basis of Neurodegeneration 
 
 
- 99 - 
 
expressed in the N2102Ep cells. That may be consistent with RyRIII presenting 
a high expression in undifferentiated NTERA-2 cells since both N2102Ep and 
undifferentiated NTERA-2 cells are human embryonal carcinoma. 
 
Nevertheless in contrast, the differentiation of SH-SY5Y cell line was 
accompanied by an increased RyRIII expression. The RT-PCR results from 
SH-SY5Y cell line suggested that the RyRIII expression was increased after 
retinoic acid induced differentiation (see Fig. 3.15). Importantly, the difference 
was confirmed and was significant in Q-PCR as well. 
 
But, the increase of RyRIII expression does not necessarily mean an increase 
of the total RyR present, since the expression of the other two isoforms have 
not been tested. The increase of RyRIII expression only means the cells are 
more “neuronal” since RyRIII is the brain type ryanodine receptor. 
Nevertheless, what the difference is amongst three isoforms of RyR in terms of 
function, and why brain neurones require more RyRIII than the other types of 
cells do, has seldom been discussed previously. In this study, the expression of 
RyRIII in SH-SY5Y cell line has been linked with the resistance to insults and 
the response to RyR modulators. The relevant data are now presented in 
Chapter 4 and Chapter 5.  
 
3.5 Conclusion 
 
To summarise the results above, it is suggested that RyRIII may have a higher 
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expression in a neuronal cell line than it has in most other organs, but germ or 
embryonal carcinoma might be an exception. Therefore, the SH-SY5Y cell line 
was selected as the primary cell model in future work, although MOG-G-UVW 
and NTERA-2 cells were not overlooked. 
 
The main purpose or aim of this thesis was not solely to find out where RyRIII  
was expressed, but to assay its role in neurodegeneration, and to ascertain 
whether it could be a potential target for the neurodegeneration treatment. If 
RyRIII is believed to play an important role in neurodegeneration, especially in 
neuronal death, the cell line which has a higher RyRIII expression (i.e. 
differentiated SH-SY5Y) should be more sensitive to the counterpart which has 
a lower RyRIII expression (i.e. undifferentiated SH-SY5Y). Hence, cell insult 
models were established next. In order to test the relative sensitivities of 
differentiated SH-SY5Y cells and undifferentiated ones, modulators, including 
RyR modulators, were then tested in those models. 
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4. Cell Insult Models 
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4. Cell Insult Models 
 
4.1 Introduction 
 
A number of cell insults can mimic or trigger neurodegeneration or cell death. 
The cell insult models used here were tested in cell proliferation and MTS 
assays, and were established to find the kind of insults which could be 
deployed to mimic neurodegeneration. 
 
Obviously, since one proposed hypothesis of AD is the deposition of Aβ on the 
cell membrane, Aβ is the insult which is closest to AD. Aβ1-42 was therefore 
selected as an insult in this work and has been proved to be toxic to neuronal 
cells in previous cell proliferation and assays studies (Tweedie et al., 2006, 
Mulder et al., 2003, Folin et al., 2005). 
 
Aβ1-42 is however expensive, is not easy to use since it has to be aggregated to 
fibrils to cause insult to cells (Ueda et al., 2002), hence some alternative 
models were adopted also. As discussed in the introduction, the toxic function 
of Aβ1-42 may be via formation of a Ca
2+
 channel on the cell membrane with a 
resultant increase in [Ca
2+
]i (Arispe et al., 2007, Berridge, 2010). An 
alternative model should thus mimic neurodegeneration by reducing cell 
viability through increasing the [Ca
2+
]i. 
 
To achieve this, hypoxia induced by CoCl2 was selected as another neuronal 
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insult in this project. Hypoxia was studied as a model of neurodegeneration of 
relevance to Alzheimer’s disease (Bazan et al., 2002, Gasperi et al., 2010). 
CoCl2 has been used as a hypoxia mimetic (Gasperi et al., 2010), and was 
found to increase the generation of Aβ via up-regulating the expression of APP 
as well as the expression of β-secretase and γ-secretase (Zhu et al., 2009). 
Hence, it is reasonable to propose that CoCl2 induced hypoxia can be used as a 
neuronal insult to challenge cells and to test modulators. 
 
Besides the hypoxia mimetic challenge, oxidative stress induced by H2O2 was 
selected as a cell insult model. Previous studies have suggested a link between 
oxidative stress and neurodegeneration, such as AD (Lin and Beal, 2006, Floyd, 
1999, Floyd and Hensley, 2002). H2O2 is a freely diffusible form of reactive 
oxygen species and has been used as oxidative stress model (Ishimura et al., 
2008), and can increase [Ca
2+
]i (Krebs et al., 2007). Therefore, H2O2 was 
selected as a second neuronal insult model here to challenge the cells and test 
modulators. 
 
In addition to CoCl2 and H2O2 insults, glutamate is another insult model which 
has been previously studied and linked with neurodegeneration. Glutamate can 
increase [Ca
2+
]i and induce neurodegeneration and such an effect can be 
prevented by the blockade of muscarnic receptor (Mattson, 1989). One other 
study also believed that glutamate-induced stimulation of NMDA receptors 
mediates toxic increases in [Ca
2+
]i (Dolga et al., 2011) 
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4.2 Methods and materials 
 
The cell insult model was based on the methods of cell proliferation and MTS 
assay described in section 2.11. 
 
In the Aβ1-42 insult model, amyloid can be incubated and aggregated, and its 
aggregation viewed by electron microscope. This method is going to be 
discussed in section 4.2.1 under Aβ1-42 aggregation. 
 
For all the three insults, especially in the case of the CoCl2 and H2O2 insult, a 
range of dosages of “insult” (100 nM – 1 mM) were selected to estimate the 
relevant EC50 (half maximal effective concentration), i.e. a dosage to kill 50% 
of cells reducing the relative cell number to be 0.5. The EC50 of CoCl2 or H2O2 
of each cell line was then set as standard insult for further test of modulators. 
This chapter discusses how the EC50 was estimated for each insult and each 
cell line. 
 
4.2.1 Aβ1-42 aggregation 
 
As discussed in the introduction (see Chapter 1), soluble APP does not induce 
cell apoptosis directly, it generates the Aβ which is deposited on the cell 
membrane as plaques and putative Ca
2+
 channels may be formed. The toxic 
effect of aggregated Aβ1-42 has previously been studied on both dog (Torp et al., 
2000) and human (Roher et al., 1993) tissues. The Aβ1-42 sample was incubated 
Cellular Basis of Neurodegeneration 
 
 
- 105 - 
 
to induce aggregation and examined under the electron microscope before 
being adopted as an insult to the cells. 
 
To form aggregates and fibres, the Aβ1-42 sample was dissolved in PBS at 100 
μM and incubated at 37 °C for a few days. The incubation duration was 
variable from 3 days (Qahwash et al., 2007) to 6 days (Fülöp et al., 2004). In 
this work, the longest incubation period, 1 week, was selected. 
 
The incubated Aβ1-42 solution was sampled and diluted for transmission 
electron microscope (TEM) study. A 50 μL droplet of 1 μM solution was laid 
on a clean surface and the droplet was incubated on the surface of the grid. 
After passing the grid from droplet to droplet, the suspension of specimen was 
incubated on the grid for about 15 min. Then, the sample was treated with 1% 
glutaraldehyde in buffer for about 10 min. Thereafter, it was washed 3 times 
with buffer with 1 min washing each time and 6 times with H2O. Finally, it was 
treated with 2% aqueous uranyl acetate [UO2(CH3COO)2·2H2O] for about 5 
min. The grid was picked up on tweezers and dried at room temperature. The 
sample was then viewed through TEM. 
 
For each TEM experiment, the negative control, which was the grid without 
any Aβ1-42 sample, was prepared. Ideally, there should not be any amyloid 
viewed in the negative control. Then, the comparison between the figures of 
Aβ1-42 before and after incubation indicates whether the amyloid had grown 
longer and was aggregated or not. 
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Photography under the electron microscope was done by the Central 
Biotechnology Services, School of Medicine, Cardiff University. Visual 
comparison and photographs was suffice to determine whether the amyloid was 
aggregated. 
 
4.2.2 EC50 estimation 
 
In this study, the EC50 of either H2O2 or CoCl2 was estimated in three groups of 
triplicated MTS assays. The doses selected in each group were based on 
logarithmic steps. 
 
Taking the CoCl2 insult to NTERA-2 cells as an example, 5 different doses, 
100 nM, 1 μM, 10 μM, 100 μM and 1 mM, were tested in the first triplicated 
group. According to the relative cell number result from the first group, it can 
be seen for example that 100 nM or 1 μM had little effect on cell numbers. 
Hence, 100 nM and 1 μM were not subsequently tested. Another two doses 
were included in the second triplicated test, such that the second 5 different 
doses were 10 μM, 30 μM, 100 μM, 300 μM and 1 mM. If with the new result, 
300 μM and 1 mM were deemed too high, they were not subsequently tested, 
and, another two doses were included in the third triplicated test. So, the 5 
doses in the last triplicated experiment would be 10 μM, 20 μM, 30 μM, 50 μM 
and 100 μM. 
 
Finally, after the 3 groups of triplicated experiments, all the relative cell 
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number results collected from the dosages between 100 nM and 1 mM were 
analysed. The logarithmic dose (lg dose) – effect (relative cell number) curve 
was constructed and a cumulative logistic distribution trend line fitted to the 
data. Therefore, according to the logistic regression, the dose which reduced 
the relative cell number (effect) to 0.5 was taken as the EC50. 
 
The details of logistic regression are explained here. If the relative cell number 
is P at the dose of C, then the cumulative logistic distribution trend line is a line 
showing P against lg C. Here, “lg” means log based 10, and lg x = log10 x. To 
estimate the EC50, following calculations were undertaken. Firstly, the logit (P) 
value was calculated. 
logit (P) = ln 
   
 
 
Here “ln” means log based e, and ln x = loge x. The logit (P) value should be a 
linear relation with lg C. Thus, the linear trend line of logit (P) against lg C was 
constructed, and, a linear function between logit (P) and lg C was plotted, 
namely: 
logit (P) = a × lg C + b 
Here, both “a” and “b” are constant numbers. According to the definition of 
EC50, P should be 0.5 at EC50 dose and logit (P) should be 0. Hence, the lg C 
value which makes logit (P) to be 0 is the one needed, and the C value here is 
EC50. 
lg C = 
            
 
 
lg EC50 = 
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EC50 =   
  
  
 
The EC50 of Aβ1-42 was estimated from only one group of triplicated MTS 
assay since the amyloid was expensive and was less convenient to use than the 
other two models. The dose range for Aβ1-42 was much narrower, since 
previous studies have pointed out that 10 μM can induce neuronal cell 
apoptosis (Kajkowski et al., 2001). Thus, the dose range tested for Aβ1-42 insult 
model was between 625 nM and 40 μM. 
 
4.2.3 Drug solutions 
 
All Aβ1-42, CoCl2 and H2O2 are from Sigma-Aldrich. Aβ1-42 was dissolved in 
PBS at 100 μM and was incubated at 37 °C for 7 days before being applied to 
cells (see Section 4.2.1). CoCl2 is dissolved in H2O at 10 mM for stock. H2O2 
is diluted in PBS at 1 M for stock. Both CoCl2 and H2O2 are light sensitive and 
both stocks are stored at 4 °C. Glutamate is from Fisher Scientific and was 
dissolved in PBS at 1 M for stock. The glutamate stock was also stored at 4 °C. 
The haemocytometer for counting cell number is from Mrienfeld. 
 
4.3 Results 
 
4.3.1 CoCl2 insult 
 
The CoCl2 insult was applied to the MOG-G-UVW cells first, and the data in 
Cellular Basis of Neurodegeneration 
 
 
- 109 - 
 
the form of a dose – response curve is shown in Fig. 4.1. 
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Fig. 4.1 Dose – response curve of CoCl2 insult in MOG-G-UVW cell line. The points 
are the means of 3 for 100 nM, 1 μM, 20 μM, 50 μM and 300 μM, 6 for 30 μM, 100 
μM and 1 mM, and 9 for 10 μM. 
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Fig. 4.2 Logistic regression of the dose – response curve of CoCl2 insult in the MOG-
G-UVW cell line. 
 
A one way ANOVA test for all the groups in Fig. 4.1 suggested p < 0.001, and 
the Dunnett’s post test (comparing each group to control) suggested that 10 μM 
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or above caused a significant reduction in the relative cell number from control 
(p < 0.01 for 10 μM group, and p < 0.001 for 20 μM to 1 mM groups). Logistic 
regression is shown in Fig. 4.2 and the EC50 is then calculated. 
 
EC50 =   
      
      
 
So, the EC50 of CoCl2 to MOG-G-UVW was estimated as between 30 and 40 
μM. This was the concentration for the CoCl2 experiments which was used in 
further modulator tests with these cells. 
 
In comparison, the action of CoCl2 in the SH-SY5Y cells is shown in the dose 
– response curve of Fig. 4.3 
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Fig. 4.3 Dose – response curve for CoCl2 in both undifferentiated and differentiated 
SH-SY5Y cells 
 
For the undifferentiated cells, data points were the means of 3 for 20 μM, 40 
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μM, 80 μM, 150 μM and 160 μM, 6 for 1 μM and 300 μM, and 9 for 10 μM, 
100 μM, 1 mM and the control. For the differentiated cells, data points were 
the means of 3 for 100 nM, 1 μM, 5 μM, 20 μM, 40 μM, 80 μM, 100 μM and 1 
mM groups, 6 for 10 μM and the control. 
 
A one way ANOVA test for the CoCl2 effects in the undifferentiated SH-SY5Y 
cells suggested that the difference amongst those groups was significant (p < 
0.001), and the Dunnett’s post test (comparing each group with the control) 
indicated that 40 μM or higher dose of CoCl2 had a significant effect on the 
relative cell number from the control group (p < 0.001). The one way ANOVA 
test for the insults in the differentiated cells showed that the difference amongst 
the groups was significant also (p < 0.001), and the Dunnett’s post test 
(comparing each group with the control) showed that 20 μM CoCl2 or higher 
has significantly reduced the cell number. The significances were p < 0.01 for 
20 μM and p < 0.001 for 40 μM and above. 
 
To estimate the EC50 doses of CoCl2 in undifferentiated and differentiated SH-
SY5Y cells, logistic regressions were carried out and EC50 doses were 
calculated (see Fig. 4.4 & Fig. 4.5). 
 
Hence the EC50 of CoCl2 in undifferentiated SH-SY5Y cells was calculated as: 
EC50 =   
      
      = 0.0000437 M = 43.7 μM 
 
The EC50 of CoCl2 in differentiated SH-SY5Y cells was calculated as: 
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EC50 =   
      
      = 0.0000321 M = 32.1 μM 
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Fig.4.4 Logistic regression of the dose – response curve of CoCl2 insult in 
undifferentiated SH-SY5Y cell line 
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Fig.4.5 Logistic regression of the dose – response curve of CoCl2 insult in 
differentiated SH-SY5Y cell line 
 
Thus, the EC50 doses for CoCl2 in undifferentiated and differentiated SH-SY5Y 
cells were estimated as about 44 μM and 32 μM respectively. These are the 
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CoCl2 concentrations used in future modulator test experiments in SH-SY5Y 
cells. 
 
In addition, the relative cell number for undifferentiated and differentiated cells 
were 0.930 (± 0.0473) and 0.878 (±0.0529) respectively (p < 0.05, t test) at 10 
μM, and were 0.484 (± 0.0489) and 0.379 (± 0.0565) respectively (p < 0.05, t 
test) at 20 μM. The relative cell numbers in differentiated SH-SY5Y cells were 
consistently lower than the counterparts in undifferentiated cells under 10 μM 
and 20 μM CoCl2. 
 
Finally, the action of CoCl2 was tested on undifferentiated NTERA-2 cells. The 
dose – response curve for these experiments is shown in Fig. 4.6. 
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Fig. 4.6 Dose - response curve for CoCl2 in undifferentiated NTERA-2 cells. The data 
points were the means of 3 for 100 nM, 1 μM, 20 μM, 50 μM and 300 μM, 6 for 30 
μM and 1 mM, and 9 for 10 μM, 100 μM and the control. 
 
A one way ANOVA test for CoCl2 against undifferentiated NTERA-2 cells 
indicated that the difference amongst those groups was significant (p < 0.001), 
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and the Dunnett’s post test (comparing each group with the control) indicated 
that CoCl2 at 20 μM or higher significantly reduced cell number from the 
control (p < 0.01 at 20 μM, and p < 0.001 at 30 μM and above). 
 
To estimate the EC50 of CoCl2 in undifferentiated NTERA-2, the logistic 
regression is shown in Fig. 4.7. 
 
y = 3.319x + 15.647
R² = 0.965
-2
-1
0
1
2
3
4
5
6
-6 -5 -4 -3 -2
L
o
g
it
 (
P
)
Lg Concentration (M)
 
Fig. 4.7 Logistic regression of the dose – response curve of CoCl2 in undifferentiated 
NETA-2 cells 
 
Thus, EC50 is calculated as: 
EC50 =   
     
     
 
The EC50 for CoCl2 in undifferentiated NTERA-2 cells was estimated between 
10 and 20 μM. Hence, 15 μM is the CoCl2 concentration used in future 
modulator test experiments in undifferentiated NTERA-2 cells. 
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4.3.2 H2O2 insult 
 
The action of H2O2 was tested on both undifferentiated and differentiated SH-
SY5Y cells. The dose – response curves for these experiments are shown in Fig 
4.8: 
 
A one way ANOVA test for the H2O2 effects in undifferentiated SH-SY5Y 
cells suggested that the difference amongst those groups was significant (p < 
0.001), and the Dunnett’s post test (comparing each group with the control) 
indicated that 300 μM or higher dose of H2O2 had a significant effect on the 
relative cell number from the control group (p < 0.01at 300 μM and p < 0.001 
for 450 μM or above). 
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Fig. 4.8 Dose – response curve for H2O2 in both undifferentiated and differentiated 
SH-SY5Y cells. 
 
A one way ANOVA test for the insults in differentiated cells showed that the 
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difference amongst the groups was also significant (p < 0.001), and the 
Dunnett’s post test (comparing each group with the control) showed that 150 
μM H2O2 or higher would significantly reduce the cell number. The 
significances were p < 0.01 for 150 μM, and p < 0.001 for 300 μM and above. 
 
A one way ANOVA test with Tukey’s post test (comparing every two groups) 
for the comparison of the action of H2O2 in both undifferentiated and 
differentiated cells indicated that the relative cell numbers were significantly 
different (p < 0.001) between the undifferentiated group and differentiated 
group at 300 μM. 
 
To estimate the EC50, a linear logistic regression was carried out. 
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Fig. 4.9 Logistic regression of the dose – response curve of H2O2 in undifferentiated 
SH-SY5Y cells 
 
The EC50 of H2O2 in undifferentiated SH-SY5Y cells is calculated as: 
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EC50 =   
     
     = 0.000286 M = 286 μM 
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Fig. 4.10 Logistic regression of the dose – response curve of H2O2 in differentiated 
SH-SY5Y cells 
 
The EC50 of H2O2 in differentiated SH-SY5Y cells is calculated as: 
EC50 =   
     
     = 0.000230 M = 230 μM 
 
Hence, the EC50 concentration of H2O2 was estimated around 286 μM in 
undifferentiated SH-SY5Y cells and around 230 μM in differentiated SH-
SY5Y cells. Therefore these are the H2O2 concentrations used in further 
modulator test experiments in SH-SY5Y cells. 
 
4.3.3 Aβ1-42 aggregation and fibril 
 
Before Aβ is applied in cell proliferation assays, it should be incubated and 
aggregated first. TEM photos were taken for Aβ1-42 before and after the 1 week 
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incubation. These figures are shown in Fig. 4.11. 
 
          
 
 
Fig. 4.11 TEM graph of Aβ1-42 aggregation. A: negative control, B: Aβ1-42 before 
incubation, and C: Aβ1-42 after 1 week aggregation. Scale bar is 200 nM. 
A 
B 
C 
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Aβ1-42 aggregation and fibril formation are obvious in Fig. 4.11C. Compared 
with the negative control (Fig. 4.11A), the non-aggregated Aβ1-42 (Fig. 4.11B) 
is a short peptide of about 400 – 600 nm length. After 7 days incubation and 
aggregation, the aggregated Aβ1-42 was longer than 1 – 2 μm in length (Fig. 
4.11C). This confirms that the Aβ1-42 is aggregated after 7 days incubation. 
 
4.3.4 Aβ1-42 insult 
 
The Aβ1-42 insult was carried on the undifferentiated SH-SY5Y cells first, and 
the relevant dose – response curve is shown in Fig. 4.12. 
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Fig. 4.12 Dose – response curve for Aβ1-42 insult in undifferentiated SH-SY5Y cells. 
The data points were the means of 3 for 1 – 15 μM Aβ1-42 insult and the control, and 1 
for 40 μM Aβ1-42. 
 
From the figure, it can be seen that above 10 μM Aβ1-42 may cause cell death in 
undifferentiated SH-SY5Y cells, the relative cell number at 10 μM being 0.797 
± 0.00849. However, the standard errors in several groups are very large. A 
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one way ANOVA test for all the groups showed that the difference amongst 
the groups was not significant, but a t test between the 10 μM insult and the 
control showed a significant difference in the relative cell number (p < 0.01). 
 
The highest concentration of Aβ1-42 in this experiment only reduced the relative 
cell number to be 0.600, therefore, the EC50 could not be estimated from these 
data. 
 
The Aβ1-42 insult was then tested on differentiated SH-SY5Y cells for 
comparison. The relevant dose – response curve is shown in Fig. 4.13. 
 
-6.5 -6.0 -5.5 -5.0 -4.5
0.0
0.5
1.0
Lg Concentration (M)
R
e
la
ti
v
e
 c
e
ll
 n
u
m
b
e
r
 
Fig. 4.13 Dose – response curve for Aβ1-42 insult in differentiated SH-SY5Y cells 
 
This experiment was carried out in only one 96 well plate, but measurements 
were made in triplicate. The relative cell number was calculated from the 
average of the 3 wells. 
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To estimate the EC50 of Aβ1-42 on differentiated SH-SY5Y cell line, a linear 
logistic regression was carried out. The trend line is shown in Fig. 4.14. 
 
Hence, the EC50 was calculated as: 
EC50 =   
 
     
      = 0.0000361 M = 36.1 μM 
This EC50 is out of the dose range selected in the insult experiment, thus, it 
cannot be considered an acceptable EC50. 
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Fig. 4.14 Logistic regression to the dose – response curve of Aβ1-42 insult in 
differentiated SH-SY5Y cell line. 
 
4.3.5 Glutamate insult 
 
The glutamate insult was applied to the MOG-G-UVW cells and the data in the 
form of a dose – response curve is shown in Fig. 4.15. 
 
A one way ANOVA test for all the groups suggested that the difference  
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Fig. 4.15 Dose – response curve of glutamate insult in MOG-G-UVW cells. The data 
points are the means of 12 for 10 mM and the control, 9 for 300 μM, 1 mM and 30 
mM, 6 for 100 μM, 3 mM and 100 mM, and 3 for 10 μM, 5 mM and 20 mM. 
 
amongst those groups was significant (p < 0.001), and the Dunnett’s post test 
(comparing each group with the control) indicated that 1 mM, 3 mM, 10 mM, 
30 mM or higher dose of glutamate caused a significant reduction in the 
relative cell number from the control (p < 0.05 for 1 mM and p < 0.001 for the 
others). To estimate the EC50 of glutamate in MOG-G-UVW cells, the logistic 
regression is shown in Fig. 4. 16. 
 
EC50 =   
      
     = 0.0298 M = 29.8 mM 
So, the EC50 of glutamate to MOG-G-UVW cells was estimated as 29.8 mM.  
 
4.4 Discussion 
 
Based on the results above, the following ideas can be summarised. 
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y = 1.074x + 1.638
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Fig. 4.16 Logistic regression of the dose – response curve of glutamate insult in the 
MOG-G-UVW cell line. 
 
4.4.1 CoCl2 insult 
 
The “threshold” CoCl2 doses were 40 μM and 20 μM for undifferentiated and 
differentiated SH-SY5Y cells respectively, and the EC50 doses for CoCl2 were 
44 μM and 32 μM for undifferentiated and differentiated SH-SY5Y cells 
respectively. In addition, the relative cell number in differentiated SH-SY5Y 
cells was lower than the counterparts in undifferentiated cells under 10 μM and 
20 μM CoCl2. It would seem clear that the differentiated SH-SY5Y cells are 
more sensitive than the undifferentiated ones. It is tempting to suggest that this 
difference between undifferentiated and differentiated SH-SY5Y cells in 
sensitivities to CoCl2 insult could be linked to the difference on RyRIII 
expression in Q-PCR. 
 
From the Q-PCR results described in Chapter 3, it was shown that the 
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differentiated SH-SY5Y cells had a potentially higher expression RyRIII than 
the undifferentiated ones (about 6 fold). Hence we can tentatively propose that 
the cells with a higher RyRIII expression are more sensitive to CoCl2 insult. 
 
Why might this be the case? As mentioned in Section 4.1, CoCl2 is a hypoxia 
mimetic which may induce neuronal death (Gasperi et al., 2010), and also 
upregulates the expression of APP so increasing the generation of Aβ (Zhu et 
al., 2009). Further, as discussed in the introduction (see Chapter 1), Aβ plaque 
deposited on the neuronal membrane may form a Ca
2+
 channel and so 
potentially increase [Ca
2+
]i (Arispe et al., 2007, Berridge, 2010, Jang et al., 
2010). The end result is that CoCl2 may increase the [Ca
2+
]i in neurones. Also 
the RyR is a CICR channel on the ER and if activated would further increase 
[Ca
2+
]i finally precipitating cell death (Berridge, 2010, Manunta, 2000). This 
may then be the basis that the cells with higher RyRIII expression would be 
more sensitive to the [Ca
2+
]i increase induced by those insult models. 
 
Thus, when the same dose of CoCl2 was applied to both undifferentiated and 
differentiated SH-SY5Y cells, the same change in [Ca
2+
]i would occur initially 
and the RyR would be activated. Nevertheless, since there are more RyRIII 
expressed in the differentiated cells, more Ca
2+
 channels would be opened on 
the ER when they are activated, more Ca
2+
 would then be released from the ER 
in the differentiated cells. Consequently the [Ca
2+
]i increase would be greater in 
the differentiated cells than in the undifferentiated ones leading to more cell 
apoptosis or cell death. 
Cellular Basis of Neurodegeneration 
 
 
- 125 - 
 
However, this conclusion is debatable. The RyRIII expression in differentiated 
SH-SY5Y cells was 6 fold more than it in the undifferentiated cells, but the 
differences in EC50 in respect of relative cell numbers in the presence of 10 μM 
or 20 μM CoCl2 were not so markedly different, although significant. The 
possible reason to explain this is that [Ca
2+
]i homeostasis is maintained by a 
number of interacting systems, rather than RyR only. For example, IP3R 
(another Ca
2+
 release channel on the ER) can be blocked by Bcl-2 when the 
[Ca
2+
]i is increased (Berridge, 2010, Rong et al., 2008). Hence, the increase in 
[Ca
2+
]i caused by RyR activation would be possibly balanced by some other 
receptor or modulator so influencing Ca
2+
 levels. 
 
4.4.2 H2O2 insult 
 
From the H2O2 insult to both undifferentiated and differentiated SH-SY5Y 
cells, a similar difference was noticed. Differentiated cells could be 
compromised by H2O2 at a dose of 150 μM or higher, but the undifferentiated 
ones were not affected until the dose was increased to 300 μM. The relative 
cell numbers of the differentiated cells were lower than those of 
undifferentiated cells below 300 μM H2O2 insult, the relative cell numbers 
being 0.678 (± 0.127) and 0.223 (± 0.0310) respectively. In addition, the EC50 
in the undifferentiated cells (about 286 μM) was higher than the one in 
differentiated ones (230 μM). This difference between undifferentiated and 
differentiated SH-SY5Y cells in sensitivities to H2O2 insult can also be linked 
to the difference in RyRIII expression in Q-PCR, the differentiated SH-SY5Y 
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cells with a higher RyRIII expression being more sensitive to H2O2 insult. 
 
As discussed, previously oxidative stress has been linked with 
neurodegeneration, such as occurs in AD (Lin and Beal, 2006, Floyd, 1999, 
Floyd and Hensley, 2002), and H2O2 application, a model for oxidative stress 
(Ishimura et al., 2008), increases [Ca
2+
]i (Krebs et al., 2007). Therefore, the 
difference in susceptibility to H2O2 insult between undifferentiated and 
differentiated SH-SY5Y cells would possibly be contributed by the different 
expression of RyRIII. 
 
4.4.3 Aβ1-42 aggregation 
 
A number of previous studies have reported aggregation results. Reviews of the 
literature indicated that the aggregation of amyloid was quite variable in 
different samples or labs. In some of the studies, the aggregation was quite 
successful and the aggregated fibril of Aβ1-42 was even longer than 1 μm (see 
Fig. 4.17), while some others have failed to demonstrate such a long fibril after 
aggregation (see Fig. 4.18). 
 
 
Fig. 4.17 Aggregation of Aβ after 0 h, 12 h, 24 h, 48 h and 72 h of incubation (scale 
bar: 50 nm). It can be clearly observed that the amyloid fibril was aggregated and 
much longer than it was at the beginning. (Qahwash et al., 2007) 
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Fig. 4.18 Aggregation of Aβ25-35a after 6 days. They were short, rod-like aggregates 
with an average length in the interval 20 – 120 nm. (Fülöp et al., 2004) 
 
In the work reported here, the aggregation results of Aβ1-42 were also quite 
variable. Some of the successful aggregation results, and where long fibrils 
were present were comparable with data above (see Fig. 4.1), however, there 
were also some short aggregates even after 1 week incubation at 37 °C (see Fig. 
4.19). 
 
 
Fig. 4.19 TEM of Aβ1-42 after 1 week aggregation. It sould be noticed that some of the 
fibrils were still as short as 200 nm or less. Scale bar is 200 nm. 
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4.4.4 Aβ1-42 insult 
 
It was clear that the standard errors in the MTS assays of the challenge 
presented by Aβ1-42 were very large. Given the results of Aβ1-42 aggregation, it 
could be argued that the variable aggregation of the amyloid had resulted at 
least in part of the variation of the insult result. 
 
As discussed before, the non-aggregated Aβ1-42 has a limited toxic effect. 
Hence, one would expect that the cells treated with the non-aggregated Aβ1-42 
would show a higher relative cell number to the ones treated with the 
aggregated long fibrils. Therefore, the triplicated samples with the “same” 
treatment would produce quite different results and this would result in the 
large standard error. Thus, it may be reasonable that the mean of cell numbers 
under 20 μM Aβ1-42 insult is higher than the counterpart under 10 μM Aβ1-42 
insult in undifferentiated SH-SY5Y cells. Obviously, the standard error was 
significant in the Aβ insult results. 
 
Therefore, large variability of amyloid aggregation and the variable effect of 
Aβ1-42 were the reasons that Aβ1-42 was not selected as the primary cell insult in 
the future tests with modulators. However, even if there was significant 
variability, it still could be seen that the cell numbers, in both undifferentiated 
and differentiated SH-SY5Y cells, were reduced by the Aβ1-42 insult at 10 – 20 
μM or higher. Those results confirm at least that Aβ1-42 reduce the cell numbers 
in neuronal cell line. 
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4.4.5 Glutamate insult 
 
The EC50 of glutamate insult in MOG-G-UVW cells was very high (29.8 mM), 
in comparison with previous studies. The relative cell number results in 
glutamate were unstable in this work, for example 20 mM and 50 mM 
glutamate insult did not have any significant effect on the relative cell number 
in the Dunnett’s post test. This dose is much higher than the glutamate-receptor 
affinity requires (Km), it might be argued whether glutamate would induce 
neuronal death through binding with NMDA receptor. In addition, glutamate is 
easily switched into glutamine, which is non-toxic to most cells, in H2O 
solution. Hence, glutamate was not selected as an insult model to test the 
possible effects of RyR and K
+
 channel modulators. 
 
4.5 Conclusions 
 
4.5.1 Aβ1-42 aggregation 
 
Aβ1-42 is aggregated after 7 days incubation at 37 °C. The length of the amyloid 
is increased from about 400 nm to more than 1 μm or even 2 μm. 
 
The result of aggregation was however quite variable with some amyloid not 
been aggregated even after 1 week incubation. This has led to significant 
variability in the cell insult and MTS assays results with the peptide. 
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4.5.2 Cell insults 
 
Since the aim of this section of work was to try to establish the cell insult 
models in different cell lines, the first consideration is about the validity of 
these insult models. 
 
Aβ1-42 was toxic to both undifferentiated and differentiated SH-SY5Y cells, 10 
μM Aβ1-42 significantly reducing the relative cell number of undifferentiated 
SH-SY5Y cells, but the relative cell number was still higher than 0.5 even at 40 
μM. For the differentiated SH-SY5Y cells however, the relative cell number at 
20 μM is lower than 0.5. However, since the variability in respect of Aβ1-42 
aggregation was significant and the standard errors in the MTS assays were 
high also, Aβ1-42 was not selected as the principle cell insult model, but was 
used once to test the RyR modulators. 
 
CoCl2 as a hypoxia mimetic was established in both neuronal cell lines and the 
astrocytoma cell line used in this work. For the MOG-G-UVW cells, 10 μM or 
higher significantly reduced relative cell number, and the EC50 was estimated 
between 30 μM and 40 μM. For the undifferentiated SH-SY5Y cells, 40 μM or 
higher significantly reduced the relative cell number, and the EC50 was 
estimated at about 44 μM. For the differentiated SH-SY5Y cells, 20 μM or 
higher significantly reduced the relative cell number, and the EC50 was 
estimated at about 32 μM. And finally, for the undifferentiated NTERA-2 cells, 
20 μM or higher significantly reduced the relative cell number, and the EC50 
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was estimated at about 15 μM. 
 
H2O2, as a mimic of oxidative stress, was established in both undifferentiated 
and differentiated SH-SY5Y cells. For the undifferentiated SH-SY5Y cells, 
300 μM or higher significantly decreased the relative cell number, and the EC50 
was estimated at about 286 μM. For the differentiated SH-SY5Y cells, 150 μM 
or higher significantly decreased the relative cell number, and the EC50 was 
estimated at about 230 μM. 
 
The relevant data for the EC50 doses which were chosen for further 
experiments are listed in Table 4.1. 
 
Table 4.1 EC50 of each insult 
 MOG-G-UVW 
Undifferentiated 
NTERA-2 
Undifferentiated 
SH-SY5Y 
Differentiated 
SH-SY5Y 
CoCl2 32.2 μM 15 μM 40 μM 33 μM 
H2O2 - - 286 μM 230 μM 
 
4.5.3 Cell sensitivities to the insults 
 
As reported in the results and discussed above, it has been concluded that 
differentiated SH-SY5Y cells, which had a higher RyRIII expression than the 
undifferentiated ones, were more sensitive to both CoCl2 and H2O2 insults. 
 
Since it was presumed that a hypoxia mimetic, like CoCl2, and oxidative stress, 
like H2O2, reduced the cell viability by increasing the [Ca
2+
]i, and that RyRIII, 
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is a CICR channel in the neuronal cells, it is reasonable to propose that a higher 
expression of RyRIII could make the cells more sensitive to those insults. A 
corollary then is that RyRIII blockers, or other modulators which maintain the 
[Ca
2+
]i homeostasis, would potentially have a neuronal protective effect, at 
least against a hypoxia mimetic or an oxidative stress insult. Therefore, RyR 
modulators were tested subsequently in this thesis and this part of the work is 
presented in Chapter 5.  
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5. The Action of RyR Modulators 
on the Cell Insult Models 
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5. The Action of RyR Modulators on the Cell Insult Models 
 
5.1 Introduction 
 
 As soon as the Aβ1-42, hypoxia mimetic and oxidative stress insult models 
were established, the next step was to test whether the RyR blockers would 
have any neuroprotective effect or not, and whether RyRIII was more 
important than the other two isoforms of RyR. 
 
In the introduction (see Chapter 1), the point was made that the key problem in 
AD is the deposition of Aβ on the neuronal cell membrane and the forming of 
putative Ca
2+
 channels by Aβ plaque (Arispe et al., 2007, Berridge, 2010). As 
discussed in the previous section (see Section 4.1), both the hypoxia mimetic 
state induced by CoCl2 and oxidative stress caused by H2O2 may underpin 
neurodegeneration, such as occurs in AD (Gasperi et al., 2010, Lin and Beal, 
2006, Floyd and Hensley, 2002). Further, CoCl2 was found to increase the 
generation of Aβ via up-regulation of the expression of APP (Zhu et al., 2009) 
and H2O2 was found to increase the [Ca
2+
]i also (Krebs et al., 2007). As soon as 
[Ca
2+
]i is increased, the RyR, which is a Ca
2+
 release channel on ER, would be 
activated and could potentially further increase the [Ca
2+
]i. The large increase 
[Ca
2+
]i would stimulate and/or start cell apoptosis (Berridge, 2010). Therefore, 
in principle blocking of the RyR might present a neuroprotective strategy and 
hence it was considered worthwhile to test RyR modulators to see whether they 
could demonstrate any protective effect against the established cell insult 
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models. 
 
As discussed previously in Section 1.2.2 and Section 1.4.1, 3 isoforms of RyR 
have been identified with RyRI, RyRII and RyRIII mainly located in skeletal 
muscle, cardiac muscle and brain tissue respectively (Hakamata et al., 1992, 
Furuichi et al., 1994). This means, if a generic RyR blocker was applied, it 
would most likely have skeletal and/or cardiac side effects, even if there is any 
neuroprotective benefit. RyRIII is suggested to be the primary brain type of 
RyR, and was found to have a higher expression in the differentiated SH-SY5Y 
cells, human neurones which have been shown above to be more sensitive to 
both CoCl2 and H2O2 insults, than undifferentiated SH-SY5Y cells, RyRIII was 
therefore proposed to be the more likely putative target, rather than the other 2 
isoforms, for neuroprotection. Hence, the blockers for the RyRIII were tested 
in this section in the insults. 
 
However, there is no selective RyRIII blocker so far identified. The only 
proven RyRIII channel blockers are ruthenium red and dantrolene, but 
ruthenium red has been shown to block the other 2 isoforms of RyR and 
dantrolene blocks RyRI also (Alexander et al., 2009). Thus, it is impossible to 
test whether blocking RyRIII alone would protect the neurones against Aβ, 
hypoxia or oxidative insults. To deal with this problem, the idea adopted here 
was to use ruthenium red, dantrolene and the selective blockers for the RyRI 
and RyRII only, to see which, if any, would demonstrate any neuroprotective 
effect. There are two proven “selective” RyRI and RyRII blockers, ryanodine (> 
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100 μM) and procaine (Alexander et al., 2009). Ryanodine has a two-way 
effect on RyR, and not only blocks RyRI and RyRII but also activates all 3 
isoforms of RyR at low concentration (nM – μM). In addition, if it is believed 
that the activation to RyR, especially RyRIII, is an important pathogenesis in 
neuronal death, RyRIII activators should further induce the cell death when 
they are applied in combination with the cell insults. So, to test this hypothesis, 
RyR activators were also tested in this study. But, there is no selective RyRIII 
activator so far identified. The two available activators, which have been tested 
in this study, are generic RyR activators, caffeine and ryanodine (nM – μM) 
(Alexander et al., 2009). 
 
To summarise, the aims in this part of work were: 
a. to test whether RyR blockers, especially ruthenium red and dantrolene, 
protect the neuronal cells against the insults established; 
b. to test whether RyR activators, such as caffeine and ryanodine (nM – 
μM), further induce cell death in combination with the insults 
established; and 
c. to determine whether RyRIII is more important than the other 2 
isoforms of RyR in neuroprotection. 
 
5.2 Methods and materials 
 
5.2.1 Methods 
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The modulators were tested in the cell proliferation MTS assays, with the 
CoCl2 or Aβ1-42 tested against MOG-G-UVW, undifferentiated NTERA-2, 
undifferentiated SH-SY5Y and/or differentiated SH-SY5Y cells. The means 
were calculated from at least 3 plates and each plate was in triplicate wells. 
 
For ruthenium red, it has been suggested by previous studies that 1 – 500 μM 
blocks the RyR channel (Mori et al., 2005, Rosa et al., 1997). Hence, 1 – 500 
μM ruthenium red was tested in cell proliferation assays first to ascertain the 
dose effects which would result in little overt changes in cell numbers. Then, if 
this was the case, 1 – 500 μM ruthenium red was combined with the cell insults 
where the EC50 of each insult for each cell line was used. Then polynomial fits 
of cell number of ruthenium red and the respective insult were constructed and 
the optimal dose of ruthenium red, i.e. the dose which provided maximum 
protection, was estimated. 
 
For dantrolene, it has been suggested by previous studies that 100 nM – 100 
μM would block the RyR channel (Chen et al., 2011, Egea et al., 2007). Hence, 
100 nM – 100 μM dantrolene was tested in cell proliferation assays first to 
ascertain the doses which would result in little overt changes in cell numbers. 
Then, 100 nM – 100 μM dantrolene was combined with the CoCl2 insult where 
the EC50 dose for each cell line was used. The logistic regression was used to 
estimate, if possible, the EC50 of dantrolene alone, and the polynomial fit of 
cell number of dantrolene and CoCl2 insult was constructed and the optimal 
dose of dantrolene, i.e. the dose which provided maximum protection, was 
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estimated. 
 
For procaine, it was reported previously that 100 μM – 5 mM procaine blocks 
the RyRI or RyRII receptor (Rosa et al., 1997, Kimball et al., 1996, Usachev et 
al., 1993). Hence, 100 μM – 5 mM procaine alone was tested in cell 
proliferation assays first to find out the dose range which was safe for the cells. 
Then, 100 μM – 5 mM procaine was combined with the cell insult, where the 
EC50 of each insult for each cell line was used. 
 
For caffeine, it was reported previously that about 20 mM caffeine would 
active the RyR and 100 μM – 100 mM caffeine can increase the intracellular 
Ca
2+
 (Kato and Rubel, 1999, Parri and Crunelli, 2003). Hence, 100 μM – 100 
mM caffeine alone was tested in cell proliferation assays first to construct the 
dose – response curve and to ascertain the dose which would result in little 
overt changes in cell numbers. Then, 100 μM – 100 mM caffeine was 
combined with CoCl2 insult (EC50) to see its effect, if any, on cell numbers. 
 
For ryanodine, it has been suggested by previous studies that 10 nM – 2.5 μM 
can active the RyR channel (Hohenegger et al., 2002, Humerickhouse et al., 
1993), and higher concentrations at about hundred μM can block RyRI and 
RyRII (Humerickhouse et al., 1994). Considering the cost of ryanodine, only 
10 nM – 100 μM ryanodine was tested in cell proliferation assays first to 
construct the dose – response. Then, 10 nM – 100 μM ryanodine was combined 
with CoCl2 insult (EC50) to see its effects, if any, on cell numbers. 
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5.2.2 Polynomial regression 
 
Polynomial trend line was constructed to estimate the optimal dose of each 
drug, if protective. Polynomial regression can be a mimetic of any other 
functions, since any function can be expanded into a polynomial expansion 
according to Taylor series. For example, when x = a, function f(x) can be 
expanded as: 
f(x) =      
     
 
   
      
   
      
     
  
    
Here, n is a positive integer and n → positive infinity. 
 
The order of the polynomial regression should be 2 less than the population of 
data points. The optimal dose, i.e. the dose which provided maximum 
protection, is one of the inflection points of the polynomial trend line. 
Derivtisation was used to find the inflection points since, for any function, the 
first derivative should be 0 at the extrema. 
 
5.2.3 Drug preparation 
 
The five test compounds used are described below: 
 
 
Caffeine: C8H10N4O2, was from Sigma-Aldrich, was dissolved in PBS as 100 
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mM for stock and stored at 4 °C. 
 
Dantrolene: C14H10N4O5, sodium salt, was from Sigma-Aldrich, was dissolved 
in PBS as 10 mM for stock and stored at 4 °C. Dantrolene is light sensitive. 
 
 
Procaine hydrochloride: C13H20N2O2·HCl, > 97%, was from Sigma-Aldrich, 
was dissolved in PBS as 100 mM for stock and stored at 4 °C. 
H2N
O
O
N
 
 
Ruthenium red: Ruthenium oxychloride ammoniated, dye content approx. 40%, 
was from Sigma-Aldrich, was dissolved in H2O as 10 mM for stock and stored 
at 4 °C. Ruthenium red is light sensitive. 
  
 
Ryanodine: C25H35NO9, was from Tocris, was dissolved in PBS as 10 mM for 
stock and stored at -20 °C. Its structure is shown in Section 1.2.2. 
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5.3 Results 
 
5.3.1 Ruthenium red against CoCl2 insult 
 
5.3.1.1 On MOG-G-UVW cells 
 
The dose – response curve for ruthenium red in MOG-UVW cells is shown in 
Fig. 5.1: 
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Fig. 5.1 Dose-response curve of ruthenium red action in MOG-G-UVW cells. The 
points were the means of 3 for 2 μM, 5 μM, 25 μM and 250 μM, and were 6 for 1 μM, 
125 μM, 500 μM and the control. 
 
The one way ANOVA test for all the groups indicated that the difference 
among all the groups was significant (p < 0.001), and the Dunnett’s post test 
(comparing each group with the control) indicated that 25 μM or higher dose 
had a significant effect on the relative cell number from the control group (p < 
0.01 at 25 μM). Thus, it can be ascertained that the highest dose of ruthenium 
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red which would result in little overt change in cell number in MOG-G-UVW 
cells was 5 μM. Logistic regression is shown in Fig 5.2 and the EC50 is 
calculated thereafter. 
 
y = 0.9881x + 3.0331
R² = 0.7823
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Fig. 5.2 Logistic regression to the dose – response curve of ruthenium red action in 
MOG-G-UVW cells 
 
Hence, the EC50 of ruthenium red in MOG-G-UVW cells was calculated as: 
EC50 =   
      
       = 0.000852 M = 852 μM 
However, this concentration, 852 μM, is higher than the highest dose which 
has been tested, so, it is not good enough to be considered as the EC50 of 
ruthenium red in MOG-G-UVW cells. 
 
Then, ruthenium was tested on CoCl2 insult in MOG-G-UVW cells, and the 
dose – response curve is shown in Fig. 5.3. 
 
The one way ANOVA test for all the groups indicated that the difference  
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y = -0.0912x4 - 1.7522x3 - 12.4221x2 - 38.4521x - 43.3386
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Fig. 5.3 The effect of Ruthenium red (RR) in combination with an EC50 of CoCl2 (32.2 
μM) in MOG-G-UVW cells. Above: bar graph showing the significant protective 
effect, and bottom: dose – response curve of ruthenium red in the presence of an EC50 
of CoCl2. The data points are the means of 3 for CoCl2 + 1 μM ruthenium red, CoCl2 + 
24 μM ruthenium red, CoCl2 + 160 μM ruthenium red, and CoCl2 + 500 μM 
ruthenium red, and 6 for CoCl2 + 8 μM ruthenium red, CoCl2 + 64 μM ruthenium red, 
CoCl2 alone and the control. 
 
amongst the groups was significant (p < 0.001), and the Dunnett’s post test 
(comparing each group with CoCl2 insult) indicated that EC50 dose of CoCl2 
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had a significant effect on the relative cell number from the control group (p < 
0.001) and indicated that 64 μM or 160 μM ruthenium red in combination with 
an EC50 of CoCl2 had a significant effect on the relative cell numbers compared 
with the CoCl2 insult group (p < 0.001 and p < 0.01 respectively). 
 
The optimal dose of ruthenium red against CoCl2 insult in MOG-G-UVW cells 
was then calculated according to the polynomial trend line shown in Fig. 5.3. 
y = -0.0912 x
4
 + 0.437 x
3
 – 0.587 x2 + 0.193 x + 0.429 
Here, y represents the relative cell number and x represents the lg 
concentration of ruthenium red (M), and R
2
 = 0.925. 
 
To calculate the optimal dose, which is one of the inflection points in the 
function above, the first derivative of it should be 0. 
y’ = 0, so 
y’ = 4 × (-0.0912) × x3 + 3 × 0.437 × x2 – 2 × 0.587 × x + 0.193 = 0 
thus, x = 0.000201 = 201 μM 
 
Hence, the optimal dose of ruthenium red against CoCl2 insult in MOG-G-
UVW cells, which provided maximum protection, was estimated as 201 μM. 
 
5.3.1.2 Undifferentiated NTERA-2 cells 
 
Besides the astrocytoma cell line, the action of ruthenium red was also tested 
on neuronal cells. The dose – response curve of ruthenium red action in 
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undifferentiated NTERA-2 cells is shown in Fig. 5.4. 
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Fig. 5.4 Dose – response curve of ruthenium red action in undifferentiated NTERA-2 
cells. The data points are the means of 3 in each group. 
 
The one way ANOVA test for all the groups indicated that the difference 
amongst the groups was significant (p < 0.01), and the Dunnett’s post test 
indicated that 500 μM ruthenium red had a significant effect on the relative cell 
number from the control group (p < 0.05). Hence, 125 μM or lower dose of 
ruthenium red did not cause an overt reduction in cell number from the control 
in undifferentiated NTERA-2 cells. 
 
Ruthenium red was then tested on the CoCl2 insult (15 μM) in undifferentiated 
NTERA-2 cells, and the results are shown in Fig. 5.5. 
 
The one way ANOVA test for all the groups indicated that the difference 
amongst the groups was not significant. That was because of the large standard  
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Fig. 5.5 The effect of ruthenium red (RR) in combination with an EC50 of CoCl2 (15 
μM) in undifferentiated NTERA-2 cells. Above: bar graph, and bottom: dose – 
response curve of ruthenium red effect. The points are the means of 3. 
 
error in the CoCl2 + 1 μM ruthenium red group. After this group was removed 
from the statistical test, the one way ANOVA test indicated that the difference 
amongst the rest of the groups was significant (p < 0.001), and the Dunnett’s 
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post test (comparing each group with the CoCl2 group) indicated that 64 μM 
ruthenium red in the presence of an EC50 of CoCl2 caused a significant increase 
in the relative cell number from the CoCl2 insult (p < 0.05). 
 
The optimal dose of ruthenium red against CoCl2 insult was then calculated 
based on the polynomial trend line in Fig. 5.5. 
y = -0.131 x
2
 – 1.24 x + 2.15 
Here, y represents the relative cell number, and x represents the lg 
concentration of ruthenium red (M). 
 
To calculate the optimal does, which is the inflection point of the polynomial 
trend line above: 
y’ = 2 × (-0.131) × x – 1.24 = 0 
Hence, the optimal dose of ruthenium red, which provided maximum 
protection, was estimated as 18.8 μM. 
 
5.3.1.3 Undifferentiated SH-SY5Y cells 
 
In addition to NTERA-2 cell line, another neuronal cell line, SH-SY5Y, was 
also selected to test the action of ruthenium red in this study. Firstly, the dose – 
response curve of ruthenium red alone in undifferentiated SH-SY5Y cells is 
shown in Fig. 5.6. 
 
The one way ANOVA test for all the groups indicated that the difference  
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Fig. 5.6 Dose – response curve of ruthenium red action in undifferentiated SH-SY5Y 
cells. The data points are the means of 6. 
 
amongst the groups was significant (p < 0.001), but the Dunnett’s post test 
(comparing each group with the control) did not indicate any significant 
difference in relative cell numbers in ruthenium red treatment comparing with 
the control group. That means ruthenium red is safe for undifferentiated SH-
SY5Y cells in this dose range (1 – 500 μM). 
 
Then, ruthenium red was tested on CoCl2 insult in undifferentiated SH-SY5Y 
cells, and the results are shown in Fig. 5.7. 
 
The one way ANOVA test for all the groups indicated that the difference 
among those groups was significant (p < 0.001), and the Dunnett’s post test 
(comparing each group with CoCl2 alone) suggested that 40 μM CoCl2 had a 
significant effect on the relative cell number from the control (p < 0.001), 10 
μM ruthenium red in presence of CoCl2 insult caused an increase in the relative 
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Fig. 5.7 The effect of ruthenium red (RR) in combination with an EC50 of CoCl2 (40 
μM) in undifferentiated SH-SY5Y cells. The data points are the means of 9 for CoCl2 
+ 10 μM RR, CoCl2 alone and the control, and 3 for CoCl2 + 1 μM RR and CoCl2 + 
100 μM RR. 
 
cell number from CoCl2 alone (p < 0.05), and 100 μM ruthenium red in 
presence of CoCl2 insult caused a reduction from CoCl2 alone (p < 0.001). 
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Then, the optimal dose of ruthenium red against CoCl2 insult was calculated 
based on the polynomial trend line in Fig. 5.7: 
y = -0.285x
2
 – 2.96x -7.18 
Here, “y” represents the relative cell number, and “x” represents the lg 
concentration of ruthenium red. To calculate the optimal dose, which is the 
inflection point of the above function, following calculation was done 
thereafter: 
y’ = 2 × (-0.285) × x – 2.96 = 0 
 Hence, the optimal dose of ruthenium red against CoCl2 insult in 
undifferentiated SH-SY5Y cells, which provided the maximum protection, was 
estimated as 6.46 μM. 
 
5.3.1.4 Differentiated SH-SY5Y cells 
 
Further to the undifferentiated SH-SY5Y cells, the effect of ruthenium red was 
also tested on the differentiated counterpart. The dose – response curve of 
ruthenium red in differentiated SH-SY5Y is shown in Fig. 5.8. 
 
The one way ANOVA test for all the groups indicated that the difference 
among those groups was significant (p < 0.01), and the Dunnett’s post test 
(comparing each group with the control) suggested that 5 μM ruthenium red 
caused a significant increase in the relative cell number from the control group 
(p < 0.05). That means ruthenium red is safe for differentiated SH-SY5Y cells 
in this range of dose (1 – 500 μM). 
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Fig. 5.8 Dose – response curve of ruthenium red in differentiated SH-SY5Y cells. The 
data points are the means of 9. 
 
Then, ruthenium red was tested on the CoCl2 insult in differentiated SH-SY5Y 
cells. The results are shown in Fig. 5.9. 
 
The one way ANOVA test for all the groups indicated that the difference 
among those groups was significant (p < 0.001), and the Dunnett’s post test 
(comparing each group with the CoCl2 alone) indicated that 30 μM CoCl2 
alone caused a significant reduction in the relative cell number from the control, 
and 20 μM ruthenium red in the presence of CoCl2 insult had a significant 
effect on the relative cell number from CoCl2 alone (p < 0.05). 
 
Then, the optimal dose of ruthenium red in differentiated SH-SY5Y cells was 
calculated based on the polynomial trend line in Fig. 5.9: 
y = -1.587x
2
 – 14.62x – 32.77 
Hence, the optimal dose, which is the inflection point of the trend line above, 
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Fig. 5.9 The effect of ruthenium red (RR) in combination with CoCl2 insult (30 μM) in 
differentiated SH-SY5Y cells. The data points are the means of 6 for CoCl2 + 20 μM 
ruthenium red, and 3 for all the other groups. 
 
was calculated. 
y’ = 2 × (-1.587) × x – 14.62 = 0 
Thus, the optimal dose, which provided the maximum protection, against 
CoCl2 insult in differentiated SH-SY5Y was estimated as 24.8 μM. 
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5.3.2 Dantrolene against CoCl2 insult 
 
Besides ruthenium red which is a generic RyR blocker, another RyR blocker, 
dantrolene, was also tested in the presence of CoCl2 insult. As introduced 
before, dantrolene can “selectively” block RyRI and RyRIII (see Section 5.1). 
 
5.3.2.1 On MOG-G-UVW cells 
 
The dose-response curve for dantrolene in MOG-G-UVW cells is shown in Fig. 
5.10. 
 
The one way ANOVA test for all the groups in Fig. 5.10 indicated that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the control) indicated that 100 μM 
dantrolene caused a significant reduction in the relative cell number (p < 0.001), 
but the 1% vehicle, DMSO, did not have any overt effect on relative cell 
number. That means dantrolene is ineffective in MOG-G-UVW cells at 10 μM 
or lower concentration. 
 
Dantrolene was then tested on CoCl2 insult in MOG-G-UVW cells, and the 
results are shown in Fig. 5.11. 
 
The one way ANOVA test for all the groups in Fig. 5.11 suggested that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s  
Cellular Basis of Neurodegeneration 
 
 
- 154 - 
 
-7 -6 -5 -4
0.0
0.5
1.0
Lg Concentration (M)
R
e
la
ti
v
e
 c
e
ll
 n
u
m
b
e
r
 
 
Fig. 5.10 Dose – response of dantrolene in MOG-G-UVW cells. Above: dose – 
response curve of dantrolene alone, and bottom: bar graph showing the vehicle, 
DMSO. The data points are the means of 3. 
 
post test (comparing each group with CoCl2 alone) indicated that CoCl2 insult 
caused a significant reduction in the relative cell number from the control (p < 
0.001), and 100 nM, 300 nM and 1 μM dantrolene in the presence of CoCl2 had 
significant effects on the relative cell number from CoCl2 alone (p < 0.001, p < 
0.05 and p < 0.001 respectively). 
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Fig. 5.11 The effect of dantrolene in combination with an EC50 of CoCl2 (32.2 μM). 
Above: bar graph, and bottom: polynomial trend line. The data points are the means of 
30 for CoCl2 alone and the control, 6 for CoCl2 + 100 nM dantrolene, CoCl2 + 1 μM 
dantrolene and CoCl2 + 10 μM dantrolene, and 3 for all the rest groups. 
 
Then, the optimal dose of dantrolene against CoCl2 insult in MOG-G-UVW 
cells, which provided the maximum protection, was calculated based on the 
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polynomial trend line in Fig. 5.11, which is: 
y = 0.0643x
5
 + 1.820x
4
 + 20.45x
3
 + 113.9x
2
 + 314.3x + 343.8 
Here, “y” represents the relative cell number, and “x” represents the lg 
concentration of dantrolene. The optimal dose, which should be one of the 
inflection points, was calculated thereafter. 
y’ = 5 × 0.0643 × x4 + 4 × 1.820 × x3 + 3 × 20.45 × x2 + 2 × 113.9 × x + 314.3 
= 0 
Hence, the optimal dose of dantrolene against CoCl2 insult in MOG-G-UVW 
cells was estimated as 200 nM. 
 
5.3.2.2 On undifferentiated SH-SY5Y cells 
 
In addition to the astrocytoma cell line, the effect of dantrolene was also tested 
on the neuronal cell line, SH-SY5Y. The dose – response curve for dantrolene 
in undifferentiated SH-SY5Y cells is shown in Fig. 5.12. 
 
The one way ANOVA test for all the groups in Fig. 5.12 indicated that the 
difference among those groups was significant (p < 0.001), and Dunnett’s post 
test (comparing each group with the control) indicated that 10 μM and 100 μM 
dantrolene alone caused a significant reduction in the relative cell number from 
the control (p < 0.05 and p < 0.001) respectively, but the vehicle, DMSO, did 
not have any overt effect on the relative cell number from the control group. 
 
Dantrolene was then tested on a CoCl2 insult in undifferentiated SH-SY5Y  
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Fig. 5.12 Dose - response of dantrolene alone in undifferentiated SH-SY5Y cells. 
Above: dose – response curve, and bottom: bar graph showing the vehicle, DMSO. 
The data points are the means for 3. 
 
cells. The results are shown in Fig. 5.13. 
 
The one way ANOVA test for all the groups in Fig. 5.13 showed that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the CoCl2 insult) indicated that 40 μM  
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Fig. 5.13 The effect of dantrolene in combination with an EC50 of CoCl2 (40 μM). 
Above: bar graph, and bottom: polynomial trend line of dantrolene effect in presence 
of CoCl2 insult. The data points are the means of 3. 
 
CoCl2 caused a significant reduction in the relative cell number from the 
control (p < 0.001), 100 nM, 600 nM and 4 μM dantrolene in presence of 
CoCl2 insult caused a significant increase in the relative cell numbers from the 
CoCl2 insult (p < 0.001, p < 0.01 and p < 0.001 respectively), but 160 μM 
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dantrolene in presence of CoCl2 insult caused a further reduction in the relative 
cell number from the CoCl2 insult ( p < 0.001). 
 
Thereafter, the optimal dose of dantrolene against CoCl2 insult in 
undifferentiated SH-SY5Y cells, which provided the maximum protection, was 
calculated based on the polynomial trend line in Fig. 5.13. 
y = -0.0169x
3
 – 0.3111x2 – 1.896x – 3.508 
Here, “y” represents the relative cell number, and “x” represents the lg 
concentration of dantrolene. The optimal dose, which is one of the inflection 
points of the above trend line, is therefore calculated. 
y’ = 3 × (-0.0169) × x2 – 2 × 0.3111 × x -1.896 = 0 
The optimal dose of dantrolene against CoCl2 insult in undifferentiated SH-
SY5Y cells was then estimated as 2.34 μM. 
 
5.3.3 Procaine effect on CoCl2 insult 
 
Besides the generic RyR blocker (ruthenium red) and a “selective” RyRI & 
RyRIII blocker (dantrolene), a third RyR blocker, procaine, has also been 
tested in this Thesis. As introduced above (see Section 5.1), procaine is a 
“selective” blocker for RyRI and RyRII. 
 
5.3.3.1 On MOG-G-UVW cells 
 
The dose – response curve of procaine in MOG-G-UVW cells is shown in Fig. 
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Fig. 5.14 Dose – response curve of procaine in MOG-G-UVW cells. The data points 
are the means of 15 for 700 μM and the control, 6 for 100 μM, 250 μM and 2 mM, and 
3 for 1.9 mM and 5 mM.  
 
The one way ANOVA tested for all the groups in Fig. 5.14 showed that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the control) indicated that 1.9 mM or 
higher dose of procaine caused significant reduction in the relative cell number 
from the control (p < 0.01 for 1.9 mM, and p < 0.001 for 2 mM and 5 mM). 
That means 700 μM or lower dose of procaine had little effect on the relative 
cell number in MOG-G-UVW cells. 
 
To estimate the EC50 of procaine in MOG-G-UVW cells, a logistic regression 
was done and the trend line is shown in Fig. 5.15. 
 
Then, the EC50 of procaine is calculated below: 
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Fig. 5.15 Logistic regression of procaine action in MOG-G-UVW cells 
 
EC50 =   
      
      = 0.004887 M = 4.89 mM. 
 
Procaine was then tested on a CoCl2 insult in MOG-G-UVW cells and the 
results are shown in Fig. 5.16. 
 
The one way ANOVA test for all the groups in Fig. 5.16 indicated that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with CoCl2 insult) indicated that CoCl2 insult 
caused a significant reduction in the relative cell number from the control (p < 
0.001), and 5 mM procaine in presence of CoCl2 had a significant effect on the 
relative cell number from CoCl2 alone (p < 0.01). The results suggested that 
procaine did not protect the MOG-G-UVW cells from an EC50 dose of CoCl2 
insult. 
 
5.3.3.2 On undifferentiated NTERA-2 cells 
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Fig. 5.16 The effect of procaine in combination with an EC50 of CoCl2 (32.2 μM) in 
MOG-G-UVW cells. The data points are the means of 3. 
 
In addition to the astrocytoma cell line, the possible effect of procaine, if any, 
has also been tested on neuronal cell lines. The results in undifferentiated 
NTERA-2 cells are presented here in Fig. 5.17. 
 
The one way ANOVA test for all the groups in Fig. 5.17 indicated that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the CoCl2 alone) indicated that CoCl2 
insult caused a significant reduction in the relative cell number from the control 
(p < 0.001), but procaine in the presence of CoCl2 insult did not have any 
significant effect on the relative cell number from CoCl2 alone. The results 
suggested that procaine has not protected the NTERA-2 cells from an EC50 of 
CoCl2 insult. 
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Fig. 5.17 The effect of procaine in combination with an EC50 of CoCl2 (15 μM) in 
undifferentiated NTERA-2 cells. The data points are the means of 6 for CoCl2 alone 
and the control, and 3 for procaine in combination with CoCl2 insult. 
 
5.3.3.3 Differentiated SH-SY5Y cells 
 
Besides the NTERA-2 cells, another neuronal cell line, differentiated SH-
SY5Y cells, was also selected to test the possible effect, if any, of procaine. 
One dose of procaine (5 mM) has been tested in combination with an EC50 
dose of CoCl2 insult (30 μM) in differentiated SH-SY5Y cells. The results are 
shown in Fig. 5.18. 
 
The one way ANOVA test for all the groups in Fig. 5.18 indicated that the 
difference among those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 insult  
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Fig. 5.18 The effect of procaine (5 mM) in combination with CoCl2 insult (30 μM) in 
differentiated SH-SY5Y cells. The data points are the mean of 21 for the CoCl2 alone 
and the control, 6 for 5 mM procaine alone, and 3 for procaine in combination with 
CoCl2 insult. 
 
caused a significant reduction in the relative cell number from the control (p < 
0.001), and procaine in the presence of CoCl2 insult had a significant effect on 
the relative cell number from the CoCl2 alone (p < 0.01), but procaine alone 
did not cause any overt reduction in the relative cell number from the control. 
The results suggested that procaine aggravates the insult of CoCl2 in 
differentiated SH-SY5Y cells. 
 
5.3.4 Ryanodine effect on CoCl2 insult 
 
Besides procaine, ryanodine is another “selective” RyRI and RyRII blocker. 
But, ryanodine has a two-way effect on the RyR, as introduced above (see 
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Section 5.1): it can be a generic RyR activator at low concentrations (nM – 
μM), and can block RyRI and RyRII at a high concentration (about hundred 
μM). Thus, the possible effect, if any, of ryanodine in the presence of hypoxia 
mimetic has been tested in MOG-G-UVW cells. The dose - response of 
ryanodine alone is shown in Fig. 5.19. 
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Fig. 5.19 Dose - response of ryanodine in MOG-G-UVW cells. The results are the 
means of 3. 
 
The one way ANOVA test for all the groups in Fig. 5.19 indicated that the 
difference among those groups was not significant. That shows ryanodine has 
little effect on the relative cell number in MOG-G-UVW cells in this dose 
range (10 nM – 100 μM). The effect of ryanodine was then tested in 
combination with CoCl2 insult in MOG-G-UVW cells, and the results are 
shown in Fig. 5.20. 
 
The one way ANOVA test for all the groups in Fig. 5.20 suggested that the 
Cellular Basis of Neurodegeneration 
 
 
- 166 - 
 
 
Fig. 5.20 The effect of ryanodine in combination with an EC50 of CoCl2 insult (32.2 
μM). The results are the mean of 3. 
 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the CoCl2 alone) indicated that CoCl2 
insult caused a significant reduction in the relative cell number from the control 
(p < 0.001), 10 μM and 200 μM ryanodine in presence of CoCl2 insult had 
significant effects on the relative number from the CoCl2 insult (p < 0.01 and p 
< 0.05 respectively), but 4.5 μM or higher dose of ryanodine in presence of 
CoCl2 did not have any significant effect on the relative cell number from the 
CoCl2 insult. The results suggested that ryanodine aggravates the insult of 
CoCl2 at a low concentration which actives all the three isoforms of RyR, but 
has little effect on the relative cell number at a high concentration, which 
blocks both RyRI and RyRII. 
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5.3.5 Caffeine effect on CoCl2 insult 
 
In addition to a high dose of ryanodine, another generic RyR activator, caffeine, 
has also been tested in this Thesis. The dose – response curve of caffeine alone 
in MOG-G-UVW cells is shown in Fig. 5.21. 
 
-4 -3 -2 -1
0.0
0.5
1.0
Lg Concentration (M)
R
e
la
ti
v
e
 c
e
ll
 n
u
m
b
e
r
 
Fig. 5.21 Dose – response curve of caffeine in MOG-G-UVW cells. The data points 
are the means of 3. 
 
The one way ANOVA test for all the groups in Fig. 5.21 indicated that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the control) indicated that 3 mM or 
higher dose of caffeine caused a significant reduction in the relative cell 
number from the control (p < 0.001). 
 
To estimate the EC50 of caffeine in MOG-G-UVW cells, the logistic regression 
has been constructed in Fig. 5.22. 
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Fig. 5.22 Logistic regression of the effect of caffeine alone in MOG-G-UVW cells 
 
Hence, the EC50 of caffeine in MOG-G-UVW is: 
EC50 =   
      
      = 0.00564 M = 5.64 mM 
 
Caffeine was then tested on CoCl2 insult in MOG-G-UVW cells, and the 
results are shown in Fig. 5.23. 
 
The one way ANOVA test for all the groups in Fig. 5.23 indicated that the 
difference among those groups was significant (p < 0.001), and the Dunnett’s 
post test (comparing each group with the CoCl2 alone) indicated that CoCl2 
insult caused a significant reduction in the relative cell number from the control 
(p < 0.001), and 10 mM – 100 mM caffeine in the presence of CoCl2 insult had 
significant effects on the relative cell number from the CoCl2 alone (p < 0.001). 
The results suggested that caffeine cannot protect MOG-G-UVW cells from 
CoCl2 insult. 
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Fig. 5.23 The effect of caffeine in combination with an EC50 of CoCl2 insult (32.2 μM) 
in MOG-G-UVW cells. The results are the means of 3. 
 
5.3.6 Ruthenium red and procaine effect on Aβ1-42 insult 
 
In addition to the hypoxia mimetic effect induced by CoCl2, another insult, 
Aβ1-42, has also been selected to test for a possible effect, if any, of the RyR 
blockers, such as ruthenium red and procaine. The results are shown in Fig. 
5.24. 
 
The one way ANOVA test for all the groups indicated that the difference 
among those groups was significant (p < 0.001), and the Tukey’s post test 
(comparing every two groups) indicated that 5 mM procaine in the presence of 
Aβ1-42 had a significant effect on the relative cell number from the Aβ1-42 alone. 
The results suggested that procaine is not protective in presence of Aβ1-42, and 
ruthenium red has a trend to be protective, although not significant. 
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Fig. 5.24 The action of ruthenium red (10 μM) or procaine (5 mM) on Aβ1-42 insult 
(15.5 μM) in undifferentiated SH-SY5Y cells. The results are the mean of 3. 
 
5.4 Discussion 
 
From all those results above, the effects of RyR modulators can be summarised 
as below: 
 
5.4.1 RyR blockade 
 
As introduced before (see Section 1.2.2 and 1.4.1), the RyR activation induced 
by the overload of [Ca
2+
]i stress in cells, can release more Ca
2+
 from ER and 
further increase the [Ca
2+
]i which can induce cell death. And, according to the 
Q-PCR results in Section 3 and the cell insult results in Section 4, the cells 
with higher RyRIII expression (i.e. differentiated SH-SY5Y) are more sensitive 
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to the cell insults which may increase the [Ca
2+
]i, including the hypoxia 
mimetic effect induced by CoCl2 and oxidative stress induced by H2O2, than 
those with lower expression (i.e. undifferentiated SH-SY5Y). If it is the case 
that the RyR is partly responsible to the cell death, the blockade of RyR should 
be protective. Hence, RyR blockers ruthenium red and dantrolene have been 
tested here. 
 
According to the results above, ruthenium red, a generic RyR blocker, is 
protective. In MOG-G-UVW cells, ruthenium red in combination with an EC50 
dose of CoCl2 insult caused an increase in the relative cell number from the 
CoCl2 alone, although ruthenium red alone caused a reduction in the cell 
number from the control (see Section 5.3.1.1). In undifferentiated NTERA-2 
cells, ruthenium red in the presence of CoCl2 insult caused an increase in the 
relative cell number at a dose where ruthenium red alone had little effect on the 
cell number (see Section 5.3.1.2). In both undifferentiated and differentiated 
SH-SY5Y cells, ruthenium red alone did not cause any overt reduction in the 
cell number, but ruthenium red in combination with CoCl2 insult caused an 
increase in the relative cell number from the CoCl2 alone (see Section 5.3.1.3 
and 5.3.1.4). In addition to the CoCl2 insult, ruthenium red has also shown a 
trend to be protective in the presence of Aβ1-42 insult in MOG-G-UVW cells, 
although not significantly (see Section 5.3.6). All of those results suggested 
that generic blockade of the RyR by ruthenium red is protective in the cells. 
 
Furthermore, dantrolene, which is a “selective” RyRI and RyRIII blocker, is 
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also protective. In both MOG-G-UVW and undifferentiated SH-SY5Y cells, 
dantrolene in combination with the EC50 of CoCl2 insult caused an increase in 
the relative cell number from the CoCl2 alone at low concentration (100 nM – 
μM) where dantrolene alone has little effect on the cell numbers (see Section 
5.3.2). 
 
Thus, it can be suggested that generic blockade is protective, at least against 
the hypoxia mimetic effect induced by CoCl2, in both astrocytoma and 
neuronal cell lines. And, as for the selectivity amongst all the three isoforms of 
RyR, it is possible that RyRI and/or RyRIII are/is playing an important role 
rather than RyRII because of the protective effect demonstrated by dantrolene. 
 
5.4.2 RyR activation 
 
In addition to the blockade, the opposite modulation was also considered and 
tested in this Thesis. If it is believed that blockade of the RyR is protective in 
the presence of the insult, the activation to RyR should aggravate the effect of 
insult, or at least cannot be protective. Hence, two generic RyR activators, 
caffeine and ryanodine (10 nM – 1 μM) were tested in this Thesis. 
 
Caffeine is not protective. In MOG-G-UVW cells, caffeine in combination 
with an EC50 of CoCl2 insult caused a reduction in the relative cell number 
from the CoCl2 alone. This effect of caffeine appeared at a high dose where 
caffeine alone caused a reduction in the relative cell number (see Section 5.3.5). 
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Nevertheless, ryanodine has aggravated the CoCl2 insult. In MOG-G-UVW 
cells, with an EC50 of CoCl2 challenge, a low concentration of ryanodine, 
which is an active dose for RyR, caused a reduction in the relative cell number 
from CoCl2 alone. The dose of ryanodine alone had little effect on the relative 
cell number (see Section 5.3.4). 
 
Therefore, it can be suggested that the blockade of the RyR, especially RyRI 
and/or RyRIII can be protective in these cells, but the activation of RyR is not 
protective, or even may aggravate the insult. 
 
5.4.3 RyRIII as a selective target 
 
Although the blockade of the RyR is suggested to be protective, there is still 
one concern left: generic blockade of the RyR can cause side effects on tissues 
or organs other than brain neurones. So, it is important to know which isoform 
of RyR is more important in neuronal death, if there is any selectivity among 
the three isoforms. 
 
Thus, procaine and ryanodine (high dose), which are “selective” RyRI and 
RyRII blockers, were also tested in this study. 
 
Procaine is not protective. In MOG-G-UVW cells, procaine in combination 
with an EC50 of CoCl2 insult caused a reduction in the relative cell number 
from the CoCl2 alone. This effect appeared at a high dose of procaine which 
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alone had caused a reduction in the cell number (see Section 5.3.3.1). In 
undifferentiated NTERA-2 cells, procaine in the presence of CoCl2 insult did 
not have any effect on the relative cell number from the CoCl2 alone. And, in 
differentiated SH-SY5Y cells, in the face of an EC50 dose of CoCl2, procaine 
has aggravated the insult at a dose where procaine alone has little effect on the 
cell number. 
 
Ryanodine at a high dose (> 10 μM) is not protective either. In MOG-G-UVW 
cells, ryanodine in combination with CoCl2 insult did not have any effect on 
the relative cell number at a high dose, although it has caused a reduction at 
low doses which can activate RyR. 
 
Hence, it can be suggested that the blockade of the RyRI and RyRII is not 
protective against the hypoxia mimetic effect induced by CoCl2. It is then 
possible that another isoform of RyR, RyRIII, is more important in neuronal 
death than RyRI and RyRII. This is consistent with previous studies which 
suggest that RyRIII is the brain type of RyR (see Section 1.2.2), and is 
consistent with the results in Chapter 3 and 4. However, whether RyRIII may 
possibly be expressed in other tissues or organs is still unsure. Therefore, PCR 
or western blot work to test the expression of RyRIII in the tissues or organs 
other than neurones is also needed. If the results might be negative, it would be 
more solid to suggest that RyRIII is a good neuroprotective target for future 
drug development. 
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5.5 Conclusions 
 
Summarising all the results and discussion in this chapter, it may be concluded 
that: 
 
a. generic activation of RyR, with caffeine or a low dose of ryanodine is 
not protective in cells against a hypoxia mimetic effect induced by 
CoCl2, and may even aggravate the insult by further reducing the 
relative cell number; 
b. generic blockade of the RyR with ruthenium red, or blockade of the 
RyRI and RyRIII with dantrolene, is protective in both astrocytoma and 
neuronal cells on the hypoxia mimetic effect induced by CoCl2, and 
may even tend to be protective against the Aβ1-42 insult; 
c. selective blockade of the RyRI and RyRII, with procaine or high dose 
of ryanodine, is not protective in either astrocytoma or neuronal cells on 
the hypoxia mimetic effect induced by CoCl2. 
 
Therefore, it is possible that selective blockade of the RyRIII could be 
neuroprotective. If this is the case, RyRIII could be a good target for neuronal 
protection which could avoid the side effects on the other tissues or organs. 
Thus, possible future work can be: 
a. to test the modulators above on other insults, such as oxidative stress 
induced by H2O2; 
b. to test other RyR modulators if available, such as suramin, which is an 
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activator of RyRI and RyRII; and 
c. to study the modulator binding domains on RyR, especially the 
differences in binding domains between RyRIII and the other two 
isoforms of RyR. 
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6. The Action of BK Modulators on the Cell Insult Models 
 
6.1 Introduction 
 
In addition to RyRIII, a K
+
 channel, such as the BK, has been demonstrated as 
being neuroprotective. As discussed in the introduction (see Section 1.4.2.1), 
previous studies have found that BK channel prevalence was increased in 
hippocampal neurones from a transgenic AD mouse model (Tg2576, 
KM670/671NL) (Coles et al., 2008) and the activation of BK channel can 
protect neurones from glutamate insult (Liao et al., 2010). Since a selective 
RyRIII blocker is still unavailable, K
+
 channel modulators were tested in this 
Thesis to determine some other possible targets to protect the neurones. The 
work on the BK channel is introduced in this chapter. 
 
It has been proposed that neuronal death is mediated by an increase of [Ca
2+
]i, 
for example via the Ca
2+
 influx channel formed by Aβ plaque, and the possible 
neuroprotective effect presented by BK channel activation is related to the 
reduction of Ca
2+
 influx. It was suggested that neurones can be hyperpolarized 
by K
+
 leaving the cells and driving the membrane potential towards the K
+
 
equilibrium potential. Such a repolarisation, or even hyperpolarisation, would 
cause a negative feed-back-regulation of Ca
2+
 influx and neurotransmitter 
release, and may thus constitute a powerful stop on cell excitation, Ca
2+
 
accumulation and excitotoxicity (Liao et al., 2010). For the details about the 
“negative feed-back-regulation of Ca2+ influx”, some other studies have shown 
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that BK channel in the presynaptic terminal membrane can cause spike 
narrowing and thus limit Ca
2+
 entry (Robitaille and Charlton, 1992). Other 
studies also suggest that BK activation can block Ca
2+
 entry through Cav 
channels and NMDA receptors by hyperpolarizing neurones and thus 
preventing neurotransmitter release and Ca
2+
-overload (Wulff and Zhorov, 
2008, Gribkoff et al., 2001). 
 
Previous studies on homozygous mice lacking the BK channel α subunit have 
found that neuronal cell death, brain tissue infarct volume and area, animal 
mortality percentage and neurological deficit score were significantly increased 
compared with the wild type counterparts (Liao et al., 2010). A Ca
2+
 
fluorescence study on nerve terminals has also found that the entry of Ca
2+
 into 
nerve terminals was increased after blockade of Ca
2+
 activated K
+
 channel with 
charybdotoxin (CTX) (Robitaille and Charlton, 1992). The results of previous 
studies are shown below in Fig. 6.1 and Fig. 6.2: 
 
Therefore, this chapter tests whether the BK channel exists and is functional in 
the neuronal cells used and whether its activation would protect the cells from 
those established insults. 
 
6.2 Methods and materials 
 
Whether the BK channel exists and is functional in SH-SY5Y cells was tested 
by RT-PCR and single channel patch clamp, and the possible effects of BK  
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Figure 6.1 CTX increases Ca
2+
 entry in nerve terminals. A and B: Ca
2+
 signal before 
and 1 s after beginning of a train of stimuli [200 hertz (Hz)]. C and D: Ca
2+
 signal 
before and 1 s after the beginning of stimulation at 200 Hz, 15 min after application of 
CTX (10 nM) to block BK channel. (Robitaille and Charlton, 1992) 
 
  
Figure 6.2 Deletion of BK channel increases mortality and severity of brain infarction 
after transient middle cerebral artery occlusion. a: Mortality within 7 h after 
reperfusion; b: the neurological deficit score evaluated 7 h after reperfusion; d: the 
infarction area of different brain sections; and e: the resulting infarction volume of the 
ipsilateral hemisphere. (Liao et al., 2010) 
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modulators were tested in cell proliferation MTS assays. 
 
6.2.1 PCR 
 
The PCR condition was optimised for the amplification of BK subunits in 
N2102Ep cells. The recommended annealing temperatures were 55 °C and 
58 °C on Primer III website. So, the PCR condition optimisation was started 
from 55 °C, 40 cycles and 1.5 mM Mg
2+
. Following that, another two PCR 
conditions were tried to make the target band more specific. The other two 
PCR conditions were: 58 °C, 40 cycles with 1.5 mM Mg
2+
, and 58 °C, 30 
cycles with 1.5 mM Mg
2+
. The optimisation details are shown in the results 
section (Section 6.3.2). 
 
After the PCR conditions were optimised, the PCR amplification of BK 
channel was carried out with MOG-G-UVW, N2102Ep, undifferentiated 
NTERA-2, differentiated NTERA-2, undifferentiated SH-SY5Y and 
differentiated SH-SY5Y cells to see whether the messages of BK subunits 
existed in the mRNA of those cell lines. 
 
6.2.2 Electrophysiology 
 
Patch recording was carried out on undifferentiated SH-SY5Y cells. The target 
channel for patching was BK. Hence, Na
+
 Locke was both the bath solution 
and the reference electrode, and a high K
+
 solution filled the recording 
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electrode. The compositions of Na
+
 Locke and high K
+
 solution are listed in 
Section 2.13. 
 
6.2.3 Cell proliferation and MTS assays 
 
The cell proliferation MTS assays were carried out on both undifferentiated 
and differentiated SH-SY5Y cells to test the possible effect, if any, of BK 
activators or blockers in combination with the established insults, such as 
oxidative stress and hypoxia. 
 
The BK activators used here were NS1619 and isopimaric acid (IPA). 
 
NS1619 [1-(2’-hydroxy-5’-trifluoromethylphenyl)-5-trifluoromethyl-
2(3H)benzimidazolone], was the first synthetic BK activator identified in 1992 
and was widely used as a pharmacological tool (Wulff and Zhorov, 2008). 
NS1619 was reported to directly activate the α subunit (Papassotiriou et al., 
2000, Gribkoff et al., 1996) which means it can activate all of the BK channel 
isoforms regardless which β subunit(s) there is/are. It was reported that 3 – 30 
μM NS1619 can increase the BK current and shift the I-V relationship toward 
more negative membrane potentials (Olesen et al., 1994). The chemical 
structure of NS1619 is: 
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In previous studies, pimaric acid has been identified as another BK channel 
activator and it also can target the α subunit to activate BK channel (EC50 ≈ 3 
μM), regardless which β subunit(s) there is/are (Wulff and Zhorov, 2008). The 
chemical structure of IPA is: 
 
 
The three blockers which have been tested in this Thesis were 
tetraethylammonium (TEA), tetrandrine and iberiotoxin (IbTX). 
 
TEA is not a selective BK blocker, but a generic K
+
 channel blocker. TEA was 
used, in previous studies, to inhibit many K
+
 channels at a high concentration 
range (μM – mM), and it has little or no effect on sodium (Na+) or chloride (Cl-) 
channel. To block the K
+
 channel, TEA binds to an open channel from the 
cytoplasmic side (Wulff and Zhorov, 2008). The chemical structure of TEA is: 
 
 
Tetrandrine is an alkaloid from the root of the creeper Stephania tetrandra S. 
Moore, which has been used as a traditional herb in the far east, such as China, 
for centuries as an analgesic and antipyretic agents (Wang and Lemos, 1995). It 
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induces a flickery blockade in the BK channel, and such a blockade was quasi 
selective compared to its blockade of the L-type Ca
2+
 channel (50 times more 
potent) (Wang and Lemos, 1995). But, studies on its blockade of the BK 
channel are quite limited, and its therapeutic value from blocking the BK 
channel was only investigated in skeletal or cardiac muscle, and tumors in 
recent years (Wang et al., 2004). The herb Stephania tetrandra S. Moore and 
the chemical structure of tetrandrine are shown in Fig. 6.3. 
 
  
Fig. 6.3 Stephania tetrandra S. Moore and tetrandrine. Left hand panel: leaves and 
root of Stephania tetrandra S. Moore (picture from the webpage of Guiyang Medical 
Institute: http://210.40.160.21/zybbg/ffj.html), and right hand panel: chemical 
structure of tetrandrine. 
 
Previous studies have suggested that IbTX is a BK blocker with an EC50 at 
about 10 nM (Wulff and Zhorov, 2008), and its blockade of the BK channel is 
β subunit dependent. The BK channel with β4 subunit could for example be 
resistant to IbTX (Meera et al., 2000). The chemical structure of IbTX is: 
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NS1619, IPA, TEA, tetrandrine and IbTX were tested on either H2O2 or CoCl2 
insults in SH-SY5Y cell line to see whether they would protect the cells or not. 
 
6.2.4 Drug solutions 
 
NS1619, IPA, tetrandrine and IbTX are from Sigma-Aldrich, and TEA is from 
Fisher Scientific. NS1619 was dissolved in C2H5OH, IPA and tetrandrine were 
dissolved in DMSO, IbTX and TEA were dissolved in PBS. 100 mM NS1619 
stock, 100 mM TEA stock and 10 mM tetrandrine stock were stored at 4 °C, 
and 100 μM IbTX stock and 100 mM IPA stock were stored at -20 °C. 
 
6.3 Results 
 
6.3.1 Primer design 
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The primers for BK channel subunits are listed in the table below: 
 
Table 6.1 Primers for BK subunits 
Subunits Description Primer Location 
α 
KCNMA1, 
mRNA, 3,537 bp 
in total 
Forward 
5’-
ACGCAATCTGCCTCGCAGAGTTG 
1,639 – 
2,047 bp 
Reverse 5’-CATCATGACAGGCCTTGCAG 
β1 
KCNMB1, mRNA, 
1,518 bp in total 
Forward 5’-CTGTACCACACGGAGGACACT 668 – 865 
bp Reverse 5’-GTAGAGGCGCTGGAATAGGAC 
β2 
KCNMB2, 
transcript variant 1, 
mRNA, 2,543 bp 
in total 
Forward 5’-CATGTCCCTGGTGAATGTTG 
808 – 
1,044 bp 
Reverse 5’-TTGATCCGTTGGATCCTCTC 
β3 
KCNMB3, 
transcript variant 3, 
mRNA, 1,835 bp 
in total 
Forward 5’-AACCCCCTTTTCATGCTTCT 
1,404 – 
1,680 bp 
Reverse 5’-TCTTCCTTTGCTCCTCCTCA 
β4 
KCNMB4, mRNA, 
1,631 bp in total 
Forward 5’-GTTCGAGTGCACCTTCACCT 648 – 892 
bp Reverse 5’-TAAATGGCTGGGAACCAATC 
(Henney, 2008, Reviriego, 2009, Henney et al., 2009) 
 
6.3.2 PCR condition optimisation 
 
According to the results in Fig. 6.4 – 6.6, it can be seen that 55 °C, as an 
annealing temperature, was not ideal to prevent extra bands, and 40 cycles 
were too many for the amplification of BK subunits. Hence, the optimised PCR 
condition for BK subunits, with those primers above, was set at 58 °C for 
annealing temperature and 30 cycles for amplification. 
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Figure 6.4 BK subunits in N2102Ep, 55 °C, 40 cycles. The bands of β subunits were 
clear but unspecific. 
 
 
Figure 6.5 BK subunits in N2102Ep, 58 °C, 40 cycles. The bands were clear but there 
was primer dimer band in the α subunit amplification. 
 
 
Figure 6.6 BK subunits in N2102Ep, 58 °C, 30 cycles. The bands were clear and 
specific. 
 
Ladder                   α                     β1        β2        β3        β4 
1,000 bp 
 
 
300 bp 
Ladder              α                  β1         β2       β3        β4 
1,000 bp 
 
 
300 bp 
Ladder                   α                     β1        β2        β3        β4 
1,000 bp 
 
 
300 bp 
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6.3.3 RT-PCR 
 
The RT-PCR results for BK channel subunits in the cell lines used are shown 
in Figs. 6.7 to 6.10.  
 
 
            Ladder II         BKα             BKβ1          BKβ2          BKβ3         BKβ4 
Fig. 6.7 BK channel subunits in MOG-G-UVW cells. There were messages for BKα, 
β3 and β4 subunits, but no message for BKβ1 or BKβ2. 
 
 
         Ladder II                   BKα                      BKβ1     BKβ2    BKβ3     BKβ4 
Fig. 6.8 BK channel subunits in undifferentiated NTERA-2 cells. There were 
messages for BKα, β2, β3 and β4 subunits, but was only a tiny message for BKβ1 
subunits. 
 
 
           Ladder II                  BKα                       BKβ1      BKβ2     BKβ3     BKβ4 
Fig. 6.9 BK channel subunits in differentiated NTERA-2 cells. There were messages 
for BKα, β2, β3 and β4 subunits, but any band for BKβ1 subunit was absent. 
 
300 bp 
300 bp 
300 bp 
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Fig. 6.10 BK channel subunits in undifferentiated (above) and differentiated (bottom) 
SH-SY5Y cells. There were messages for all the five BK subunits in both 
undifferentiated and differentiated SH-SY5Y cells. 
 
6.3.4 Electrophysiology 
 
Raw data from a typical inside out patch recording in an undifferentiated SH-
SY5Y cell is shown below in Fig. 6.11: 
 
From Fig. 6.11a, it can be seen that the open probability of this channel was 
voltage dependent, with high activity in high Ca
2+
 which is a feature of BK  
Ladder II         BKα             BKβ1            BKβ2          BKβ3          BKβ4 
1,000 bp 
 
300 bp 
1,000 bp 
 
300 bp 
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                a    b 
Figure 6.11 Illustration of BK channel activity in an SH-SY5Y inside-out patch with 
asymmetrical reverse gradient 140 mM [K
+
]o / 3 mM [K
+
]i. a: raw records illustrating 
effect of voltage on BK, and b: I – V relationship. 
 
channel. From Fig. 6.11b, it can be calculated that the conductance, which is 
the slope of the linear trend line, was about 222 pS. Hence, it can be concluded 
that the ion channel being patched was a voltage – dependent, Ca2+-activated 
K
+
 channel with a large conductance, which is likely to be a BK channel. After 
the BK channel was confirmed to exist and to be functional in the SH-SY5Y 
cell line, BK modulators were then tested. 
 
6.3.5 BK openers effect on H2O2 insult 
 
Two BK openers, NS1619 and IPA, were tested here, on the H2O2 insult 
models established in Section 4. 
 
Firstly, the possible effect, if any, of NS1619 was tested on the SH-SY5Y cell 
line, and the dose – response curves are shown in Fig. 6.12: 
 
As was discussed in Section 4.3.2, differentiated SH-SY5Y cells were more  
C 
O 
C 
O 
C 
O1 
O1+2 
O1+2+3 
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Figure 6.12 Dose – response curve for H2O2 in both undifferentiated and differentiated 
SH-SY5Y cells, with or without NS1619. Data points are the means of 3. 
 
sensitive to the H2O2 insult than undifferentiated SH-SY5Y cells. The relative 
cell number in the differentiated cells was lower than the counterpart in the 
undifferentiated cells at 300 μM H2O2 insult. 
 
In Fig. 6.12, it can be seen that 10 μM NS1619, in combination with H2O2 
insult, has not markely changed the relative cell number from H2O2 alone in 
undifferentiated SH-SY5Y cells. The difference in the relative cell number 
between the H2O2 alone and H2O2 + NS1619 was not significant at the same 
dose of H2O2 insult. Thus, it can be concluded that 10 μM NS1619 did not 
protect the undifferentiated SH-SY5Y cells from H2O2 insult. 
 
However, 10 μM NS1619, in combination with H2O2, has reduced the relative 
cell number from H2O2 alone in differentiated SH-SY5Y cells. A one way 
ANOVA test for all the groups in differentiated SH-SY5Y cells suggested that 
the difference amongst those groups was significant (p < 0.001), and the 
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Tukey’s post test (comparing every two groups) indicated that the relative cell 
numbers were significantly different between H2O2 + NS1619 and H2O2 alone 
at 150 µM H2O2 (p < 0.05). Furthermore, t tests also indicated that NS1619 in 
combination with H2O2 caused a significant reduction in the relative cell 
number from the same doses of H2O2 alone at 100 µM and 300 µM H2O2 (p < 
0.001 and p < 0.05 respectively). Hence, it can be concluded that 10 µM 
NS1619 did not protect the differentiated SH-SY5Y cells from H2O2 insult, 
and somehow had aggravated the insult of oxidative stress. 
 
Another BK opener, isopimaric acid (IPA) was also tested in the SH-SY5Y cell 
line. A single dose of IPA, 10 µM, was tested against the H2O2 insult in 
undifferentiated SH-SY5Y cells and the results are shown in Fig. 6.13. 
 
A one way ANOVA test for all the groups in Fig. 6.13 suggested that the 
difference amongst those groups was significant (p < 0.01), but the 
Bonferroni’s post test (comparing every two groups) did not indicate any 
significant difference in the relative cell numbers between H2O2 alone and 
H2O2 + IPA. Hence, it can be concluded that 10 μM IPA did not protect the 
undifferentiated SH-SY5Y cells from H2O2 insult. 
 
IPA was also tested in the presence of H2O2 insult in differentiated SH-SY5Y 
cells, and the results are shown in Fig. 6.14. 
 
A one way ANOVA test for all the groups in Fig. 6.14 suggested that the  
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Figure 6.13 The effect of isopimaric acid (IPA, 10 µM) in combination with an EC50 
of H2O2 (300 μM) in undifferentiated SH-SY5Y cells. The results are the means of 6 
for IPA alone and the control, and 3 for H2O2 alone and H2O2 + IPA. 
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Figure 6.14 Dose – response curve of H2O2 insult with or without isopimaric acid (IPA, 
10 μM) in differentiated SH-SY5Y cells. Data points are the means of 6 for H2O2 
alone and 3 for H2O2 + IPA. 
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difference amongst those groups was significant (p < 0.001). In addition, a t 
test indicated that IPA in combination with H2O2 caused a significant reduction 
in the relative cell number from H2O2 alone at 450 µM H2O2 (p < 0.01). Hence, 
it can be suggested that IPA did not protect the differentiated SH-SY5Y cells 
from H2O2 insult, and may even aggravate the insult. 
 
6.3.6 BK openers against a CoCl2 insult 
 
In addition to oxidative stress induced by H2O2, the possible effect of BK 
openers, if any, was also tested on the hypoxia mimetic effect induced by 
CoCl2 in both undifferentiated and differentiated SH-SY5Y cells. 
 
Firstly, NS1619, in combination with an EC50 of CoCl2 insult, was tested in 
undifferentiated SH-SY5Y cells and the results are shown in Fig. 6.15. 
 
A one way ANOVA test for all the groups in Fig. 6.15 suggested that the 
difference amongst those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control (p < 
0.001), NS1619 alone also had a significant effect on the relative cell number 
from the control (p < 0.001), but NS1619 in combination with CoCl2 caused a 
significant reduction in the relative cell number from the same dose of CoCl2 
alone (p < 0.01). 
 
Then, NS1619 in combination with CoCl2 insult was also tested in  
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Figure 6.15 The effect of NS1619 (10 μM) in combination with an EC50 of CoCl2 (40 
μM) in undifferentiated SH-SY5Y cells. The results are the means of 3. 
 
differentiated SH-SY5Y cells and the results are shown in Fig. 6.16. 
 
A one way ANOVA test for all the groups in Fig. 6.16 suggested that the 
difference amongst those groups was significant (p < 0.01), and the Dunnett’s 
post test (comparing each group with 30 µM CoCl2 alone) indicated that CoCl2 
alone caused a significant reduction in the relative cell number from the control 
(p < 0.001) and NS1619 in combination with CoCl2 also had a significant 
effect on the relative cell number from the same dose of CoCl2 alone (p < 0.05). 
 
To summarise the results shown in Fig. 6.15 and Fig. 6.16, it can be suggested 
that 10 μM NS1619 protects neither undifferentiated nor differentiated SH-
SY5Y cells from CoCl2 insult and aggravates the insult by further reducing the  
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Fig. 6.16 The effect of NS1619 (10 μM) in combination with an EC50 of CoCl2 insult 
(30 μM) in differentiated SH-SY5Y cells. The results are the means of 3. 
 
relative cell number from CoCl2 alone. In addition, despite NS1619 alone 
increasing the relative cell number in undifferentiated SH-SY5Y cells (see Fig. 
6.15), it can be seen that NS1619 potentiats the CoCl2 insult in undifferentiated 
SH-SY5Y cells. 
 
Besides NS1619, another BK opener, IPA, was also tested on the CoCl2 insult 
in the SH-SY5Y cell line. The results in undifferentiated SH-SY5Y cells are 
shown in Fig. 6.17. 
 
A one way ANOVA test for all the groups in Fig. 6.17 suggested that the 
difference amongst those groups was significant (p < 0.001), and the Dunnett’s  
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Figure 6.17 The effect of isopimaric acid (IPA, 10 μM) in combination with CoCl2 
insult (50 μM) in undifferentiated SH-SY5Y cells. The results are the means of 3. 
 
post test (comparing each group with CoCl2 alone) indicated that CoCl2 alone 
had a significant effect on the relative cell number from the control (p < 0.001) 
and IPA in combination with CoCl2 caused a significant reduction in the 
relative cell number from CoCl2 alone (p < 0.001). 
 
IPA was then tested on the CoCl2 insult in differentiated SH-SY5Y cells. The 
results are shown in Fig. 6.18. 
 
A one way ANOVA test for all the groups in Fig. 6.18 suggested that the 
difference amongst those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control (p <  
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Fig. 6.18 The effect of isopimaric acid (IPA, 10 μM) in combination with an EC50 of 
CoCl2 (30 μM) in differentiated SH-SY5Y cells. The results are the means of 3. 
 
0.001), and IPA also had a significant effect on the relative cell number from 
the control (p < 0.01): but the Dunnett’s post test (comparing each group with 
CoCl2 alone) indicated that IPA in combination with CoCl2 caused a significant 
reduction in the relative cell number from the same dose of CoCl2 alone (p < 
0.05). 
 
To summarise the results shown in Fig. 6.17 and Fig. 6.18, it can be concluded 
that IPA did not protect SH-SY5Y cells, either undifferentiated or 
differentiated, from a CoCl2 insult, and even aggravates this insult by further 
reducing the relative cell number from CoCl2 alone.  Furthermore, since IPA 
alone increases the relative cell number from the control in differentiated SH-
SY5Y cells, it can also be concluded that IPA may potentiate the CoCl2 insult 
in differentiated SH-SY5Y cells. 
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To summarise the results of BK activators, it can be seen that neither NS1619 
nor IPA can protect SH-SY5Y cells from the CoCl2 insult, and, both of these 
may even potentiate the CoCl2 insult since NS1619 or IPA alone increases, or 
at least tend to increase, the cell proliferation in SH-SY5Y cells. Therefore, in 
the case of both insults, the oxidative stress induced by H2O2, and the hypoxia 
mimetic effect induced by CoCl2, neither of the two BK openers has shown any 
neuroprotective effect. Hence, the K
+
 channel blockers were then tested to see 
whether they might have any effects. 
 
6.3.7 K
+
 channel blockers effect on CoCl2 insult 
 
As introduced in Section 6.2.3, the three blockers tested here are generic K
+
 
blockers TEA, and the BK blocker tetrandrine and IbTX. Firstly, the results of 
TEA in combination with a CoCl2 insult in undifferentiated SH-SY5Y cells are 
shown in Fig. 6.19. 
 
A one way ANOVA test for all the groups in Fig. 6.19 suggested that the 
difference amongst those groups was significant (p < 0.001) and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control (p < 
0.001) and TEA alone also had a significant effect on the relative cell number 
from the control (p < 0.01). TEA in combination with a CoCl2 insult tended to 
increase the relative cell number from CoCl2 alone, although not significantly. 
But, the protective effect of TEA in the presence of CoCl2 insult was  
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Figure 6.19 The effect of TEA (3 mM) in combination with an EC50 of CoCl2 (40 μM) 
in undifferentiated SH-SY5Y cells. The results are the means of 3. 
 
significant at a higher dose of CoCl2, and the results are shown in Fig. 6.20. 
 
 
Fig. 6.20 The effect of TEA (3 mM) in combination with 50 μM CoCl2 in 
undifferentiated SH-SY5Y cells. The results are the means of 3. 
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A one way ANOVA test for all the groups in Fig. 6.20 suggested that the 
difference amongst those groups was significant (p < 0.001), the Bonferroni’s 
post test (comparing every two groups) indicated that CoCl2 alone caused a 
significant reduction in the relative cell number from the control (p < 0.001), 
TEA alone also had a significant effect on the relative cell number from the 
control (p < 0.001), and the Dunnett’s post test (comparing each group with the 
CoCl2 alone) indicated that TEA in combination with CoCl2 insult caused a 
significant increase in the relative cell number from the same dose of CoCl2 
alone (p < 0.05). 
 
TEA was then tested on the CoCl2 insult in differentiated SH-SY5Y cells. The 
results are shown in Fig. 6.21. 
 
A one way ANOVA test for all the groups in Fig. 6.21 suggested that the 
difference amongst those groups was significant (p < 0.001), the Bonferroni’s 
post test (comparing every two groups) indicated that CoCl2 alone caused a 
significant reduction in the relative cell number from the control (p < 0.001), 
TEA alone also had a significant effect on the relative cell number from the 
control (p < 0.01), and the Dunnett’s post test (comparing each group with the 
CoCl2 alone) indicated that TEA in combination with CoCl2 insult caused a 
significant increase in the relative cell number from the same dose of CoCl2 
alone (p < 0.05). Hence, 3 mM TEA protects the differentiated SH-SY5Y from 
an EC50 of CoCl2 insult. 
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Fig. 6.21 The effect of TEA (3 mM) in combination with an EC50 of CoCl2 (30 μM) in 
differentiated SH-SY5Y cells. The results are the means of 3. 
 
In addition to TEA, another K
+
 channel blocker, tetrandrine, was also tested on 
the CoCl2 insult in differentiated SH-SY5Y cells. The results are shown in Fig. 
6.22. 
 
A one way ANOVA test for all the groups in Fig. 6.22 suggested that the 
difference amongst those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control (p < 
0.001), tetrandrine also had a significant effect on the relative cell number from 
the control (p < 0.001), and tetrandrine in combination with a CoCl2 insult 
caused a significant increase in the relative cell number from the same dose of  
CoCl2 alone (p < 0.001). It can then be concluded that 1 μM tetrandrine 
protects differentiated SH-SY5Y cells from 40 μM CoCl2. 
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Figure 6.22 The effect of tetrandrine (1 μM) in combination with CoCl2 insult (40 μM) 
in differentiated SH-SY5Y cells. The results are means of 3. 
 
To summarise the results in Fig. 6.19 to Fig. 6.22, it may be concluded that K
+
 
channel blockers, TEA and tetrandrine, may protect differentiated SH-SY5Y 
cells from a CoCl2 insult. In addition to TEA and tetrandrine, a selective BK 
channel blocker, IbTX, was also tested on a CoCl2 insult in the SH-SY5Y cell 
line. The results in undifferentiated SH-SY5Y cells are shown in Fig. 6.23. 
 
A one way ANOVA test for all the groups in Fig. 6.23 suggested that the 
difference amongst those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control (p < 
0.01), but the difference in the relative cell numbers between CoCl2 alone and 
CoCl2 + IbTX was not significant. 
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Figure 6.23 The effect of iberiotoxin (IbTX, 100 nM) in combination with an EC50 of 
CoCl2 (40 μM) in undifferentiated SH-SY5Y cells. The results are the means of 3. 
 
IbTX was also tested on the differentiated SH-SY5Y cells and the results are 
shown in Fig. 6.24. 
 
A one way ANOVA test for all the groups in Fig. 6.24 showed that the 
difference amongst those groups was significant (p < 0.001), and the 
Bonferroni’s post test (comparing every two groups) indicated that CoCl2 alone 
caused a significant reduction in the relative cell number from the control, 
IbTX alone also had a significant effect on the relative cell number, but the 
difference in the relative cell numbers between CoCl2 alone and CoCl2 + IbTX 
was not significant. 
 
Hence, it can be seen from the results in Figs. 6.23 and 6.24, the BK blocker,  
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Fig. 6.24 The effect of iberiotoxin (IbTX, 50 nM) in combination with an EC50 of 
CoCl2 (30 μM) in differentiated SH-SY5Y cells. The results are the means of 6. 
 
IbTX, cannot protect SH-SY5Y cells, either undifferentiated or differentiated, 
from a CoCl2 insult. 
 
6.4 Discussion 
 
To summarise those cell proliferation MTS assays results above, the following 
considerations are presented. 
 
6.4.1 BK activators cannot protect the cells from the established insults 
 
From the results shown in section 6.3.5 and 6.3.6, it can be seen that NS1619 
alone increases cell proliferation in undifferentiated SH-SY5Y cells, but cannot 
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protect the cells from the established insults, and may even potentiate the 
CoCl2 insult. NS1619 also aggravates the insults of H2O2 and CoCl2 in 
differentiated SH-SY5Y cells. IPA cannot protect undifferentiated SH-SY5Y 
cells either and aggravates the insult of CoCl2 at high CoCl2 dose (50 μM). In 
differentiated SH-SY5Y cells, IPA alone may increase cell proliferation but 
IPA may potentiate the insults of H2O2 and CoCl2. 
 
Therefore, to summarise BK activators, NS1619 and IPA, cannot protect the 
SH-SY5Y cells from either oxidative stress or a hypoxia mimetic effect, 
although the modulators alone may increase cell proliferation. The negative 
results might be due to the different selectivity for different BKβ subunits of 
the BK modulators, since the BK channel coassembled with certain β subunit(s) 
might be resistant to some BK modulators (see Section 6.4.3). However, both 
NS1619 and IPA bind to the BKα subunit, which is the functional and essential 
part of BK channel (Wulff and Zhorov, 2008). The messages of BKα subunit 
are present in both undifferentiated and differentiated SH-SY5Y cells in RT-
PCR (see Section 6.3.3) and the BK channel has also been shown to be 
functional in SH-SY5Y cell line in patch recordings (see Section 6.3.4). Hence, 
the negative results with NS1619 and IPA are not because of the resistance or 
lack of presence of the BK channel in the SH-SY5Y cell line. 
 
The BK activators potentiated the effects of the insults in some cases above, 
and this has been discussed in previous studies already. As discussed in the 
introduction (see Section 1.4.2.1), the BK channel is activated by intracellular 
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Ca
2+
. Both of the insults, H2O2 and CoCl2, increase [Ca
2+
]i (see Section 4.1), in 
which case, the BK channel in the cells would have been activated already 
when the cells were treated with the insults. Thus, if the BK channel was 
further opened with BK channel openers, the K
+
 efflux would be further 
increased, possibly resulting in undesirable cell shrinkage and death (see Fig. 
6.25) (Burg et al., 2006). 
 
 
Figure 6.25 K
+
 efflux and cell shrinkage (Burg et al., 2006). 
 
Nevertheless, these negative results with BK activators are not exactly in 
contradiction to previous studies which suggested a neuroprotective role of the 
BK channel. As introduced in Section 6.1, the activation of the BK channel 
may protect neurones by reducing Ca
2+
 influx from an extracellular source. 
Obviously, the entry of extracellular of Ca
2+
 is not the only source to increase 
the [Ca
2+
]i. The intracellular Ca
2+
 release channel on the ER, such as the RyR 
which has been discussed before, is also responsible for any increase of [Ca
2+
]i 
(Stutzmann and Mattson, 2011). 
 
6.4.2 K
+
 channel blockers can be neuroprotective against CoCl2 insult 
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Since the BK activators, NS1619 and IPA, cannot protect the cells from either 
H2O2 or CoCl2 insult, some K
+
 channel blockers, such as TEA and tetrandrine, 
have been tested in this Thesis. 
 
From the results shown in Section 6.3.7, interestingly it can be seen that TEA 
alone increases cell proliferation in both undifferentiated and differentiated 
SH-SY5Y cells, and it protects the cells from CoCl2 insult. Tetrandrine also 
increases cell proliferation in differentiated SH-SY5Y cells and additionally 
protects the cells. 
 
The neuroprotective effect of the K
+
 channel blocker, TEA, has been studied 
previously. One study in 1998 has shown that 100 μM to 5 mM TEA 
significantly reduces the neuronal death induced by Aβ25-35 in 24 – 48 h (Yu et 
al., 1998). The results from that study are shown below in Fig. 6.26. 
 
 
Figure 6.26 TEA can reduce the neuronal death induced by Aβ25-35 (Yu et al., 1998). 
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Thus, the results in this chapter were consistent with those from previous 
studies. But, whether the neuroprotective effect presented by TEA is because 
of the blockade of BK channel or not is still uncertain. So, more work should 
be done with selective BK blockers, rather than generic K
+
 channel blockers, to 
see whether the blockade of the BK channel, rather than any other K
+
 channel, 
would be neuroprotective or not. 
 
6.4.3 Selectivity in respect of the BKβ subunits for BK blocker 
 
The potential neuroprotective effect of K
+
 channel blockers might be argued 
against by the negative results with IbTX (see Fig. 6.23 and Fig. 6.24), which 
is a selective BK channel blocker. From those results, it can be seen that 50 nM 
IbTX increases cell proliferation in differentiated SH-SY5Y cells, but 50 – 100 
nM IbTX did not protect either undifferentiated or differentiated SH-SY5Y 
cells from CoCl2 insult. 
 
Actually, these negative results might be explained by the selectivity in respect 
of BKβ subunits for BK blockers. A review has suggested that β1 enhances the 
toxin binding but complexes with β4 with BK are resistant to IbTX (Wulff and 
Zhorov, 2008). According to the PCR results shown in section 6.3.3, there was 
certainly the message for the BKβ4 subunit in both undifferentiated and 
differentiated SH-SY5Y cells. That might explain why IbTX has shown a 
negative effect in both undifferentiated and differentiated SH-SY5Y cells. 
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Therefore, in future work, blockers which are generic for all BKβ subunits, 
such as paxilline, should be tested on the established insults, including both 
oxidative stress and hypoxia mimetic effects, to see whether they would be 
neuroprotective or not. If the BK blockers afford neuronal protection, a future 
strategy could be working on the features of BKβ subunits to develop, if 
possible, selective BK blockers which would target neuronal cells only. This 
kind of selective BK blocker could be the BK strategy for any drug 
development against neurodegeneration. 
 
6.5 Conclusions 
 
Based on all of the results and discussions above, the findings here can be 
summarised: 
 
a. The BK channel exists and is functional in the SH-SY5Y cell line. 
Additionally, the messages for all the 4 BKβ subunits exist in the 
mRNA of both undifferentiated and differentiated SH-SY5Y cells. 
b. BK activators, NS1619 and IPA, cannot protect either undifferentiated 
or differentiated cells. Furthermore, the activators alone may increase 
cell proliferation. When applied in combination however with either 
H2O2 or CoCl2, they may aggravate the insults by further reducing 
relative cell number. 
c. K+ channel blockers, TEA and tetrandrine, can be neuroprotective. Both 
TEA and tetrandrine protect the differentiated SH-SY5Y cells from a 
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CoCl2 insult, and TEA may also protect the undifferentiated SH-SY5Y 
cells from a CoCl2 insult at a high dose of CoCl2. 
d. IbTX, which is a selective BK blocker, cannot protect either 
undifferentiated or differentiated SH-SY5Y cells from the insult of 
hypoxia induced by CoCl2. This negative result is probably due to the 
existence of the BKβ4 subunit in the SH-SY5Y cell line. 
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7. Consideration of Other K+ Channels 
 
7.1 Introduction 
 
As discussed in Section 1.4.2, other K
+
 channels may also be implicated in 
neuronal death and therefore afford a neuroprotective property. For example a 
mutation in a voltage-gated K
+
 channel, Kv3.3, can cause degenerative and 
developmental central nervous system phenotypes (Waters et al., 2006). 
Another voltage-gated K
+
 channel, Kv3.4, was found to be up-regulated in the 
early stages of AD (Angulo et al., 2004). KATP was also suggested to be 
neuroprotective (Yamada et al., 2001, Héron-Milhavet et al., 2004, Sun et al., 
2006) (see Section, 1.4.2.2). Hence, some work has also been done on KATP, 
Kv3.3 and Kv3.4 channels in this Thesis and this is introduced here. 
 
7.1.1 KATP channel 
 
As introduced in the introduction (see Section 1.4.2.2), two opposite opinions 
have been put forward for the possible role of KATP channel in neuronal death. 
For example, one study suggested that diazoxide, a KATP opener, treatment in 
neurones could reduce neuronal death from insults of Aβ25-35 or hypoxia 
induced by FeSO4 (Goodman and Mattson, 1996), but another study on rat 
preadipocytes argued that diazoxide can reduce cell number (Wang et al., 
2007). 
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Hence, the possible role of KATP channel in cells was studied in this Thesis 
with PCR, and cell proliferation MTS assays using KATP modulators. The KATP 
channel activators used here were cromakalim, diazoxide, nicorandil, and the 
blockers were glibenclamide, tolbutamide. 
 
In previous studies, 10 µM levcromakalim evoked a hyperpolarisation under 
current clamp, and this effect of levcromakalim can be inhibited by 
glibenclamide with an EC50 of 55 nM. 10 µM glibenclamide alone depolarises 
the neurones (Hogg and Adams, 2001). For diazoxide, 200 – 500 µM can 
increase the channel opening probability by 480  ± 120% (Allen and Brown, 
2003). For the KATP blocker, it has been found in previous studies that the KATP 
channel current (IKATP) can be inhibited reversibly by tolbutamide with an EC50 
at 34.1 µM, and can be inhibited irreversibly by 0.3 – 3 nM glibenclamide 
(Allen and Brown, 2003). The inhibitory effect of tolbutamide was confirmed 
in a current clamp experiment suggesting that 100 µM tolbutamide depolarises 
the neurones (Hogg and Adams, 2001). An irreversible effect of glibenclamide 
was argued by another study which suggested that the dose of glibenclamide to 
induce half-maximal inhibitory effect was increased from 9.1 µM to only 10.6 
µM by 1 mM nicorandil (Obata and Yamanaka, 2000). The chemical structures 
of those modulators above are shown below: 
 
7.1.2 Kv channels 
 
In addition to BK and KATP channels, voltage-gated K
+
 (Kv) channel were also  
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Chemical structure of cromakalim 
 
 
Chemical structure of diazoxide 
 
 
Chemical structure of nicorandil 
 
 
Chemical structure of glibenclamide 
 
 
Chemical structure of tolbutamide 
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studied here, such as Kv3.3 and Kv3.4. 
 
The Kv channel is known to be involved in the regulation of cell volume, for 
example the cell shrinkage caused by K
+
 efflux, and hence may contribute to 
cell death. Besides, pro-apoptotic agents, such as staurosporine etc., can 
enhance the sensitivity of Kv channel to its blockers like TEA and 4-
aminopyridine (4-AP). In pulmonary artery smooth muscle cells, the function 
and expression of Kv channel was up-regulated by mitochondrial oxidative 
phosphorylation, and a Kv channel was activated during nitric oxide (NO) – 
induced cell apoptosis. In addition, the Fas- and ceramide-mediated apoptosis 
was believed to be induced by tyrosine kinase inhibition caused by an 
enhancement of the Kv channel activity. For neuronal cells, previous studies 
have believed that apoptosis was accompanied by the increase of K
+
 
conductance via Kv channel (Burg et al., 2006). In addition to the role of Kv 
channel in cell death, some other studies have also linked Kv channel with 
neurodegeneration (Angulo et al., 2004, Waters et al., 2006) (see Section 
1.4.2.3). 
 
In this study, the messages of Kv3.3 and Kv3.4 in neuronal cells were studied 
with RT-PCR and the possible effect of Kv channel activity is discussed in 
Section 7.4. 
 
7.2 Methods and materials 
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7.2.1 Methods 
 
The messages of KATP subunits were tested by RT-PCR in the mRNA of 
MOG-G-UVW cells and two different PCR conditions were applied: 55 °C as 
the annealing temperature for 30 cycles and 58 °C as the annealing temperature 
for 40 cycles. In addition, the messages of Kv3.3 and Kv3.4 channel were tested 
for in N2102Ep and NTERA-2 cell lines. The PCR condition was 60 °C as the 
annealing temperature for 30 cycles. 
 
Besides PCR, cell proliferation MTS assays were applied to test the possible 
effects, if any, of KATP modulators in MOG-G-UVW cells. In the MTS assays 
here, the cell density was 3,000 cells per well in 96 well plates, unless specific 
information was given (Khudheyer, 2010). 
 
7.2.2 Drug solutions 
 
Cromakalim, diazoxide, nicorandil and tolbutamide are from Sigma-Aldrich, 
and glibenclamide is from Tocris. Cromakalim, diazoxide and glibenclamide 
were dissolved in DMSO at 10 mM for stock. Nicorandil and tolbutamide were 
dissolved in C2H5OH at 10 mM for stock. Diazoxide and nicorandil stocks 
were stored at -20 °C. Cromakalim, glibenclamide and tolbutamide stocks were 
stored at 4 °C. 
 
7.3 Results 
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7.3.1 Primer design 
 
The primers for KATP channel are listed in Table 7.1: 
 
Table 7.1 Primers for KATP subunits 
Primer Sequence Location 
Kir6.1 
NM_004982 
Forward 5’-CATCTTTACCATGTCCTTCC-3’ 560 – 893 bp in total 
3,281 bp Reverse 5’-GTGAGCCTGAGCTGTTTTCA-3’ 
Kir6.2 
D50582 
Forward 5’-ACTCCAAGTTTGGCAACACC-3’ 1,197 – 1,550 bp in 
total 1,635 bp Reverse 5’-CTGCTGAGGCCAGAAATAGC-3’ 
SUR1 
L78207 
Forward 5’-ATGAGGAAGAGGAGGAAGAG-3’ 2,941 – 3,433 bp in 
total 4,892 bp Reverse 5’-GCGATGGTGTTACAGTCAGA-3’ 
SUR2A 
NM_005691.2 
Forward 5’-GGCCTTTGCTTCACTGTCTC-3’ 1,730 – 1,939 bp in 
total 4,670 bp Reverse 5’-TTTGGCTGAACTCCAGTGTG-3’ 
SUR2B 
NM_020297 
Forward 5’-TGGGAACACATTTTCTGCAA-3’ 1,528 – 1,677 bp in 
total 4,650 bp Reverse 5’-CGCATGGGTCACAAATGTAG-3’ 
 
The primers of Kv3.3 and Kv3.4 channel are shown in Table 7.2. 
 
Table 7.2 Primers for Kv channels 
Channel Primer Sequence 
Kv3.3, KCNC3 
Forward 5’-GCTCTTCGAGGACCCCTACT-3’ 
Reverse 5’-ACCTCCACGTTGGTGATGTT-3’ 
Kv3.4, KCNC4 
Forward 5’-CTCTTCGAGGATCCCTACTC-3’ 
Reverse 5’-TGTGAACCACAGCACACATA-3’ 
 
7.3.2 RT-PCR 
 
Two annealing temperatures, 55 °C and 58 °C, have been trialled on the 
amplification of KATP subunits in MOG-G-UVW cell line. The figures are 
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shown in Figs. 7.1 and 7.2. 
 
 
 
Fig. 7.1 KATP subunits in MOG-G-UVW, 55 °C, 30 cycles. 
 
 
 
Figure 7.2 KATP subunits in MOG-G-UVW, 58 °C, 40 cycles. The bands are 
unspecific. 
 
From the two figures, it can be seen that higher annealing temperature with 
more amplification cycles make the bands for Kir6.1, SUR1 and SUR2B visible 
and make the SUR2A band clearer, but this condition also causes the bands to 
be unspecific. From Fig. 7.1, it may also be noticed that Kir6.2 with SUR2A 
might be the main subunit composition of KATP channel in MOG-G-UVW cells, 
but the existence of Kir6.1, SUR1 and SUR2B cannot be eliminated. 
 
The messages of Kv3.3 and Kv3.4 have been identified for in the mRNA 
samples from both N2102Ep and undifferentiated NTERA-2 cell lines in RT-
PCR. The results are shown in Figs. 7.3 and 7.4. 
 
Ladder II  negative control  β-actin  Kir6.1      Kir6.2      SUR1    SUR2A   SUR2B 
300 bp 
Ladder II                 β-actin                       Kir6.1       SUR1     SUR2A  SUR2B 
300 bp 
Cellular Basis of Neurodegeneration 
 
 
- 220 - 
 
 
 
Figure 7.3 Kv3.3 and Kv3.4 in N2102Ep 
 
 
 
Figure 7.4 Kv3.3 and Kv3.4 in undifferentiated NTERA-2 cell line. 
 
From those figures, it can be seen that the messages of both Kv3.3 and Kv3.4 
channels exist in both N2102Ep and undifferentiated NTERA-2 cell lines. 
 
7.3.3 KATP activators effect against CoCl2 insult 
 
Firstly, the possible effect, if any, of diazoxide alone on the cell proliferation 
was tested in MOG-G-UVW cells. The results are shown in Fig. 7.5. 
 
A one way ANOVA test for all the groups in Fig. 7.5 suggested that the 
difference amongst those groups was significant (p < 0.05), and the Dunnett’s 
post test (comparing each group with the control) indicated that 125 μM 
diazoxide caused a significant reduction in the relative cell number from the 
control (p < 0.01): the vehicle, DMSO, and 100 μM diazoxide did not have any 
significant effect on the relative cell number. It can be concluded that 
diazoxide cannot induce cell death in MOG-G-UVW cells at concentrations of 
100 μM or lower. 
Ladder II               Kv3.3                  Kv3.4 
300 bp 
Ladder II                    Kv3.3                  Kv3.4 
300 bp 
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Figure 7.5 The effect of diazoxide alone in MOG-G-UVW cells. The results were the 
means of 9 for 125 μM diazoxide and the control, and 3 for DMSO vehicle and 100 
μM diazoxide. 
 
Diazoxide was then tested against two different doses of CoCl2 in MOG-G-
VUW cells. The results are shown in Fig. 7.6. 
 
For the results shown in Fig. 7.6A, a one way ANOVA test for all the groups 
showed that the difference amongst those groups was significant (p < 0.001), 
and the Tukey’s post test (comparing every two groups) indicated that 65 μM 
CoCl2 caused a significant reduction in the relative cell number from the 
control (p < 0.001). A one tail t test suggested that 100 μM diazoxide in 
combination with 65 μM CoCl2 had a significant effect on the relative cell 
number from the same dose of CoCl2 alone (p < 0.05). 
 
Interestingly, the opposite effect can be seen with a high dose of CoCl2. From  
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Fig. 7.6 The effect of diazoxide (diaz.) in combination with CoCl2 insult in MOG-G-
UVW cells. A: 65 µM CoCl2, the results are the means of 30 for CoCl2 alone and the 
control, 9 for CoCl2 + 10 μM diazoxide, 6 for CoCl2 + 100 μM diazoxide, and 3 for 
diazoxide alone. And B: 125 µM CoCl2, the results are the means of 12 for CoCl2 
alone and the control, 9 for CoCl2 + 10 μM diazoxide, 6 for CoCl2 + 100 μM 
diazoxide, and 3 for diazoxide alone.  
 
the results shown in Fig. 7.6B, a one way ANOVA test for all the groups 
suggested that the difference amongst those groups was significant (p < 0.001), 
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and the Tukey’s post test (comparing every two groups) indicated that 125 μM 
CoCl2 alone caused a significant reduction in the relative cell number from the 
control (p < 0.001), and 10 μM diazoxide in combination with 125 μM CoCl2 
also had a significant effect on the relative cell number in comparison with the 
same dose of CoCl2 alone (p < 0.001). 
 
Thus, it can be concluded that diazoxide cannot protect MOG-G-UVW cells 
from a low dose of CoCl2 (65 μM), and may even further reduce the relative 
cell number from CoCl2 alone. However, in the presence of a high dose of 
CoCl2 (125 μM), 10 μM diazoxide can paradoxically protect the cells. 
 
Besides diazoxide, another KATP activator, nicorandil was also tested on the 
CoCl2 insult in MOG-G-UVW cells. The results are shown in Fig. 7.7. 
 
For the results shown in Fig. 7.7A, a one way ANOVA test for all the groups 
showed that the difference amongst all the groups was significant (p < 0.001), 
and the Tukey’s post test (comparing every two groups) indicated that 65 μM 
CoCl2 caused a significant reduction in the relative cell number from the 
control. However the difference in the relative cell numbers between CoCl2 + 
nicorandil and CoCl2 alone was not significant. 
 
For the results shown in Fig. 7.7B, a one way ANOVA test for all the groups 
suggested that the difference amongst those groups was significant (p < 0.001), 
and the Tukey’s post test (comparing every two groups) indicated that 125 μM  
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Fig. 7.7 The effect of nicorandil (nico.) in combination with CoCl2 insult in MOG-G-
UVW cells. A: 65 µM CoCl2, the results are the means of 30 for 65 μM CoCl2 alone 
and the control, and 9 for 125 μM nicorandil alone, 65 μM CoCl2 + 10 μM nicorandil 
and 65 μM CoCl2 + 100 μM nicorandil. And B: 125 µM CoCl2, the results are the 
means of 12 for CoCl2 alone and the control, and 9 for 125 μM nicorandil alone, 125 
μM CoCl2 + 10 μM nicorandil and 125 μM CoCl2 + 100 μM nicorandil. 
 
CoCl2 caused a significant reduction in the relative cell number from the 
control, and 10 μM or 100 μM nicorandil in combination with 125 μM CoCl2 
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also had a significant effect on the relative cell number in comparison with the 
same dose of CoCl2 alone. 
 
Thus, it can be concluded that nicorandil cannot protect MOG-G-UVW cells 
against a low dose of CoCl2 (65 μM), but protects the cells against a high dose 
of CoCl2 (125 μM). This property is similar to the effect of diazoxide on CoCl2 
in MOG-G-UVW cells. 
 
In addition to diazoxide and nicorandil, the third KATP activator, cromakalim, 
was also tested against the same doses of CoCl2 in MOG-G-UVW cells. The 
results are shown in Fig. 7.8. 
 
For the results shown in Fig. 7.8A, a one way ANOVA test for all the groups 
suggested that the difference amongst those groups was significant (p < 0.001), 
and the Tukey’s post test (comparing every two groups) indicated that 65 μM 
CoCl2 caused a significant reduction in the relative cell number from the 
control (p < 0.001), but 10 – 100 μM cromakalim in combination with 65 μM 
CoCl2 did not have any significant effect on the relative cell number from the 
same dose of CoCl2 alone. 
 
From the results shown in Fig. 7.8B, it can be seen that cromakalim did not 
protect the cells from a high dose of CoCl2 (125 μM) either. A one way 
ANOVA test for all the groups suggested that the difference amongst those 
groups was significant (p < 0.001), the Tukey’s post test (comparing every two  
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Fig. 7.8 The effect of cromakalim (crom.) in combination with CoCl2 in MOG-G-
UVW cells. A: 65 µM CoCl2, the results are the means of 30 for 65 μM CoCl2 alone 
and the control, and 6 for 125 μM cromakalim alone, 65 μM CoCl2 + 10 μM 
cromakalim and 65 μM CoCl2 + 100 μM cromakalim. And B: 125 µM CoCl2, the 
results are the means of 21 for 125 μM CoCl2 alone and the control, and 6 for 125 μM 
cromakalim alone, 125 μM CoCl2 + 10 μM cromakalim and 125 μM CoCl2 + 100 μM 
cromakalim. 
 
groups) indicated that 125 μM CoCl2 alone caused a significant reduction in 
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the relative cell number from the control (p < 0.001), and the Dunnett’s post 
test (comparing each group with the CoCl2 alone) indicated that 100 μM 
cromakalim in combination with 125 μM CoCl2 also had a significant effect on 
the relative cell number from the same dose of CoCl2 alone (p < 0.05). 
 
To summarise the cell proliferation MTS assays results on KATP activators, it 
can be reported that none of them can protect MOG-G-UVW cells against a 
low dose of CoCl2 (65 μM). However, against a high dose of CoCl2 (125 μM), 
diazoxide and nicorandil protect MOG-G-UVW cells, and cromakalim has the 
opposite effect by further reducing the relative cell number from 125 μM 
CoCl2 alone. 
 
7.3.4 KATP blockers effect on CoCl2 insult 
 
In addition to KATP activators, the blockers, tolbutamide and glibenclamide, 
were also tested in MOG-G-UVW cells. The results of tolbutamide in 
combination with CoCl2 insult are shown in Fig. 7.9. 
 
For the results shown in Fig. 7.9A, a one way ANOVA test for all the groups 
suggested that the difference amongst those groups was significant (p < 0.001), 
and the Tukey’s post test (comparing every two groups) indicated that both 65 
μM CoCl2 alone and 100 μM tolbutamide alone caused significant reductions 
in the relative cell numbers from the control (p < 0.001 for both), and 10 μM or 
100 μM tolbutamide in combination with 65 μM CoCl2 also had a significant  
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Fig. 7.9 The effect of tolbutamide (tolb.) in combination with CoCl2 in MOG-G-UVW 
cells. A: 65 µM CoCl2, the results are the means of 30 for 65 μM CoCl2 alone and the 
control, and 6 for 100 μM tolbutamide alone, 65 μM CoCl2 + 10 μM tolbutamide and 
65 μM CoCl2 + 100 μM tolbutamide. And B: 125 µM CoCl2, the results are the means 
of 12 for 125 μM CoCl2 alone and the control, and 6 for 100 μM tolbutamide, 125 μM 
CoCl2 + 10 μM tolbutamide and 125 μM CoCl2 + 100 μM tolbutamide. 
 
effect on the relative cell number in comparison to the same dose of CoCl2 
alone (p < 0.001 for both). 
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Similar effects can be seen with a higher dose of CoCl2 (125 μM). The Tukey’s 
post test (comparing every two groups) for all the groups in Fig. 7.9B indicated 
that 10 μM or 100 μM tolbutamide in combination with 125 μM CoCl2 caused 
a significant reduction in the relative cell number from the same dose of CoCl2 
alone (p < 0.001). Therefore, it can be concluded that 100 μM tolbutamide 
alone reduces the relative cell number, and 10 μM – 100 μM tolbutamide 
cannot protect MOG-G-UVW cells from either a low dose (65 μM) or a high 
dose (125 μM) of CoCl2, and may in fact further reduce the relative cell 
number from the same of dose of CoCl2 alone. 
 
In addition to tolbutamide, another KATP blocker, glibenclamide, has also been 
tested, but only negative results were achieved (Khudheyer, 2010). The cell 
density was 5,000 per well in 24 well plates here. The dose – response for the 
CoCl2 insult in MOG-G-UVW cells was different from the one shown in 
Section 4.3.1 and the EC50 of CoCl2 in these experiments was estimated at 
about 500 µM. The glibenclamide results are shown in Table 7.3. 
 
Table 7.3 The effect of glibenclamide in combination with an EC50 of CoCl2 insult in 
MOG-G-UVW cells (n = 2) 
Glibenclamide concentration 
(in combination with 500 µM CoCl2) 
Relative cell number 
10 µM 0.621 
50 µM 0.568 
100 µM 0.428 
500 µM 0.348 
[Data from: (Khudheyer, 2010)] 
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The Bonferronni’s post test (comparing every two groups) did not suggest any 
significant difference in the relative cell number. Hence, it can be concluded 
that glibenclamide cannot protect MOG-G-UVW cells from a CoCl2 insult. 
 
Therefore, to summarise the results of the KATP channel blockers against the 
CoCl2 insult, it can be concluded that neither tolbutamide nor glibenclamide 
was protective. In addition, tolbutamide in combination with CoCl2 insult may 
even further reduce the relative cell number compared to the same dose of 
CoCl2. 
 
7.4 Discussion 
 
7.4.1 KATP channel 
 
From the PCR results shown in section 7.3.2, it can be seen that the messages 
of KATP subunits exist in the MOG-G-UVW cell line, and the subunit 
composition of KATP channel in MOG-G-UVW cell line might (tentatively) be 
Kir6.2 with SUR2A. 
 
For the possible role, if any, of the KATP channel in cell death, previous studies 
have reached different conclusions, as discussed in Section 7.1. Some studies 
believe that the activation of KATP channel can induce cell death when there 
was no insult applied to the cells, for example both diazoxide and cromakalim  
can cause a reduction in cell numbers (Wang et al., 2007, Burg et al., 2006), 
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and the blockade of KATP channel, with for example glibenclamide, may 
increase cell proliferation (Wang et al., 2007). However, in combination with 
insults, such as hypoxia and Aβ, a KATP channel activator like diazoxide might 
then be neuroprotective (Goodman and Mattson, 1996).  
 
Interestingly, the results in this Thesis did not exactly concur with those studies 
above. KATP channel activators alone, such as diazoxide, nicorandil and 
cromakalim, tended to cause a reduction in the relative cell number from the 
control, but not significantly. Only 125 μM diazoxide alone caused a 
significant reduction in the relative cell number compared to the control, and, 
KATP channel activators, like diazoxide and nicorandil, protected the cells from 
a high dose of CoCl2 (125 μM), although the results were negative in the case 
of a low dose of insult (65 μM). In addition, KATP channel blockers, for 
example tolbutamide and glibenclamide, cannot protect the cells from CoCl2 
insult, and tolbutamide in combination with CoCl2 insult may even cause a 
further reduction in the relative cell number from the same dose of CoCl2 alone. 
 
From the results shown in Section 7.3.3 and 7.3.4, a KATP channel blocker 
alone, such as tolbutamide, cannot increase cell proliferation in MOG-G-UVW 
cells, but causes a reduction in the relative cell number from the control. 
Additionally, not all KATP channel activators may protect the cells from CoCl2 
insult. Cromakalim may somehow aggravate the insult of a high dose of CoCl2 
(125 μM). 
 
Cellular Basis of Neurodegeneration 
 
 
- 232 - 
 
These results might be explained by considering the balance of [Ca
2+
]i or K
+
 
release from the cell. KATP channel activator would reduce the open probability 
of Ca
2+
 channels on both ER membrane and cell membrane (Brini, 2003). In 
normal conditions without any insult, such an effect might lower the [Ca
2+
]i to 
below a “normal” physiological level. On the other hand, as introduced in 
Section 7.1, a KATP channel blocker might reduce cellular K
+
 release and might 
cause the mitochondrial membrane hyperpolarisation. 
 
In the hypoxia environment, such as exists with a CoCl2 insult, two opposite 
results might follow the activation of the KATP channel. It can reduce the open 
probability of Ca
2+
 channels, but can also cause a K
+
 release or even efflux. 
Hence, whether the KATP channel activator is neuroprotective or not may 
depend on the balance of those two opposing effects. 
 
In addition, the difference in the effects of cromakalim and the other two KATP 
channel activators might be explained by the selectivity to different KATP 
subunits.  From the RT-PCR results shown in Section 7.3.2, it can be seen that, 
in MOG-G-UVW cell line, the expression of Kir6.2 is higher than that of Kir6.1, 
and the expression of SUR2A is higher than that of the other two SUR subunits. 
If there is any possible selectivity with respect to the different KATP channel 
subunits in the activators, it might explain the negative results shown by 
cromakalim. 
 
7.4.2 Kv3.3 and Kv3.4 channels 
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From the PCR results shown in Section 7.3.2, it can be concluded that Kv3.3 
and Kv3.4, exist in the neuronal cell lines, such as N2102Ep and NTERA-2. 
 
Previous studies have found that Kv channels can be activated during cell 
apoptosis induced by NO, and the activation of Kv channels would cause K
+
 
efflux and cell shrinkage (Burg et al., 2006). In this Thesis, the results shown in 
Section 6.3 have suggested that the generic K
+
 channel blocker, such as TEA, 
may protect the cells from CoCl2 insult. 
 
7.5 Conclusions and future work 
 
To summarise all the results and discussion in this chapter, it may be suggested 
that: 
 
a. The messages of KATP channel subunits exist in the mRNA of MOG-G-
UVW cell line, and the main subunit composition of the KATP channel 
in this cell line might be Kir6.2 with SUR2A. 
b. The messages of Kv3.3 and Kv3.4 channels exist in the mRNA of 
neuronal cell lines, such as N2102Ep and undifferentiated NTERA-2. 
c. KATP activators, such as diazoxide, nicorandil and cromakalim, cannot 
increase the cell proliferation of MOG-G-UVW cells and cannot protect 
the cells from a low dose of CoCl2 (65 μM). However, with a high dose 
of CoCl2 (125 μM), diazoxide and nicorandil protect the MOG-G-UVW 
cells, but cromakalim causes a further reduction in the relative cell 
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number from CoCl2 alone. 
d. KATP channel blockers, such as tolbutamide and glibenclamide, cannot 
increase cell proliferation in MOG-G-UVW cells, and tolbutamide 
alone may even cause a reduction in the relative cell number. Neither of 
the two blockers can protect MOG-G-UVW cells from CoCl2 insult, 
and tolbutamide may even cause a further reduction in the relative cell 
number from the same dose of CoCl2 alone. 
 
For the future work on KATP channel, the possible selectivity, if any, for 
different KATP subunits in the activators should be investigated to find out 
whether this is the reason for cromakalim to be different from the other two 
activators. If this is the case, the expression of different KATP subunits in 
neurones can be studied with Q-PCR to find out what the main subunit 
composition of KATP channel in neurones is. Furthermore, the KATP channel 
activators which can target those subunits, for example Kir6.2 and/or SUR2A, 
might point the way to a K
+
 channel strategy for neuroprotection. 
 
And as for the Kv channels, although TEA, a generic K
+
 channel blocker, may 
have a neuroprotective effect, it is uncertain which K
+
 channel(s) exactly TEA 
targets when it protects the cells. Hence, selective Kv channel blockers, such as 
dendrotoxin (Harvey and Robertson, 2004), should be tested on those 
established cell insult models in cell proliferation MTS assays to see whether 
more selective ligands may protect the cells or not. 
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8. General Discussion, Conclusion and Future Work 
 
8.1 General discussion 
 
8.1.1 [Ca
2+
]i pathogenesis in neurodegeneration and neuronal death 
 
In the general introduction (see Section 1.1), it has been argued that an 
overload of [Ca
2+
]i could be one of the key pathogenesis in neuronal death 
(Berridge, 2010). The causes of [Ca
2+
]i overload might be different in different 
neurodegenerative diseases: for example, it has been suggested that the [Ca
2+
]i 
overload and neuronal death in AD is probably because of the deposition of Aβ 
plaque on the cell membrane and the subsequent formation of a Ca
2+
 channel 
(Arispe et al., 2007). 
 
In this Thesis, the cell death induced by Aβ was confirmed in cell proliferation 
MTS assays in both undifferentiated and differentiated SH-SY5Y cells (see 
Section 4.3.4). In addition, another two cell insults which were suggested to 
increase the [Ca
2+
]i in previous studies, the hypoxia mimetic effect induced by 
CoCl2 and oxidative stress induced by H2O2 (Krebs et al., 2007), were also 
established in the cell lines used here, and were confirmed to be toxic to both 
astrocytoma (MOG-G-UVW) and neuronal (SH-SY5Y and NTERA-2) cell 
lines (see Section 4.3). Both of these insults were presumed to be related to 
[Ca
2+
]i overload causing neurodegeneration. The hypoxia mimetic effect 
induced by CoCl2 was applied as a model of ischemic stroke and has also been 
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found to increase the generation of Aβ (Zhu et al., 2009). Oxidative stress 
induced by H2O2 was also linked with, and applied as a model of 
neurodegeneration, for example AD, in previous studies (Lin and Beal, 2006, 
Floyd, 1999, Floyd and Hensley, 2002), and has been suggested to increase the 
Ca
2+
 channel open probability on the sarcoplasmic reticulum (SR, the smooth 
ER found in smooth and striated muscle cells) by possibly targeting the 
ryanodine receptor (Boraso and Williams, 1994) which is one of the key targets 
in this Thesis. 
 
Based on those previous studies mentioned above, it has been proposed that an 
increase of [Ca
2+
]i may induce cell death. Thus, those insults, CoCl2, H2O2 and 
Aβ, were then selected to establish the cell insult models in this Thesis to 
induce the neuronal death. 
 
According to previous studies on Aβ, this insult would be the model which is 
closest to the real circumstances in the neuronal cell death in AD. But, as 
discussed before in Section 4.4.3 and Section 4.4.4, the Aβ peptide is not easily 
controllable. It has to be incubated at 37 °C for one week for aggregation, and 
the length of the aggregated Aβ1-42 was quite variable, which meant some of 
the amyloid was aggregated to long fibres whereas some others still formed 
only short peptides. Different lengths of Aβ1-42 after incubation can be found in 
TEM photos from the work presented here (see Section 4.3.3 and Section 
4.4.3). As the toxic effects of aggregated and non-aggregated amyloid are 
different, the cell proliferation MTS assays results with Aβ1-42 were very 
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variable and there was little statistical significance to be found. Hence, Aβ1-42 
insult was not good enough to establish a reliable cell insult model for further 
cell proliferation MTS assays, although it might be agreed that it mimics the 
neuronal cell death environment in AD best. 
 
Thus several other insult models, which can also increase [Ca
2+
]i, were 
established here, such as hypoxia mimetic effect induced by CoCl2, oxidative 
stress induced by H2O2, and glutamate cytotoxicity via NMDA receptor 
binding and activation. As discussed in Chapters 1 and 4, they have been used 
in previous studies as models of neurodegeneration and have been shown to 
increase [Ca
2+
]i. Nevertheless, whether the [Ca
2+
]i was significantly increased 
or not by those insults has not been directly tested in this study. Although 
CoCl2, H2O2 and glutamate induce neuronal death in cell proliferation MTS 
assays, the [Ca
2+
]i, which is the key issue in neuronal death in this study, has 
not been tested in any measurement. Future work should undertake Ca
2+
 
imaging when the cells were under insult to determine directly whether [Ca
2+
]i 
was increased or not. Based on the results from cell proliferation MTS assays, 
CoCl2 and H2O2 induce reliably cell death, and such an effect is repeatable and 
statistically significant. Thus, apart from glutamate which cannot induce cell 
death until a high dose (mM), CoCl2 and H2O2 were adopted in this Thesis and 
established as neuronal insult models for further experiments. 
 
8.1.2 Cell differentiation 
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Besides the manoeuvres adopted to induce cell death, another issue which has 
been of concern in this study was the cell lines used. Two cell lines were 
required to be differentiated in this study, SH-SY5Y and NTERA-2. As 
discussed in Section 2.2, undifferentiated SH-SY5Y and NTERA-2 cells are 
neuroblastoma and pluripotent embryonal carcinoma respectively before 
differentiation. They are not human neurones unless they have been 
differentiated with retinoic acid. In this Thesis, both cell lines have been 
differentiated with retinoic acid following standard protocols and the 
morphology of the cells were examined, but it was still always an issue on how 
to evaluate a successful differentiation. 
 
As discussed in Section 3.4, some neuronal markers have been suggested in 
previous studies, although their effects might be arguable, such as PCR of 
GAP-43 (Laifenfeld et al., 2002) and western blot for transglutaminase (T-
Gase) (Joshi et al., 2007). In this study, both of these have been deployed to 
test the differentiation of SH-SY5Y cells. The results were however not 
consistent in different experiments. Such PCR results are shown in Fig. 8.1. 
 
 
 
Fig 8.1 PCR of GAP-43 in both undifferentiated and differentiated SH-SY5Y cell 
lines. Here “P” represents the passage number. 
 
From Fig. 8.1, it can be seen that the GAP-43 message expression was not 
always up-regulated after differentiation. Its expression was up-regulated at 
Ladder                  Undifferentiated SH-SY5Y                 Differentiated SH-SY5Y 
P19                             P21                             P22 
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P21, but was down-regulated at P19 and P22. 
 
In addition to the PCR of GAP-43, western blot for T-Gase was also tested, but 
there was no overt difference observed between the undifferentiated and 
differentiated SH-SY5Y cells. Therefore, a change in morphology was selected 
to evaluate the differentiation in this Thesis. As discussed in section 3.4, 
morphology was not ideal to evaluate the differentiation since the change in 
cell morphology might not be always obvious. Even in some previous studies 
which have used a change in morphology to confirm a successful 
differentiation, the difference in cell morphology between undifferentiated and 
differentiated SH-SY5Y cells was not obviously noticeable (see Fig. 3.36) 
(Lovat et al., 1997). 
 
Besides GAP-43 and T-Gase, other neuronal markers have also been utilised to 
evaluate the differentiation of a neuroblastoma cell line, for example neurites 
for the differentiation of C1300, a rat neuroblastoma cell line (Freshney, 1994). 
Antibodies which are specific for neurones have also been suggested, but 
whether they might have similar effects on neuroblastoma cell lines is not 
certain. Therefore, future work could seek to establish a reliable neuronal 
marker to evaluate the differentiation of SH-SY5Y and NTERA-2 cells. 
 
8.1.3 Ryanodine receptor function in neuronal cell death 
 
The main target in the cell lines used here is the RyR. As introduced earlier 
Cellular Basis of Neurodegeneration 
 
 
- 241 - 
 
(see Section 1.2.2), the RyR is a CICR channel on the ER membrane (Berridge, 
2010). It can be activated by cytosolic Ca
2+
 at µM level (Alexander et al., 2009) 
and releases further Ca
2+
 from the ER which may cause [Ca
2+
]i overload. Since 
the overload of [Ca
2+
]i was found in neuronal death in neurodegeneration, it is 
worthwhile to study the possible effect, if any, of the RyR in neuronal death. 
Significantly a previous study has already described the up-regulation of 
RyRIII in a transgenic mouse model of AD, and tried to link its up-regulation 
with an increase in [Ca
2+
]i (Supnet et al., 2006). 
 
8.1.3.1 RyRIII expression and cell sensitivity to the insults 
 
Considering the results from Chapters 3 and 4, it can be seen that the increased 
RyRIII message in differentiated SH-SY5Y cells was accompanied with an 
increased sensitivity to insults which might increase [Ca
2+
]i, including both the 
hypoxia mimetic effect induced by CoCl2 and oxidative stress induced by H2O2. 
For possible pathogenesis, it can be proposed that [Ca
2+
]i was firstly increased 
by the insults, either CoCl2 or H2O2, and the RyR on the ER membrane was 
then activated by the increased [Ca
2+
]i. The activated RyR channel can release 
more Ca
2+
 from the ER and further increase [Ca
2+
]i. The more RyR there is on 
the ER membrane, the more Ca
2+
 could be released through RyR channel. Thus, 
it may be suggested that the cells with a higher expression of RyR would be 
more sensitive to the insults which may cause an initial increase of [Ca
2+
]i. 
This proposed pathogenesis is briefly summarised in Fig. 8.2. 
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Fig. 8.2 Ca
2+
 induced Ca
2+
 release (CICR) route via the ryanodine receptor (RyR). 
 
Nevertheless, as discussed in Section 3.4, there is still one concern in 
concluding that a higher expression of RyR might increase cell sensitivity to 
insults. From the Q-PCR result of RyRIII expression shown in Section 3.3.6, it 
can be found that the RyRIII message in differentiated SH-SY5Y cells was 
about 6 fold higher than the undifferentiated counterpart. But, from the cell 
proliferation MTS assays results of CoCl2 insult (see Section 4.3.1), the 
differences in cell sensitivity to CoCl2 between undifferentiated and 
differentiated SH-SY5Y cells were not marked, although statistically 
significant. Thus, it might be considered debatable that the different sensitivity 
to insult was caused solely by different RyR expression. Other factors may thus 
contribute to the different sensitivity to these stressors. In addition, the 
expression of RyRIII message was only tested by PCR, but no western blot 
was carried out. Therefore, there were no data available to quantitatively 
conclude how many RyRs were present at a protein level in this cell line. 
 
As introduced in Section 1.2, RyR is not the only one receptor which can 
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modulate [Ca
2+
]i. IP3R, PS1, CALHM1 and SERCA etc. are also involved in 
the Ca
2+
 release from ER and the modulation of [Ca
2+
]i. IP3R is located on the 
ER membrane and can be activated by [Ca
2+
]i (< 300 nM) to further release 
Ca
2+
 from ER (Stutzmann and Mattson, 2011). While the RyRIII message was 
increased in SH-SY5Y cell line after differentiation, what changes in IP3R 
expression there might have been, was not investigated in this study. 
 
In addition, the increase of [Ca
2+
]i can induce both activation and inhibitory 
effects on the RyR according to different [Ca
2+
]i. µM levels of [Ca
2+
]i can 
activate RyR but mM levels of [Ca
2+
]i may inhibit it (Alexander et al., 2009). 
Such a difference is based on different binding sites and affinity of Ca
2+
 for the 
RyR (Laver, 2007) (see Fig. 8.3). The same considerations apply to the IP3R 
also. Low concentrations of Ca
2+
 (< 300 nM) can activate the channel but high 
Ca
2+
 concentrations can inhibit the channel opening (Stutzmann and Mattson, 
2011). Although it is known, from previous studies, that both a hypoxia 
mimetic insult and oxidative stress can increase [Ca
2+
]i, the [Ca
2+
]i was not 
quantitatively measured in this study. Hence, it is difficult to tell quantitatively 
how many RyR and/or IP3Rs have been activated or inhibited. 
 
To summarise, even if how important the role of RyR is in neuronal cell death 
is debatable, one conclusion stands. According to the results in this Thesis, the 
higher expression of RyRIII message is associated with a higher sensitivity of 
neuronal cells to insults which increase [Ca
2+
]i, such as a hypoxia mimetic 
effect and oxidative stress. 
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Fig. 8.3 Ca
2+
 binding sites on RyR. A-site: activation site, I1-site: inhibition site, I2-site: 
inactivation site, and L-site: luminal activation site. (Laver, 2007) 
 
8.1.3.2 RyR isoforms and blockade 
 
As introduced in Section 1.2.2, there are 3 different isoforms of RyR. RyRI is 
mainly located in skeletal muscle, RyRII is mainly found in cardiac cells, and 
RyRIII, which is the most important target in this Thesis, is mainly observed in 
brain neurones (Sorrentino, 1995). The RT-PCR results of RyRs in MG-63 
cells, an osteosarcoma cell line which is not neuronal, are consistent with 
previous studies since the message of RyRIII was absent in the MG-63 cell line 
(see Section3.3.4). 
 
Based on the findings from previous studies and the Q-PCR in this Thesis, 
blockade of the RyR was then tested to see whether the cells could be protected 
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or not. From the results presented in Chapter 5, it can be seen that ruthenium 
red, a generic RyR blocker for the 3 isoforms, protects both astrocytoma 
(MOG-G-UVW) and neuronal (SH-SY5Y and NTERA-2) cells against a 
CoCl2 insult, and tended to protect the cells against Aβ1-42 insult, although not 
significantly. The generic activation of RyR with caffeine or ryanodine (nM – 
μM) aggravates the insult by further reducing the cell numbers. Hence, it may 
be concluded that blockade of RyR is potentially neuroprotective. 
 
Obviously, one key question was how to identify the relevant isoforms of RyR. 
As mentioned in Section 5.1, there is no selective RyRIII blocker available, 
therefore, the idea here was to use other selective RyR modulators to narrow 
down the possible target. According to the results in Chapter 5, dantrolene, a 
selective RyRI and RyRIII blocker also protects both MOG-G-UVW and SH-
SY5Y cells from CoCl2 insult. But, procaine and ryanodine (100 μM), selective 
RyRI and RyRII blockers, cannot protect the cells from the insult. Thus, it was 
concluded that RyRI and RyRII may not be important targets for 
neuroprotection, but that the RyRIII, the target of ruthenium red and dantrolene, 
may offer protection to the cells. 
 
Assuming this as a potential possible target, the drug design question then 
becomes how to selectively block the RyRIII for a neuroprotective end point. 
RyRI and RyRII are widely distributed in skeletal and cardiac cells. A generic 
RyR blocker like ruthenium red would therefore cause significant and serious 
side effects, even if there is any neuroprotective benefit. The selective binding 
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domains for RyRIII blockers require to be investigated. From the previous 
limited studies on RyRIII binding domains, a simple idea can be proposed here. 
Previous studies have pointed out that the selective binding domain of 
ruthenium red on RyRIII is region 6b and 12a located at 1,861 – 2,094 and 
3,657 – 3,776 respectively in the amino acid sequence (Chen and MacLennan, 
1994). Another study has also suggested that the domain between cytoplasmic 
and transmembrane domains (3,722 – 4,610 in the amino acid sequence) could 
be the relevant binding domain of RyR (George et al., 2004), which partly 
overlaps with the selective RyRIII binding domain 12a. Thus the area between 
the cytoplasmic and transmembrane part of RyRIII may be the selective 
binding domain of RyRIII. Future work studying RyRIII blockade should 
involve an investigation on the structure of this binding domain with computer 
based modelling system to determine the requirements of a selective RyRIII 
blocker. 
 
8.1.4 K
+
 channels and neuroprotection 
 
In addition to the RyR, K
+
 channels are another important membrane target 
considered in this Thesis. As previously discussed (see Section 1.4.2) different 
considerations were raised in previous studies on the possible effects of K
+
 
channels in neuronal death and neuroprotection. Some studies claimed that 
Ca
2+
-activated K
+
 channels are relevant to a neurodegeneration model and/or 
neuroprotection (Coles et al., 2008, Liao et al., 2010), while some others 
disagree (Yu et al., 1998, Burg et al., 2006). And, different opinions have also 
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been discussed on the role of KATP channel: for example some studies suggest 
that KATP activators may protect cells from the insults of Aβ and a hypoxia 
mimetic effect (Goodman and Mattson, 1996) but some others claimed that 
KATP blockers increase cell proliferation (Wang et al., 2007). Hence, the 
possible effect, if any, of BK and KATP channels were tested here in the cell 
lines in cell proliferation MTS assays. 
 
8.1.4.1 BK channel 
 
Firstly, the BK channel was identified in undifferentiated SH-SY5Y cells in 
both RT-PCR and patch clamp recording, which means it exists and is active in 
this neuronal cell line. 
 
The activation of BK channel, with NS1619 and IPA, increased cell 
proliferation in both undifferentiated and differentiated SH-SY5Y cells. 
Neither of the two activators has shown any neuroprotective effect. As shown 
in Section 6.3.6, both NS1619 and IPA had a negative effect against the insult 
of H2O2 in the undifferentiated SH-SY5Y cells and have potentiated the toxic 
effect of the insult in the differentiated SH-SY5Y cells. In the presence of a 
hypoxia mimetic effect induced by CoCl2, both NS1619 and IPA have 
potentiated the toxic effect of CoCl2 in both undifferentiated and differentiated 
SH-SY5Y cells. 
 
For the negative results shown by the two activators, increased K
+
 efflux was 
Cellular Basis of Neurodegeneration 
 
 
- 248 - 
 
considered as a possible explanation. BK channel has been activated already in 
the presence of insults since both insults can increase the [Ca
2+
]i which is an 
activator of BK channel. Further activation with BK activators may induce an 
additional K
+
 efflux and cell shrinkage, as well as cell death (Burg et al., 2006). 
If this is the case, K
+
 channel blockers might be neuroprotective. From the 
results shown in Section 6.3.7, K
+
 channel blockers, TEA and tetrandrine, 
protect or tended to protect SH-SY5Y cells from a CoCl2 insult. Nevertheless, 
K
+
 channel blockers have not been tested in the presence of BK activators to 
see whether the blocker might reverse the effect of activator. That would be 
obvious future work. 
 
The proposed neuroprotective effect of BK blockade, if any, is still uncertain. 
Both TEA and tetrandrine are non selective BK blockers and some other K
+
 
channels have also been suggested to have a protective role, such as Kv 
channels. Additionally, a selective BK blocker, IbTX, presented a negative 
result in this study, although that might be explained by the resistance of the 
BK channel with a β4 subunit. 
 
8.1.4.2 KATP channel 
 
In addition to the BK channel, another K
+
 channel, the KATP channel was also 
studied in this Thesis. RT-PCR results indicated that there are KATP subunits in 
the MOG-G-UVW cell line and the main subunit composition might be Kir6.2 
and SUR2A (see Section 7.3). 
Cellular Basis of Neurodegeneration 
 
 
- 249 - 
 
The possible role of KATP channel in neuroprotection was tested in cell 
proliferation MTS assays in the presence of a CoCl2 insult. From the results 
shown in Section 7.3.4, it can be concluded that KATP blockers tolbutamide and 
glibenclamide were not protective. In fact tolbutamide alone reduces the cell 
number, and it may also aggravate the insult of CoCl2. 
 
That does not necessarily mean however that KATP activators are protective. 
From the results shown in section 7.3.3, it can be seen that different KATP 
activators may present different effects. KATP channel activators alone cannot 
increase the cell number, and both diazoxide and cromakalim alone may even 
reduce the cell number. In addition, KATP channel activators cannot protect the 
cells against CoCl2 insult at a low dose of CoCl2, and diazoxide may even 
aggravate the insult by further reducing the relative cell number. However, in 
the presence of a high dose of CoCl2, both diazoxide and nicorandil protect the 
cells by increasing the relative cell number from the same dose of CoCl2 alone. 
But the third activator, cromakalim, aggravated the insult by further reducing 
the relative cell number. 
 
To summarise the results from KATP modulators, it can be concluded that KATP 
channel blocker can aggravate the insult of a hypoxia mimetic effect, and the 
KATP channel activators cannot protect the cells against a low dose of CoCl2 
either. Nevertheless, whether a KATP activator strategy can be protective 
against a high dose of CoCl2 is uncertain since unfortunately different 
activators have shown different effects. In addition, KATP activators have not 
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been tested in the presence of KATP blockers to see whether the activator might 
reverse the effect of the blockers or not. That is for future work. 
 
To summarise the effects of K
+
 channels in neuroprotection, it can be 
concluded that BK activation and KATP blockade were not protective, and may 
probably potentiate or aggravate the insults by further reducing the cell number. 
On the contrary, generic K
+
 blockers, TEA and tetrandrine, were protective or 
tended to be protective against the CoCl2 insult. Activation of the KATP channel 
was not protective against a low dose of CoCl2 but was sometimes, although 
cromakalim was an exception, protective against a high dose of CoCl2. 
 
8.2 Conclusions 
 
The principal findings of the Thesis are as follows: 
 
a. The RyRIII message exists in the neuronal cell lines, but is absent in 
MG-63 cells. Its expression was up-regulated in SH-SY5Y cell line 
when the cells were differentiated from neuroblastoma to human 
neurones. 
b. The cells with higher RyRIII expression, such as differentiated SH-
SY5Y cells, were more sensitive than those with lower expression, such 
as undifferentiated SH-SY5Y cells, to insults, including a hypoxia 
mimetic effect induced by CoCl2 and oxidative stress induced by H2O2. 
c. Blockade of RyR, with ruthenium red or dantrolene, was 
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neuroprotective against CoCl2. Such an effect has been found in both 
astrocytoma (MOG-G-UVW) and neuronal (undifferentiated NTERA-2, 
undifferentiated SH-SY5Y and differentiated SH-SY5Y) cell lines. 
Ruthenium red tended to be protective against an Aβ1-42 insult as well 
in undifferentiated SH-SY5Y cells. In addition, RyR activation, with 
caffeine or ryanodine (nM – μM), can aggravate the insults of CoCl2 by 
further reducing the relative cell number. 
d. Selective blockade of RyRI and RyRII, with procaine or ryanodine (100 
μM) cannot protect the cells against CoCl2. Hence, it is suggested that 
selective blockade of RyRIII, rather than the other 2 isoforms, can be 
potentially neuroprotective. 
e. The BK channel exists and is functional in a neuronal cell line, such as 
SH-SY5Y cells. 
f. BK openers, like NS1619 and IPA, potentiate the insults of H2O2 and 
CoCl2. Generic K
+
 channel blockers, such as TEA and tetrandrine, can 
protect the cells against CoCl2. The negative results of IbTX might 
probably indicate a selectivity of BK blockers towards different β 
subunits. 
g. KATP activators, including diazoxide, nicorandil and cromakalim, 
cannot protect the cells against a low dose of CoCl2, but might be 
protective against a high dose of CoCl2. KATP blockers, such as 
tolbutamide and glibenclamide, cannot protect the cells against CoCl2 
and may even aggravate the insult. 
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8.3 Future work 
 
For future work, the following ideas might be worth investigating to firm up 
the conclusions above. 
 
a. To confirm the expression of RyRs, especially RyRIII, in neuronal cell 
lines with western blotting. 
b. To find a neuronal marker to determine whether the cells, such as 
NTERA-2 and SH-SY5Y, have been successfully differentiated or not. 
c. To apply Ca2+ imaging technique in the presence of cell insults, such as 
hypoxia mimetic or oxidative stress, to see whether the [Ca
2+
]i was 
increased, and to quantify how much the [Ca
2+
]i is increased. 
d. To use a computer based modelling system to find out the selective 
binding domain(s) of RyRIII and probably to develop selective RyRIII 
blocker(s). 
e. To further study the KATP and Kv channels with patch recording, 
pharmacology and cell proliferation MTS assays on other insult models 
or in other cell lines to determine their possible roles, if any, in 
neuronal death and neuroprotection. 
f. To test cell viability in trypan blue assays and to measure cell apoptosis 
with fluorescence-activated cell sorting (FACS) to determine how 
insults may induce cell death and to test how modulators protect the 
cells from neuronal death or apoptosis. 
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Abbreviations and Symbols
 
% percent 
°C centigrade 
Å angstrom, 10
-10
 m 
(CH3)2CHOH isopropyl alcohol 
[Ca
2+
]i intracellular Ca
2+
 concentration 
[Mg
2+
] Mg
2+
 concentration 
ι tau 
μg micro gram, 10-6 g 
μg/mL micro gram per millitre 
μm micro meter, 10-6 m 
μL micro litre, 10-6 L 
μM micromole, 10-6 M 
μm micrometre, 10-6 m 
A adenine 
Ach acetylcholine 
AD Alzheimer’s disease 
ALS amyotrophic lateral sclerosis 
ANOVA analysis of variance 
APP amyloid precursor protein 
ATP adenosine-5’-triphosphate 
Aβ beta amyloid 
BK large conductance Ca
2+
-activated K
+
 channel 
bp base pair(s) 
C cytosine 
C2H5OH ethanol 
Ca
2+
 calcium 
CaCl2 calcium chloride 
CaCl2·2H2O calcium chloride dehydrate 
CALHM1 Ca
2+
 homeostasis modulator 1 
CH3COOH acetic acid 
CH3COONa sodium acetate 
CHAPS 3-[(3-cholamidoprophl)dimethylammonio]-1-propanesulfonic acid 
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CHCl3 chloroform 
CICR Ca
2+
 induced Ca
2+
 release 
cm
2
 square centimetre 
CO2 carbon dioxide 
CoCl2 cobalt (II) chloride 
CTX charybdotoxin 
Cu copper 
Cu
+
 copper I 
CuSO4·5H2O copper (II) sulphate 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 
dGTP deoxyguanosine triphosphate 
DMEM Dulbeceo’s modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
dUTP deoxyuridine triphosphate 
EB ethidium bromide 
EC50 half maximal effective concentration 
EDTA ethylenediaminetetraacetic acid, 
(HOOCCH2)2NCH2CH2N(CH2COOH) 
EGTA ethylene glycol-bis(2-aminoethyl-ether)-N,N,N’,N’-tetraacetic acid, 
C14H24N2O10 
EMEM minimum essential medium Eagle 
ER endoplasmic reticulum 
F10 nutrient mixture F10 ham 
F12 nutrient mixture F12 ham 
FACS fluorescence – activated cell sorting 
FBS foetal bovine serum 
Fe
2+
 ferrous 
FeSO4 ferrous sulphate 
g gram, 10
-3
 kg 
G guanine 
g/cm
2
 gram per square centimetre 
GΩ giga ohm, 1012 Ω 
GAP-43 growth-associated-protein 
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GC% percentage of C and G 
h hour 
H2O water 
H2O2 hydrogen peroxide 
HCl hydrochloride acid 
HD Huntington’s disease 
Hz hertz 
I-V current – voltage 
IbTX iberiotoxin 
IP3 inositol 1,4,5-trisphosphate 
IP3R IP3 receptor 
IPA isopimaric acid 
IR inward rectifier 
K
+
 potassium 
KATP ATP-sensitive K
+
 channel 
KCl potassium chloride 
Kir inward rectifier subunit 
Kv voltage gated K
+
 channel 
M mole 
mg/mL milligram per millilitre 
Mg
2+
 magnesium 
MgCl2 magnesium (II) chloride 
min minute 
mL millilitre, 10
-3
 L 
mM milli mole, 10
-3
 M 
mm millimetre 
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt 
mV milli volt, 10
-3
 V 
N2 nitrogen 
Na
+
 sodium 
NaCl sodium chloride 
NaOH sodium hydroxide 
NEAA MEM non-essential amino acid solution 
nm nano metre, 10
-9
 m 
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nM nanomole, 10
-9
 M 
NMDA N-Methyl-D-aspartate 
NO nitric oxide 
No. number 
NS1619 1-(2’-hydroxy-5’-trifluoromethylphenyl)-5-trifluoromethyl-
2(3H)benzimidazolone 
O
·-
 superoxide 
pA pico ampere, 10
-12
 A 
pg pico gram, 10
-12
 g 
P/S penicillin-streptomycin mixture 
PBS phosphate-buffered saline 
PCR polymerase chain react 
PD Parkinson’s disease 
PIPES 1,4-piperazinediethanesulfonic acid 
PMS phenazine methosulfate 
Po open probability 
pS pico simens, 10
-12
 S 
PS1 presenilin 1 
Q-PCR quantitative PCR 
r/min round per min 
RNA ribonucleic acid 
RR ruthenium red 
RT reverse transcription 
RyR ryanodine receptor 
s second 
SERCA sarcoplasmic-endoplasmic reticulum Ca
2+
 ATPase 
SOD superoxide dismutase 
SR sarcoplasmic reticulum 
SUR sulfonylurea receptor 
T thymine 
T-Gase transglutaminase 
TEA tetraethylammonium 
TEM transmission electron microscope 
Tm melting temperature 
u unit 
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UDG uracil DNA glycosylase 
UV ultroviolet 
v/v volume to volume 
v/w volume to weight 
W watt 
w/v weight to volume 
WHO World Health Organisation 
Zn zinc 
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Appendix 
 
A. mRNA sequence of RyRIII (data from pubmed) 
 
mRNA sequence (with primer sequences shown) 
        1 cgcacgccga gcggctgccg ggggaagcag aggcgccgga ggctggggca ccgccgacgc 
       61 ctcgggagcc atggccgaag ggggagaagg aggcgaggac gagatccagt ttctgaggac 
      121 tgaggatgaa gtggtactcc agtgcatcgc caccattcat aaggagcaga ggaagttctg 
      181 cctggcagcc gagggacttg ggaatcgcct gtgcttcttg gaacccactt cagaagccaa 
      241 gtacattcct ccagatctct gcgtctgcaa ttttgtgctg gaacagtccc tatctgtcag 
      301 agccctgcag gaaatgcttg ccaacacagg tgaaaatggc ggcgaagggg cagcacaagg 
      361 aggtggccac aggaccctgt tatacggcca tgcagttctc ctgaggcact ctttcagcgg 
      421 aatgtatcta acatgcttga ctacatcaag atcccagaca gacaaacttg cctttgatgt 
      481 aggtctacgg gaacatgcca caggagaagc ctgttggtgg actatacatc ctgcttccaa 
      541 acagaggtcc gaaggagaga aagttcgaat tggcgatgac ctcatcctcg tcagcgtgtc 
      601 ctctgaaaga taccttcatc tctcagtatc aaatggtaac atacaagtgg atgcctcctt 
      661 tatgcaaaca ctctggaatg tacatcctac gtgctcagga agtagcatcg aagaaggata 
      721 cctacttggt gggcatgtag tacgtctttt ccatggtcat gatgaatgtt tgacgatacc 
      781 atctacagac cagaatgatt cccagcacag gaggatattc tacgaagctg ggggagctgg 
      841 gactcgagcc aggtctcttt ggagagtgga accccttcgg ataagctgga gtggcagtaa 
      901 catcagatgg ggccaggctt tccgactccg gcatctcacc acaggccact acctggcctt 
      961 gacagaagac caaggcctta tactgcaaga ccgggcaaag tcagacacca agtccacagc 
     1021 tttctctttc cgggcatcaa aggaactcaa ggagaaatta gactccagtc acaagcgaga 
     1081 catagaaggc atgggagttc cagaaatcaa gtatggagat tctgtctgct ttgtgcagca 
     1141 tatagccagt ggtctgtggg tgacctacaa agcacaagac gccaaaactt cccgcctggg 
     1201 acctctaaaa agaaaggtca tactccatca ggaaggccac atggatgatg gattaacact 
     1261 gcagagatgc cagcgtgagg agtcccaggc tgctcggatc atccggaaca ctacagcctt 
     1321 attcagccag tttgtcagcg gaaacaatcg cacagctgcc cccatcaccc tgcctataga 
     1381 agaagtcctg cagaccctac aggacttgat cgcctacttc cagcccccag aggaggagat 
     1441 gcgacatgaa gacaagcaga acaagctccg ctcactcaaa aacagacaaa atcttttcaa 
     1501 ggaagaggga atgttggccc ttgtcttaaa ttgcattgac cgcttaaatg tctacaatag 
     1561 cgtagcacac tttgcaggga ttgcaaggga agagagtggc atggcctgga aagaaattct 
     1621 gaacctcctc tacaaattgc tggctgctct cattcgcgga aacagaaaca attgcgctca 
     1681 attctccaat aaccttgatt ggctcatcag taaattggac agactagaat cttcctcagg 
     1741 tatcttggaa gttttgcact gcatcttaac tgaaagccca gaagccttaa atctgatagc 
     1801 ggagggccac atcaagtcga tcatctccct gttggataag cacgggcgga atcacaaggt 
     1861 tctggatatc ctgtgctccc tctgtctctg caatggggtt gcagtgagag ccaaccagaa 
     1921 tctgatctgt gacaacttgc tgccccggag aaacctactc ctgcagacac gactgattaa 
     1981 cgatgtaacc agtatccggc caaacatctt cctgggagtc gcggagggct cagcccagta 
     2041 caagaagtgg tacttcgagc tgattatcga ccaggtggac cccttcctaa cagcagagcc 
     2101 cacacatctg cgggtgggct gggcctcttc ttcaggctat gccccatacc caggaggtgg 
     2161 agaaggatgg ggaggcaatg gtgttggtga cgacctgtac tcctatggct ttgatggact 
     2221 tcacctttgg tcaggccgga tacccagagc tgtggcttcc atcaaccagc acctcctgag 
     2281 atcggatgac gtggtaagct gctgcctgga cctcggggtg cccagcatct cattccgcat 
     2341 caatgggcag cccgtgcagg ggatgtttga gaacttcaac acagacgggc tcttcttccc 
     2401 tgtgatgagc ttttcagcag gtgtcaaagt acgtttcctg atgggtggac gtcatggaga 
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     2461 gtttaagttc ctgcctccct ctggctatgc cccttgctat gaagccttac ttccaaaaga 
     2521 gaagatgaga ttggagcctg tcaaagaata taaacgtgat gctgatggca ttagagatct 
     2581 cttgggtacc acccagttcc tctcccaagc ctctttcatc ccatgccccg tagacaccag 
     2641 tcaggttatt ttgccacctc acctagaaaa gatccgagac agactagctg aaaacatcca 
     2701 tgagctttgg ggaatgaata aaatagaact tggctggact ttcggcaaga tacgagatga 
     2761 caataaaaga caacaccctt gccttgtgga gttttcaaag ctcccagaaa ctgagaagaa 
     2821 ctataacctg caaatgtcaa ctgaaacctt aaaaaccctc ttggccctgg ggtgccacat 
     2881 tgctcatgtt aacccagctg ctgaggagga tctcaagaag gtcaaactgc ccaaaaacta 
     2941 tatgatgtcc aacggctata agccagcccc tttggatttg tctgatgtga agctgttacc 
     3001 tcctcaagaa attttagtgg ataagcttgc agaaaatgca cacaatgttt gggcaaaaga 
     3061 cagaataaaa caaggatgga cctatggcat ccaacaggat ttgaagaaca aaagaaatcc 
     3121 ccgtctggtg ccatatgcat tactggatga gcgtaccaag aagtcaaaca gggacagcct 
     3181 gcgggaagct gtgcgcactt ttgttggtta cgggtataac attgagccat cagaccaaga 
     3241 actagctgac tcggctgtgg agaaggtcag catagacaag atccgatttt tccgggtaga 
     3301 gcgatcttat gcagtgagat ctggaaagtg gtattttgag tttgaagtgg tgactggagg 
     3361 agacatgcga gtcggctggg cgaggccagg ctgtcgacct gatgtcgagc tgggggccga 
     3421 tgaccaagcc tttgtgtttg aaggcaacag gggccagcgt tggcatcaag gaagtgggta 
     3481 ttttgggcgt acctggcagc caggggatgt ggtcggatgt atgattaacc tggatgatgc 
     3541 ttcaatgatc ttcacactga atggggagct gctgatcacc aacaaaggct ctgaacttgc 
     3601 cttcgctgac tacgagattg agaatggctt cgtgcccatc tgctgtctgg gtctatctca 
     3661 gatcggccgc atgaatctcg ggacagatgc cagtaccttc aagttttata ccatgtgcgg 
     3721 tctccaagag ggctttgagc cttttgctgt caacatgaac agagatgttg ctatgtggtt 
     3781 cagcaagcgc ctcccgacgt ttgtcaacgt gccaaaggat catccacaca tagaggtcat 
     3841 gaggattgat ggcaccatgg acagccctcc gtgtctcaag gtgacgcata agacatttgg 
     3901 cacacagaat agcaatgccg acatgatcta ttgccgcttg agcatgcctg tcgagtgcca 
     3961 ctcctccttc agccacagcc cctgtctgga cagtgaagct ttccagaaaa ggaaacagat 
     4021 gcaagaaata ctctctcata caacaacaca gtgctactac gccatccgca tctttgctgg 
     4081 acaggatcca tcctgtgtct gggtcggatg ggtgactcca gactatcact tgtacagtga 
     4141 aaagtttgac ctgaataaaa actgcacagt gactgtcacc ctaggggatg aaagaggccg 
     4201 ggtccatgaa agtgtgaaac gcagcaactg ctacatggtc tggggtggag acattgtagc 
     4261 cagttcccag agatcaaatc ggagcaacgt ggacctggag atcggctgtc tcgtggatct 
     4321 ggccatgggc atgttgtcct tctcagccaa tggaaaggaa ctgggcacct gctaccaggt 
     4381 ggagcctaat accaaagtgt ttccagcagt cttcctgcag cctacaagta cttctttgtt 
     4441 tcagtttgaa cttggaaagc tgaagaacgc aatgcccctg tcagcggcca tattcaggag 
     4501 tgaagagaag aacccagtcc cacagtgtcc acctcggctg gacgtccaaa ccatccagcc 
     4561 cgtgctctgg agccgcatgc ccaacagctt cctgaaggtg gagaccgagc gtgtgagcga 
     4621 gcgccacggc tgggtggtgc agtgcctgga gcccctgcag atgatggcgc tccacatccc 
     4681 cgaggagaac aggtgtgtgg atatcctgga gctctgtgag caggaggacc tgatgcggtt 
     4741 ccattaccac acgctgaggc tctacagcgc ggtgtgcgcc ctgggaaaca gccgcgtggc 
     4801 ctacgccctg tgcagccacg tggacctctc ccagctcttc tatgccattg acaacaagta 
     4861 cctccccggc ctccttcgat ctggtttcta tgacctgctc atcagcatcc acctggccag 
     4921 cgccaaggag aggaagctga tgatgaagaa cgagtacatc atccccatta ccagcaccac 
     4981 caggaatatc cgcctcttcc cggacgagtc caagaggcat ggactgcctg gggtgggcct 
     5041 gagaacatgt ctcaagcccg ggttcaggtt ctccacccct tgctttgttg tgactggtga 
     5101 ggatcaccaa aagcagagcc ccgagattcc cttggagagt ctcaggacga aggctctgag 
     5161 tatgctgaca gaggcagtgc agtgcagcgg ggcccacatc cgagaccctg taggggggtc 
     5221 tgtggagttc cagtttgtgc ctgtgctgaa actcattgga accctgctgg tcatgggcgt 
     5281 gtttgatgat gatgatgttc ggcagatcct cctcctgatt gatccctctg tgtttgggga 
     5341 gcatagtgcg gggacagagg agggagcaga aaaggaggaa gtgacccagg tggaggagaa 
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     5401 ggctgtggag gctggggaga aggccggcaa ggaggctcct gtcaaaggct tgttgcagac 
     5461 tcgattaccc gaatccgtca agctgcagat gtgtgagctc ctcagctatc tctgcgactg 
     5521 tgagctgcag caccgagtgg aggccattgt ggcatttggt gacatttatg tctccaagct 
     5581 gcaggcaaat cagaagttcc gctacaatga gctcatgcag gccctgaaca tgtctgcggc 
     5641 cctgactgcc cggaagacca aggagttccg ctcaccccca caggagcaga tcaacatgct 
     5701 gcttaacttt caactgggag agaactgccc ctgcccagag gagattcggg aggagctgta 
     5761 tgatttccat gaggaccttc tccttcactg tggggttcct ttggaagaag aggaagagga 
     5821 ggaggaggac acctcctgga caggaaaact ctgtgccttg gtttacaaaa tcaaaggccc 
     5881 acccaagcca gagaaggagc agccgacgga ggaggaggag agatgcccca caacattgaa 
     5941 ggaactcatc tcacagacga tgatctgctg ggcccaggag gaccagatcc aggattcaga 
     6001 gctggtccga atgatgttca acctcctccg gaggcagtat gacagcattg gggagctgct 
     6061 gcaggcgctg cggaagacct acaccatcag ccacacctct gtaagcgaca ccatcaacct 
     6121 gctggctgcc ctgggccaaa tccgctccct cctcagtgtc aggatgggca aggaagagga 
     6181 gttgctcatg atcaatgggc tgggagacat aatgaacaac aaggtgtttt accagcatcc 
     6241 caacctcatg agagtcctgg gcatgcacga gacggtgatg gaggtgatgg tgaacgtgtt 
     6301 gggtacagag aaatctcaga ttgcatttcc aaagatggtt gctagctgct gccgtttcct 
     6361 ttgctatttc tgtcgaatta gccggcaaaa tcagaaggcc atgtttgagc atctgagtta 
     6421 tcttctggag aatagcagtg ttggcctagc ctccccgtcg atgaggggat ccaccccgct 
     6481 ggatgtggca gcttcctctg tgatggacaa caatgagtta gcgctgagct tagaggaacc 
     6541 agacctcgag aaggtggtga cctacttggc aggctgtggc ctacagagct gccccatgct 
     6601 tctggccaaa ggataccctg atgtcggctg gaaccccatt gaaggggaac gctacctgtc 
     6661 cttcctgagg tttgctgtct tcgtgaacag tgagagtgtg gaagaaaacg ccagcgttgt 
     6721 ggtcaagctg ctcatcagac gcccagagtg cttcggcccg gccctgcggg gtgagggggg 
     6781 aaacgggctc ttggcagcca tgcagggtgc cattaagatc tctgagaacc cagcgctcga 
     6841 cctcccctct caaggataca aaagagaagt cagcacgggg gacgatgaag aggaagaaga 
     6901 aatcgtgcat atgggcaatg caattatgtc attttattcg gcccttatag atctactggg 
     6961 ccgctgtgct cctgaaatgc acctcatcca gacaggaaag ggggaagcca tccgcatcag 
     7021 gtccatcctg cgctccctgg tccccacaga agacctggtt gggatcatca gcatcccctt 
     7081 gaaactgccc tccctcaaca aagatgggtc ggtcagtgag ccagatatgg cggccaattt 
     7141 ctgccctgac cacaaggcac ctatggtgct gttcttggac cgcgtttatg gcattaagga 
     7201 tcaaactttt ctgctccact tgctggaggt tggattttta cctgacctaa gagcttctgc 
     7261 ctctctagat acagtttccc taagcaccac agaggctgcg cttgcactaa ataggtatat 
     7321 atgttctgct gtgctcccgc tcctcacaag atgtgcccct ctctttgccg gaacagaaca 
     7381 ctgcacctct ctgattgatt ccacactgca gacaatatac aggctatcca agggacgttc 
     7441 cctcaccaaa gcacaaaggg acactataga agaatgtttg cttgccattt gcaatcactt 
     7501 gaggccttcc atgttacagc aactcctgcg acgcctcgtt tttgatgtgc cgcaactcaa 
     7561 tgaatactgc aaaatgcctc tcaagcttct gacgaatcac tatgaacagt gttggaagta 
     7621 ttactgcctg ccttcaggat gggggagcta cgggctagct gtggaagaag agctgcacct 
     7681 aacggagaag cttttctggg ggatttttga ctcgctctcc cataagaaat atgacccaga 
     7741 tcttttccga atggccctgc cttgtctcag tgctatagct ggggccttgc caccagatta 
     7801 tttagatacc agaatcacag ccacgttgga gaaacagatc tcagtggatg cggatggcaa 
     7861 ctttgaccca aaacctatta acaccatgaa tttttccttg cctgaaaaat tggaatacat 
     7921 cgtcaccaag tatgctgagc attcacatga taaatgggcc tgtgacaaga gtcagagtgg 
     7981 atggaaatat gggatttccc tggatgaaaa tgtgaagacc cacccactga taaggccttt 
     8041 caagacatta acggagaagg agaaggaaat ttatcgctgg cctgcgcgag agtccctgaa 
     8101 aaccatgctg gctgtgggct ggactgtgga gaggaccaaa gagggagaag ctttggttca 
     8161 acagcgggaa aatgagaagc ttcgaagtgt gtcccaggcc aaccagggca acagctacag 
     8221 tcctgctccc ctcgacctct caaacgttgt gctctccaga gagctccagg gaatggtgga 
     8281 ggtcgtggct gagaactatc acaatatctg ggccaagaag aagaagctgg agctggagag 
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     8341 caaaggtggt ggcagccacc ctcttctggt accatatgac accttgactg ccaaggaaaa 
     8401 gttcaaggac cgggagaagg cacaggacct gtttaagttc ctccaagtga atggcatcat 
     8461 agtttccagg ggtatgaagg atatggagct ggatgcctcc tccatggaga agaggtttgc 
     8521 ctataagttc ttgaagaaga tcctgaaata cgttgattct gctcaagaat ttattgccca 
     8581 tttagaagcc attgtcagca gtgggaaaac tgaaaagtct ccccgtgacc aggagatcaa 
     8641 attctttgcc aaagttctcc tcccgctggt tgaccagtac ttcaccagtc attgcctcta 
     8701 cttcttgtca tcccctctga agccccttag cagcagcgga tatgcctccc ataaggagaa 
     8761 agaaatggtg gccggcctgt tctgcaaact tgccgctctc gttagacaca gaatttccct 
     8821 ctttggtagt gattctacta caatggtgag ctgtcttcac atcttagctc agacacttga 
     8881 cacaaggact gtcatgaagt caggctcaga gctggtgaag gctgggttac gagcattctt 
     8941 tgaaaatgct gcagaagatt tggagaagac ttcagaaaac ctgaaacttg ggaagttcac 
     9001 ccattcccga acgcagatta aaggcgtttc tcagaatatt aactacacta cagtggctct 
     9061 gctccccatc ctgacgtcca tctttgagca cgtcactcag catcagtttg gaatggatct 
     9121 actcttgggt gatgtgcaga tttcatgcta ccacatactg tgcagcctct actcccttgg 
     9181 gacgggaaag aacatttatg ttgaaaggca acgccctgcc cttggagaat gtctggcctc 
     9241 gctggcagct gccataccag tggcattcct ggagcccacc cttaatcgct acaatccact 
     9301 ctcggtcttc aacaccaaaa cccccaggga gaggtctatt ctggggatgc cagacacggt 
     9361 agaagacatg tgtcctgaca tcccccagct ggaaggcctg atgaaggaaa tcaacgacct 
     9421 ggccgagtca ggggcccggt acacagagat gccccatgtc atcgaggtga tcttacccat 
     9481 gctctgcaac tacttgtcct actggtggga gcggggtcct gagaacctgc cccccagcac 
     9541 agggccatgc tgcaccaagg tcacctctga acacctcagt ctcatcctgg gcaacattct 
     9601 gaaaatcatc aacaacaacc tgggcatcga tgaggcctcc tggatgaagc gcattgcagt 
     9661 gtatgcacag cccatcatca gcaaagccag gcccgacctg ctgagaagcc acttcatccc 
     9721 aactctggag aagctgaaga aaaaggctgt caagacggtg caggaggagg agcagttgaa 
     9781 agccgatggc aaaggggaca cccaggaggc agaactcctc atcctggacg agttcgcggt 
     9841 cctctgcaga gatctctatg ccttctaccc catgctgatc cgctacgtgg acaacaacag 
     9901 atctaactgg ctgaaaagtc ctgatgctga ttctgaccag ctcttccgca tggtggcaga 
     9961 agtcttcatt ctgtggtgta aatctcataa cttcaagaga gaagagcaaa attttgtgat 
    10021 tcagaatgaa attaataatt tggcattttt aactggagac agcaaaagca agatgtcaaa 
    10081 agccatgcaa gtaaagtctg gaggacaaga ccaggagcgg aagaagacaa agcggcgggg 
    10141 agacttgtat tccatccaga cctccctcat cgtggctgca ctcaagaaaa tgctgcccat 
    10201 tggtttgaat atgtgtactc caggcgacca ggagctgatc tccctcgcaa aatcgcgata 
    10261 cagccatagg gacacagatg aagaggtcag agaacatctg cggaacaact tgcacttgca 
    10321 ggaaaagtct gatgacccag ctgtaaaatg gcaactgaac ctctacaagg atgttctgaa 
    10381 gagtgaagaa cctttcaatc cggaaaagac agtggagcgt gtgcagagaa tttcagcagc 
    10441 tgtcttccac ctggaacagg tggaacagcc tttgaggtcc aagaaggccg tctggcacaa 
    10501 actgttatca aagcaacgga aacgggcagt ggtggcctgt ttcaggatgg cccctctcta 
    10561 caacctgccc aggcaccgct ctattaacct cttcctccat ggctatcaga gattttggat 
    10621 agaaacagag gagtattcct ttgaagagaa actagtacag gatttggcta aatctccaaa 
    10681 ggtggaagag gaggaggagg aagagacaga aaaacaacct gacccactac atcagatcat 
    10741 tctctatttt agccgcaacg ctctcacgga gaggagcaaa ttggaagacg accctttgta 
    10801 cacctcctat tccagcatga tggccaagag ttgtcaaagt ggtgaggatg aagaagaaga 
    10861 tgaagacaag gaaaaaacat tcgaagagaa agagatggag aagcaaaaaa ccctctatca 
    10921 gcaagctcgg ctgcatgagc gtggtgctgc agagatggtc cttcagatga taagcgctag 
    10981 caaaggtgag atgagcccca tggtggttga gacgctgaag ctggggatcg ccattctgaa 
    11041 cggaggcaat gctggtgtgc aacagaaaat gctagattac ctaaaggaga aaaaggatgc 
    11101 tggattcttt caaagccttt ctggtcttat gcagtcttgc agtgtccttg atttgaatgc 
    11161 atttgagagg cagaataaag ctgaaggcct ggggatggtg actgaagaag gaacactcat 
    11221 tgttcgggaa cgtggtgaaa aagtactcca gaatgacgag ttcacgcgtg atctctttag 
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    11281 attcctacag ttactttgtg agggacataa cagtgacttt cagaacttcc tgcggactca 
    11341 gatgggcaac accaccaccg tgaatgtcat catcagcact gtggactacc ttctgcgtct 
    11401 gcaggaatca atcagtgatt tctactggta ttattcaggg aaggacatca ttgatgaatc 
    11461 tggacagcac aatttttcca aagctctggc agtcaccaag cagattttca attctcttac 
    11521 agaatacatc cagggccctt gcattggtaa tcaacagagc ctggctcaca gcaggctgtg 
    11581 ggacgcagtg gttggcttcc tccatgtctt tgctaatatg cagatgaaac tctctcagga 
    11641 ttccagtcag atcgagctgc tgaaggaact cttggatctc cttcaggaca tggtggtgat 
    11701 gcttctgtcc ctcctggaag ggaatgtggt aaatggcacc attggcaagc agatggttga 
    11761 cacactggta gaatcatcta ccaatgtaga aatgatcttg aaattctttg acatgttctt 
    11821 gaaacttaaa gacttaacca gctcagacac cttcaaagaa tatgacccag atggtaaagg 
    11881 aattatctcc aaaaaagaat tccagaaggc catggaaggg caaaaacagt acacgcagtc 
    11941 agagattgac tttctcctgt cgtgtgcaga agctgatgag aatgacatgt ttaattacgt 
    12001 tgattttgta gaccggttcc atgagccagc caaggacata gggtttaatg tggctgtgtt 
    12061 attgacaaat ctttctgaac acatgccaaa cgattcccgc ctgaagtgtc tgttggaccc 
    12121 agcagaaagt gtgctaaatt acttcgaacc ctacctagga cgcatcgaga tcatgggtgg 
    12181 ggccaagaag attgagcgtg tttattttga gatcagtgaa tccagtcgca ctcagtggga 
    12241 gaagccccag gtgaaggaat ctaagcgaca gttcattttt gatgttgtca atgaaggtgg 
    12301 ggagcaggaa aagatggagc tgtttgtgaa cttctgtgag gacaccatct ttgaaatgca 
    12361 gttagcatct cagatctctg aatccgattc agctgacagg ccagaagagg aggaagaaga 
    12421 tgaagattct tcttacgtgt tagaaattgc gggtgaagag gaagaagacg ggtctcttga 
    12481 gccggcctct gcatttgcta tggcctgtgc ctctgtgaag aggaatgtca ccgacttcct 
    12541 gaagagagca accctgaaga acctcaggaa gcagtacagg aacgtgaaaa agatgactgc 
    12601 gaaggagctg gtgaaggtgc tcttctcctt tttctggatg ctgttcgtgg ggctattcca 
    12661 gttgctcttc accatcctgg gaggaatctt tcagatcctc tggagcacag tgtttggagg 
    12721 gggcctggta gaaggggcaa agaacatcag agtgaccaag atcctgggtg acatgcctga 
    12781 cccaacccaa tttggtatcc atgatgacac tatggaggct gagagggcag aggtgatgga 
    12841 gccaggtatc accactgaac tagtacactt cataaagggg gagaagggag atacagatat 
    12901 catgtcagac ctctttggac tccacccaaa gaaagagggc agcttaaagc atgggcctga 
    12961 agtgggtttg ggtgacctct cagaaattat tggcaaggat gaacccccta cattagagag 
    13021 tactgtacag aagaagagga aagctcaggc agcagaaatg aaagcagcaa atgaagcaga 
    13081 aggaaaagta gaatccgaga aggcagacat ggaagatgga gagaaggaag acaaagacaa 
    13141 agaagaggag caagctgagt acctgtggac agaagtgaca aaaaagaaga agcggcggtg 
    13201 tggtcagaag gttgagaagc cggaagcttt cacagccaat ttctttaaag ggctggaaat 
    13261 ctatcagacc aagttactgc attacctggc caggaatttc tacaacctga ggttccttgc 
    13321 tctgtttgta gccttcgcta tcaacttcat cctgcttttt tataaggtca ctgaagaacc 
    13381 tttagaagaa gagacagagg atgttgcaaa cctatggaat tcctttaatg acgaggaaga 
    13441 ggaagaagcg atggtattct ttgtccttca ggagagcacc gggtatatgg caccaaccct 
    13501 gcgtgccctg gccatcatcc ataccatcat ctctctagtc tgtgtggtgg gctactactg 
    13561 cctgaaggtg cctttggtgg ttttcaaaag ggaaaaagaa atcgccagga agctggagtt 
    13621 tgatggccta tatatcaccg aacagccatc tgaagatgac atcaaggggc agtgggaccg 
    13681 cttggtgatc aacacaccat cttttcctaa taactactgg gacaagtttg taaagagaaa 
    13741 ggtgatcaac aagtatggag atctctacgg agcagaacgc attgctgaac ttctgggttt 
    13801 ggacaaaaat gctcttgact ttagcccagt agaagagacc aaagcagaag cggcttctct 
    13861 ggtgtcatgg ctaagttcca tagacatgaa gtaccatatc tggaagcttg gagttgtttt 
    13921 tactgacaac tcctttctct accttgcctg gtatacaacc atgtcagtcc tgggccacta 
    13981 caataacttc ttctttgctg ctcacctatt ggacatcgca atgggcttca agacactgag 
    14041 gaccattctg tcatctgtaa ctcacaatgg caaacagttg gttctgactg tcggtctcct 
    14101 ggccgtggtg gtttatctct atactgtggt ggctttcaac ttcttccgca agttctacaa 
    14161 caaaagcgaa gacgatgacg agcccgatat gaagtgcgac gacatgatga cgtgttacct 
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    14221 tttccacatg tacgtgggag tgagagcagg aggtggcatt ggtgatgaaa ttgaagaccc 
    14281 tgctggtgat ccttatgaaa tgtatcgcat tgtctttgac attacctttt tcttcttcgt 
    14341 cattgtcatc ttgctggcca tcattcaagg tcttattatt gatgctttcg gagagctaag 
    14401 agaccagcag gaacaagtac gagaagatat ggagactaaa tgtttcatct gtgggattgg 
    14461 caatgactac tttgacacaa cccctcatgg ttttgaaaca catacattac aagagcacaa 
    14521 cttagccaac tacttgttct ttctgatgta tttgattaat aaagatgaaa cagagcacac 
    14581 gggtcaggaa tcttatgtct ggaagatgta ccaagaaagg tgttgggatt tcttcccagc 
    14641 cggtgactgc tttcgtaaac aatatgaaga tcagcttgga taaatctgaa tcaaagaagc 
    14701 gcgacaattc tggacagtca acttcccatg aaataaagtc ccctttttac agttctgcaa 
    14761 catatctgaa atgtgacatt ttctaaatgc ctcccttaaa aaaaaaactg ctgaaaatct 
    14821 gtgctatttt gaaattgatt tggctttttg tgcctaatgg acatacactg tgggagagaa 
    14881 cctgtcaaaa tgtcgaagaa ggaaggcgaa gaatcaagta atctctaggc aaatgccttc 
    14941 aagttttcca gttctgaggt aactagttca gtttgttggg atggaagcat gaaggaaagg 
    15001 gctagagaag tatgaaatct cgaatgtgta atacctgaaa atttaaacac ttgaatgtca 
    15061 tcatggtatc caacttgtga ctcatagggt ctgaactcac tccaaaagat aataactgca 
    15121 gtctaatttt tcccatggta cttgctagtg actgtatcca gaaaagcttt aagcagttaa 
    15181 agaaacagaa aaaaaccgac actttgtcga cactgaaata tcgattaagt gccttaaaac 
    15241 ctctttagac atagctatgc aagtttttta tgtttgtgtt ccagaaggac agttccattc 
    15301 attagttgtg atcttccgtc ttactttatg aaactgcact tgaaggttat tcatacaagt 
    15361 ttttttagta acagctgtca gtcaactgct gttattagaa gaaaagtact gtactgaaaa 
    15421 ttcagaaaaa aaatctcaac cttatgccaa aatggagtaa tgctttatgg tcccttgtaa 
    15481 gtagtggagc tgctctgttt aggtgaatct cctcaaatac aatgaagtgc ccactgcaat 
    15541 aaagtaatac gtaccaataa aaa 
 
B. Amino acid sequence of RyRIII (data from pubmed) 
 
MAEGGEGGEDEIQFLRTEDEVVLQCIATIHKEQRKFCLAAEGLGNRLCFLEPT
SEAKYIPPDLCVCNFVLEQSLSVRALQEMLANTGENGGEGAAQGGGHRTLLY
GHAVLLRHSFSGMYLTCLTTSRSQTDKLAFDVGLREHATGEACWWTIHPASK
QRSEGEKVRIGDDLILVSVSSERYLHLSVSNGNIQVDASFMQTLWNVHPTCSG
SSIEEGYLLGGHVVRLFHGHDECLTIPSTDQNDSQHRRIFYEAGGAGTRASSL
WRVEPLRISWSGSNIRWGQAFRLRHLTTGHYLALTEDQGLILQDRAKSDTKST
AFSFRASKELKEKLDSSHKRDIEGMGVPEIKYGDSVCFVQHIASGLWVTYKAQ
DAKTSRLGPLKRKVILHQEGHMDDGLTLQRCQREESQAARIIRNTTALFSQFV
SGNNRTAAPITLPIEEVLQTLQDLIAYFQPPEEEMRHEDKQNKLRSLKNRQNLF
KEEGMLALVLNCIDRLNIYNSVAHFAGIAREESGMAWKEILNLLYKLLAALIR
GNRNNCAQFSNNLDWLISKLDRLESSSGILEVLHCILTESPEALNLIAEGHIKSII
SLLDKHGRNHKVLDILCSLCLCNGVAVRANQNLICDNLLPRRNLLLQTRLIND
VTSIRPNIFLGVAEGSAQYKKWYFELIIDQVDPFLTAEPTHLRVGWASSSGYAP
CPGGGEGWGGNGVGDDLYSYGFDGLHLWSGRIPRAVASVNQHLLRSDDVVS
CCLDLGVPSISFRINGQPVQGMFENFNTDGLFFPVMSFSAGVKVRFLMGGRHG
EFKFLPPSGYAPCYEALLPKEKMRLEPVKEYKRDADGIRDLLGTTQFLSQASFI
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PCPVDTSQVILPPHLEKIRDRLAENIHELWGMNKIELGWTFGKIRDDNKRQHP
CLVEFSKLPETEKNYNLQMSTETLKTLLALGCHIAHVNPAAEEDLKKVKLPK
NYMMSNGYKPAPLDLSDVKLLPPQEILVDKLAENAHNVWAKDRIKQGWTYG
IQQDLKNKRNPRLVPYALLDERTKKSNRDSLREAVRTFVGYGYNIEPSDQELA
DSAVEKVSIDKIRFFRVERSYAVRSGKWYFEFEVVTGGDMRVGWARPGCRPD
VELGADDQAFVFEGNRGQRWHQGSGYFGRTWQPGDVVGCMINLDDASMIFT
LNGELLITNKGSELAFADYEIENGFVPICCLGLSQIGRMNLGTDASTFKFYTMC
GLQEGFEPFAVNMNRDVAMWFSKRLPTFVNVPKDHPHIEVMRIDGTMDSPPC
LKVTHKTFGTQNSNADMIYCRLSMPVECHSSFSHSPCLDSEAFQKRKQMQEIL
SHTTTQCYYAIRIFAGQDPSCVWVGWVTPDYHLYSEKFDLNKNCTVTVTLGD
ERGRVHESVKRSNCYMVWGGDIVASSQRSNRSNVDLEIGCLVDLAMGMLSF
SANGKELGTCYQVEPNTKVFPAVFLQPTSTSLFQFELGKLKNAMPLSAAIFRSE
EKNPVPQCPPRLDVQTIQPVLWSRMPNSFLKVETERVSERHGWVVQCLEPLQ
MMALHIPEENRCVDILELCEQEDLMRFHYHTLRLYSAVCALGNSRVAYALCS
HVDLSQLFYAIDNKYLPGLLRSGFYDLLISIHLASAKERKLMMKNEYIIPITSTT
RNICLFPDESKRHGLPGVGLRTCLKPGFRFSTPCFVVTGEDHQKQSPEIPLESLR
TKALSMLTEAVQCSGAHIRDPVGGSVEFQFVPVLKLIGTLLVMGVFDDDDVR
QILLLIDPSVFGEHSAGTEEGAEKEEVTQVEEKAVEAGEKAGKEAPVKGLLQT
RLPESVKLQMCELLSYLCDCELQHRVEAIVAFGDIYVSKLQANQKFRYNELM
QALNMSAALTARKTKEFRSPPQEQINMLLNFQLGENCPCPEEIREELYDFHED
LLLHCGVPLEEEEEEEEDTSWTGKLCALVYKIKGPPKPEKEQPTEEEERCPTTL
KELISQTMICWAQEDQIQDSELVRMMFNLLRRQYDSIGELLQALRKTYTISHT
SVSDTINLLAALGQIRSLLSVRMGKEEELLMINGLGDIMNNKVFYQHPNLMRV
LGMHETVMEVMVNVLGTEKSQIAFPKMVASCCRFLCYFCRISRQNQKAMFE
HLSYLLENSSVGLASPSMRGSTPLDVAASSVMDNNELALSLEEPDLEKVVTYL
AGCGLQSCPMLLAKGYPDVGWNPIEGERYLSFLRFAVFVNSESVEENASVVV
KLLIRRPECFGPALRGEGGNGLLAAMQGAIKISENPALDLPSQGYKREVSTED
DEEEEEIVHMGNAIMSFYSALIDLLGRCAPEMHLIQTGKGEAIRIRSILRSLVPT
EDLVGIISIPLKLPSLNKDGSVSEPDMAANFCPDHKAPMVLFLDRVYGIKDQTF
LLHLLEVGFLPDLRASASLDTVSLSTTEAALALNRYICSAVLPLLTRCAPLFAG
TEHCTSLIDSTLQTIYRLSKGRSLTKAQRDTIEECLLAICNHLRPSMLQQLLRRL
VFDVPQLNEYCKMPLKLLTNHYEQCWKYYCLPSGWGSYGLAVEEELHLTEK
LFWGIFDSLSHKKYDPDLFRMALPCLSAIAGALPPDYLDTRITATLEKQISVDA
DGNFDPKPINTMNFSLPEKLEYIVTKYAEHSHDKWACDKSQSGWKYGISLDE
NVKTHPLIRPFKTLTEKEKEIYRWPARESLKTMLAVGWTVERTKEGEALVQQ
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RENEKLRSVSQANQGNSYSPAPLDLSNVVLSRELQGMVEVVAENYHNIWAK
KKKLELESKGGGSHPLLVPYDTLTAKEKFKDREKAQDLFKFLQVNGIIVSRGM
KDMELDASSMEKRFAYKFLKKILKYVDSAQEFIAHLEAIVSSGKTEKSPRDQEI
KFFAKVLLPLVDQYFTSHCLYFLSSPLKPLSSSGYASHKEKEMVAGLFCKLAA
LVRHRISLFGSDSTTMVSCLHILAQTLDTRTVMKSGSELVKAGLRAFFENAAE
DLEKTSENLKLGKFTHSRTQIKGVSQNINYTTVALLPILTSIFEHVTQHQFGMD
LLLGDVQISCYHILCSLYSLGTGKNIYVERQRPALGECLASLAAAIPVAFLEPTL
NRYNPLSVFNTKTPRERSILGMPDTVEDMCPDIPQLEGLMKEINDLAESGARY
TEMPHVIEVILPMLCNYLSYWWERGPENLPPSTGPCCTKVTSEHLSLILGNILKI
INNNLGIDEASWMKRIAVYAQPIISKARPDLLRSHFIPTLEKLKKKAVKTVQEE
EQLKADGKGDTQEAELLILDEFAVLCRDLYAFYPMLIRYVDNNRSNWLKSPD
ADSDQLFRMVAEVFILWCKSHNFKREEQNFVIQNEINNLAFLTGDSKSKMSK
AMQVKSGGQDQERKKTKRRGDLYSIQTSLIVAALKKMLPIGLNMCTPGDQEL
ISLAKSRYSHRDTDEEVREHLRNNLHLQEKSDDPAVKWQLNLYKDVLKSEEP
FNPEKTVERVQRISAAVFHLEQVEQPLRSKKAVWHKLLSKQRKRAVVACFR
MAPLYNLPRHRSINLFLHGYQRFWIETEEYSFEEKLVQDLAKSPKVEEEEEEET
EKQPDPLHQIILYFSRNALTERSKLEDDPLYTSYSSMMAKSCQSGEDEEEDED
KEKTFEEKEMEKQKTLYQQARLHERGAAEMVLQMISASKGEMSPMVVETLK
LGIAILNGGNAGVQQKMLDYLKEKKDAGFFQSLSGLMQSCSVLDLNAFERQN
KAEGLGMVTEEGTLIVRERGEKVLQNDEFTRDLFRFLQLLCEGHNSDFQNFLR
TQMGNTTTVNVIISTVDYLLRLQESISDFYWYYSGKDIIDESGQHNFSKALAVT
KQIFNSLTEYIQGPCIGNQQSLAHSRLWDAVVGFLHVFANMQMKLSQDSSQIE
LLKELLDLLQDMVVMLLSLLEGNVVNGTIGKQMVDTLVESSTNVEMILKFFD
MFLKLKDLTSSDTFKEYDPDGKGIISKKEFQKAMEGQKQYTQSEIDFLLSCAE
ADENDMFNYVDFVDRFHEPAKDIGFNVAVLLTNLSEHMPNDSRLKCLLDPAE
SVLNYFEPYLGRIEIMGGAKKIERVYFEISESSRTQWEKPQVKESKRQFIFDVV
NEGGEQEKMELFVNFCEDTIFEMQLASQISESDSADRPEEEEEDEDSSYVLEIA
GEEEEDGSLEPASAFAMACASVKRNVTDFLKRATLKNLRKQYRNVKKMTAK
ELVKVLFSFFWMLFVGLFQLLFTILGGIFQILWSTVFGGGLVEGAKNIRVTKIL
GDMPDPTQFGIHDDTMEAERAEVMEPGITTELVHFIKGEKGDTDIMSDLFGLH
PKKEGSLKHGPEVGLGDLSEIIGKDEPPTLESTVQKKRKAQAAEMKAANEAE
GKVESEKADMEDGEKEDKDKEEEQAEYLWTEVTKKKKRRCGQKVEKPEAFT
ANFFKGLEIYQTKLLHYLARNFYNLRFLALFVAFAINFILLFYKVTEEPLEEETE
DVANLWNSFNDEEEEEAMVFFVLQESTGYMAPTLRALAIIHTIISLVCVVGYY
CLKVPLVVFKREKEIARKLEFDGLYITEQPSEDDIKGQWDRLVINTPSFPNNY
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WDKFVKRKVINKYGDLYGAERIAELLGLDKNALDFSPVEETKAEAASLVSWL
SSIDMKYHIWKLGVVFTDNSFLYLAWYTTMSVLGHYNNFFFAAHLLDIAMGF
KTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKSEDDDEP
DMKCDDMMTCYLFHMYVGVRAGGGIGDEIEDPAGDPYEMYRIVFDITFFFFV
IVILLAIIQGLIIDAFGELRDQQEQVREDMETKCFICGIGNDYFDTTPHGFETHTL
QEHNLANYLFFLMYLINKDETEHTGQESYVWKMYQERCWDFFPAGDCFRKQ
YEDQLG 
  
Cellular Basis of Neurodegeneration 
 
 
267 
 
References 
 
Akita T & Kuba K (2000). Functional triads consisting of ryanodine receptors, Ca
2+
 
channels, and Ca
2+
-activated K
+
 channels in bullfrog sympathetic neurons - 
plastic modulation of action potential. J. Gen. Physiol., 116, 697 - 720. 
Alarcón JM, Brito JA, Hermosilla T, Atwater I, Mears D & Rojas E (2006). Ion 
channel formation by Alzheimer's disease amyloid β-peptide (aβ40) in 
unilamellar liposomes is determined by anionic phospholipids. Piptides, 27, 
95 - 104. 
Alexander SPH, Mathie A & Peter JA (2009). Guide to receptors and channels 
(GRAC). Br. J. Pharmacol., 158, 1 - 254. 
Alford S, Frenguelli BG, Schofield JG & Collingridge GL (1993). Characterization of 
Ca
2+
 signals induced in hippocampal ca1 neurones by the synaptic activation 
of nmda receptors. J. Physiol. (Lond). 469, 693 - 716. 
Allen TGJ & Brown DA (2003). Modulation of the excitability of cholinergic basal 
forebrain neurones by KATP channels. The Journal of Physiology, 554, 353 - 
370. 
Andrews PW (1984). Retinoic acid induces neuronal differentiation of a cloned human 
embryonal carcinoma cell line in vitro. Dev. Biol., 103, 285 - 293. 
Angulo E, Noé V, Casadó V, Mallol J, Gomez-Isla T, Lluis C, et al. (2004). Up-
regulation of the Kv3.4 potassium channel subunit in early stages of 
Alzheimer’s disease. J. Neurochem., 91, 547 - 557. 
Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. 
(1995). Glutamate-induced neuronal death: A succession of necrosis or 
apoptosis depending on mitochondrial function. Neuron, 15, 961 - 973. 
Arispe N, Diaz JC & Simakova O (2007). Aβ ion channels. Prospects for treating 
Alzheimer's disease with Aβ channel blockers. Biochim. Biophys. Acta, 1768, 
1952 - 1965. 
Barltrop JA, Owen TC, Cory AH & Cory JG (1991). 5-(3-carboxymethoxyphenyl)-2-
(4,5-dimenthylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and 
related analogs of 3-(4,5-dimenthylthiazolyl)-2,5-diphenyltetrazolium 
bromide (MTT) reducing to purple water-soluble formazans as cell-viability 
indicators. Bioorganic & Medicinal Chemistry Letters, 1(11): 611-614. 
Bautista L, Castro MJ, López-Barneo J & Castellano A (2009). Hypoxia inducible 
factor-2α stabilization and maxi-K+ channel β1-subunit gene repression by 
Cellular Basis of Neurodegeneration 
 
 
268 
 
hypoxia in cardiac myocytes. Circ. Res., 104, 1364 - 1372. 
Bazan NG, Palacios-Pelaez R & Lukiw WJ (2002). Hypoxia signaling to genes - 
significance in Alzheimer's disease. Mol. Neurobiol., 26, 283 - 298. 
Berridge MJ (2010). Calcium hypothesis of Alzheimer's disease. Pflügers Arch - 
European Journal of Physiology, 459, 441 - 449. 
Bezprozvanny I (2005). The inositol 1,4,5-trisphosphate receptors. Cell Calcium, 38, 
261-272. 
Bhat MB & Ma J (2002). The transmembrane segment of ryanodine receptor contains 
an intracellular membrane retention signal for Ca
2+
 release channel. The 
Journal of Biological Chemistry, 277, 8597 - 8601. 
Bickler PE, Fahlman CS, Gray J & Mckleroy W (2009). Inositol 1,4,5-triphosphate 
receptors and NAD(P)H mediate Ca(
2+
) signaling required for hypoxic 
preconditioning of hippocampal neurons. Neuroscience, 160, 51-60. 
Boraso A & Williams AJ (1994). Modification of gating of the cardiac sarcoplasmic 
reticulum Ca
2+
-release channel by H2O2 and dithiothreitol. Am. J. Physiol., 
267, H1010 - H1016. 
Brini M (2003). Ca
2+
 signalling in mitochondria: Mechanism and role in physiology 
and pathology. Cell Calcium, 34, 399 - 405. 
Burg ED, Remillard CV & Yuan JX-J (2006). K
+
 channels in apoptosis. The Journal 
of Membrane Biology, 209, 3 - 20. 
Burgos C, Carrodeguas JA, Moreno C, Sánchez AC, Tarrafeta L, Barcelona JA, et al. 
(2005). A real time PCR (RT-PCR) alternative assay to detect the t/c mutation 
in position 1843 of the ryanodine receptor gene. Meat Science, 70, 395 - 398. 
Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, et al. (2007). 
Biological stress response terminology: Integrating the concepts of adaptive 
response and preconditioning stress within a hormetic dose-response 
framework. Toxicol. Appl. Pharmacol., 222, 122-128. 
Chapman H, Piggot C, Andrews PW & Wann KT (2007). Characterisation of large-
conductance calcium-activated potassium channels (BKca) in human NT2-N 
cells. Brain Res., 1129, 15 - 25. 
Chen SRW & Maclennan DH (1994). Identification of calmodulin-, Ca
2+
-, and 
ruthenium red-binding domains in the Ca
2+
 release channel (ryanodine 
receptor) of rabbit skeletal muscle sarcoplasmic reticulum. The Journal of 
Biological Chemistry, 269, 22698 - 22704. 
Chen X, Wu J, Lvovskaya S, Herndon E, Supnet C & Bezprozvanny I (2011). 
Cellular Basis of Neurodegeneration 
 
 
269 
 
Dantrolene is neuroprotective in Huntington's disease transgenic mouse model. 
Molecular Neurodegeneration, 6, 1 - 12. 
Chong ZZ, Li F & Maiese K (2007). Cellular demise and inflammatory microglial 
activation during β-amyloid toxicity are governed by wnt1 and canonical 
signaling pathways. Cell. Signal., 19, 1150 - 1162. 
Coles B, Wilton LaK, Good M, Chapman PF & Wann KT (2008). Potassium channels 
in hippocampal neurones are absent in a transgenic but not in a chemical 
model of Alzheimer's disease. Brain Res., 1190 1 - 14. 
Dolga A, Terpolilli N, Kepura F, Nijholt I, Knaus H-G, D'orsi B, et al. (2011). Kca2 
channels activation prevents [Ca
2+
]i deregulation and reduces neuronal death 
following glutamate toxicity and cerebral ischemia. Cell Death and Disease, 2, 
1 - 10. 
Dreses-Werringloer U, Lambert J-C, Vingtdeux V, Zhao H, Vais H, Siebert A, et al. 
(2008). A polymorphism in calhm1 influences Ca
2+
 homeostasis, Aβ levels, 
and Alzheimer's disease risk. Cell, 133, 1149 - 1161. 
Egea J, Rosa AO, Cuadrado A, García AG & López MG (2007). Nicotinic receptor 
activation by epibatidine induces heme oxygenase-1 and protects chromaffin 
cells against oxidative stress. J. Neurochem., 102, 1842 - 1852. 
Endo M (1977). Calcium release from the sarcoplasmic reticulum. Physiol. Rev., 57, 
71 - 108. 
Fernyhough P & Calcutt NA (2010). Abnormal calcium homeostasis in peripheral 
neuropathies. Cell Calcium, 47, 130-139. 
Floyd RA (1999). Antioxidants, oxidative stress and degenerative neurological 
disorders. Exp. Biol. Med., 222, 236 - 245. 
Floyd RA & Hensley K (2002). Oxidative stress in brain aging implications for 
therapeutics of neurodegenerative diseases. Neurobiol. Aging, 23, 795 - 807. 
Folin M, Baiguera S, Tommasini M, Guidolin D, Conconi MT, Decarlo E, et al. 
(2005). Effects of β-amyloid on rat neuromicrovascular endothelial cells 
cultured in vitro. Int. J. Mol. Med., 15, 929 - 935. 
Foskett JK, White C, Cheung K-H & Mak D-OD (2007). Inositol trisphosphate 
receptor Ca
2+
 release channels. Physiol. Rev., 87, 593-658. 
Freshney RI 1994. Culture of animal cells, New York, Wiley-Liss, Inc. 
Fülöp L, Zarándi M, Datki Z, Soós K & Penke B (2004). Β-amyloid-derived 
pentapeptide riigla inhibits Aβ1-42 aggregation and toxicity. Biochem. Biophys. 
Res. Commun., 324, 64 - 69. 
Cellular Basis of Neurodegeneration 
 
 
270 
 
Furuichi T, Furutama D, Hakamata Y, Nakai J, Takeshima H & Mikoshiba K (1994). 
Multiple types of ryanodine receptor/Ca
2+
 release channels are differentially 
expressed in rabbit brain. The Journal of Neuroscience, 14, 4794 - 4805. 
Garaschuk O, Yaari Y & Konnerth A (1997). Release and sequestration of calcium by 
ryanodine-sensitive stores in rat hippocampal neurones. J. Physiol. (Lond). 
502, 13 - 30. 
Gasperi RD, Sosa MaG, Dracheva S & Elder GA (2010). Presenilin-1 regulates 
induction of hypoxia inducible factor-1α: Altered activation by a mutation 
associated with familial Alzheimer's disease. Molecular Neurodegeneration, 5, 
1 - 20. 
George CH, Jundi H, Thomas NL, Scoote M, Walters N, Williams AJ, et al. (2004). 
Ryanodine receptor regulation by intramolecular interaction between 
cytoplasmic and transmembrane domains. Mol. Biol. Cell, 15, 2627 - 2638. 
Giannini G, Conti A, Mammarella S, Scrobogna M & Sorrentino V (1995). The 
ryanodine receptor/calcium channel genes are widely and differentially 
expressed in murine brain and peripheral tissues. The Journal of Cell Biology, 
128, 893 - 904. 
Good TA & Murphy RM (1996). Effect of β-amyloid block of the fast-inactivating K+ 
channel on intracellular Ca
2+
 and excitability in a modeled neuron. Proc. Natl. 
Acad. Sci. USA, 93, 15130 - 15135. 
Goodman Y & Mattson MP (1996). K
+
 channel openers protect hippocampal neurons 
against oxidative injury and amyloid β-peptide toxicity. Brain Res., 706, 328 - 
332. 
Green KN, Demuro A, Akbari Y, Hitt BD, Smith IF, Parker I, et al. (2008). Serca 
pump activity is physiologycally regulated by presenilin and regulates 
amyloid β production. J. Cell Biol., 181, 1107 - 1116. 
Gribkoff VK, Lum-Ragan JT, Boissard CG, Post-Munson DJ, Meanwell NA, 
Starrettjr JE, et al. (1996). Effects of channel modulators on cloned large-
conductance calcium-activated potassium channels. Mol. Pharmacol., 50, 506 
- 217. 
Gribkoff VK, Starrettjr JE, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, et 
al. (2001). Targeting acute ischemic stroke with a calcium-sensitive opener of 
maxi-K potassium channels. Nat. Med., 7, 471 - 477. 
Grievink H & Stowell KM (2008). Identification of ryanodine receptor 1 single-
nucleotide polymorphisms by high-resolution melting using the lightcycler 
Cellular Basis of Neurodegeneration 
 
 
271 
 
480 system. Anal. Biochem., 374, 396 - 404. 
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, et al. (2011). 
Cost of disorders of the brain in europe 2010. Eur. Neuropsychopharmacol., 
21, 718 - 779. 
Hakamata Y, Nakai J, Takeshima H & Imoto K (1992). Primary structure and 
distribution of a novel ryanodine receptor/calcium release channel from rabbit 
brain. FEBS Lett., 312, 229 - 235. 
Harvey AL & Robertson B (2004). Dendrotoxins: Structure-activity relationships and 
effects on potassium ion channels. Curr. Med. Chem., 11, 3065-3072. 
Henney NC. 2008. The expression and characteristics of ion channels in osteoblasts: 
Putative roles for TRP and K
+
 channels. Philosophiæ Doctor, Cardiff 
University. 
Henney NC, Li B, Elford C, Reviriego P, Campbell AK, Wann KT, et al. (2009). A 
large-conductance (BK) potassium channel subtype affects both growth and 
mineralization of human osteoblasts. Am. J. Physiolo. Cell Physiol., 297, 
1397 - 1408. 
Héron-Milhavet L, Xue-Jun Y, Vannucci SJ, Wood TL, Willing LB, Stannard B, et al. 
(2004). Protection against hypoxic-ischemic injury in transgenic mice 
overexpressing Kir6.2 channel pore in forebrain. Mol. Cell. Neurosci., 25, 585 
- 593. 
Ho K, Nichols CG, Lederer WJ, Lytton J, Vassilev PM, Kanazirska MV, et al. (1993). 
Cloning and expression of an inwardly retifying ATP-regulated potassium 
channel. Nature, 362, 31 - 38. 
Hogg RC & Adams DJ (2001). An ATP-sensitive K
+
 conductance in dissociated 
neurones from adult rat intracardiac ganglia. J. Physiol. (Lond). 534, 713 - 
720. 
Hohenegger M, Suko J, Gscheidlinger R, Drobny H & Zidar A (2002). Nicotinic acid-
adenine dinucleotide phosphate activates the skeletal muscle ryanodine 
receptor. Biochem. J., 367, 423 - 431. 
Holtzman DM (2004). In vivo effects of apoe and clusterin an amyloid-β metabolism 
and neuropathology. J. Mol. Neurosci., 23, 247 - 254. 
Hosoi E, Nishizaki C, Gallagher KL, Wyre HW, Matsuo Y & Sei Y (2001). 
Expression of the ryanodine receptor isofirms in immune cells. The Journal of 
Immunology, 167, 4887 - 4894. 
Humerickhouse RA, Besch HR, Gerzon K, Ruest L, Sutko JL & Emmick JT (1993). 
Cellular Basis of Neurodegeneration 
 
 
272 
 
Differential activating and deactivating effects of natural ryanodine congeners 
on the calcium release channel of sarcoplasmic reticulum: Evidence for 
separation of effects at functionally distinct sites. Mol. Pharmacol., 44, 412 - 
421. 
Humerickhouse RA, Bidasee KR, Gerzon K, Emmick JT, Kwon S, Sutko JL, et al. 
(1994). High affinity C10-Oeq ester derivatives of ryanodine - activator-
selective agonists of the sarcoplasmic reticulum calcium release channel. The 
Journal of Biological Chemistry, 269, 30243 - 30253. 
Hunya Á, Földi I, Szegedi V, Soós K, Zarándi M, Szabó A, et al. (2008). Difference 
between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma 
cells after Aβ(1-42) and nac treatment. Brain Res. Bull., 75, 648 - 654. 
Ishimura A, Ishige K, Taira T, Shimba S, Ono S-I, Ariga H, et al. (2008). 
Comparative study of hydrogen peroxide- and 4-hydroxy-2-nonenal-induced 
cell death in HT22 cells. Neurochem. Int., 52, 776 - 785. 
Jämsä A, Hasslund K, Cowburn RF, Bäckström A & Vasänge M (2004). The retinoic 
acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as 
a model for Alzheimer's disease-like tau phosphorylation. Biochem. Biophys. 
Res. Commun., 319, 993 - 1000. 
Jang H, Arce FT, Ramachandran S, Capone R, Azimova R, Kagan BL, et al. (2010). 
Truncated β-amyloid peptide channels provide an alternative mechanism for 
Alzheimer's disease and Down syndrome. PNAS, 107, 6538 - 6543. 
Jolly-Tornetta C, Gao Z-Y, Lee VM-Y & Wolf BA (1998). Regulation of amyloid 
precursor protein secretion by glutamate receptors in human NTera 2 neurons 
(NT2N). The Journal of Biological Chemistry, 273, 14015 - 14021. 
Joshi S, Guleria RS, Pan J, Dipette D & Singh US (2007). Heterogeneity in retinoic 
acid signaling in neuroblastomas: Role of matrix metalloproteinases in 
retinoic acid-induced differentiation. Biochim. Biophys. Acta, 1772, 1093 - 
1102. 
Kagan BL, Hirakura Y, Azimov R, Azimova R & Lin M-C (2002). The channel 
hypothesis of Alzheimer's disease: Current status. Peptides, 23, 1311 - 1315. 
Kajkowski EM, Lo CF, Ning X, Walker S, Sofia HJ, Wang W, et al. (2001). Β-
amyloid peptide-induced apoptosis regulated by a novel protein containing a 
G protein activation module. The Journal of Biological Chemistry, 276, 18748 
- 18756. 
Kanichai M, Ferguson D, Prendergast PJ & Campbell VA (2008). Hypoxia promotes 
Cellular Basis of Neurodegeneration 
 
 
273 
 
chondrogenesis in rat mesenchymal stem cells: A role for akt and hypoxia-
inducible factor (HIF)-1α. J. Cell. Physiol., 216, 708 - 715. 
Kar S (2002). Role of amyloid beta peptides in the regulation of central cholinergic 
function and its relevance to Alzheimer's disease pathology. Drug Dev. Res., 
56, 248-263. 
Kar S, Issa AM, Seto D, Auld DS, Collier B & Quirion R (1998). Amyloid beta-
peptide inhibits high-affinity choline uptake and acetylcholine release in rat 
hippocampal slices. J. Neurochem., 70, 2179-2187. 
Kato BM & Rubel EW (1999). Glutamate regulates IP3-type and CICR stores in the 
avian cochlear nucleus. J. Neurophysiol., 81, 1587 - 1596. 
Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, et al. (1999). 
Alterations in the ryanodine receptor calcium release channel correlate with 
Alzheimer's disease neurofibrillary and β-amyloid pathologies. Neuroscience, 
92, 499 - 513. 
Khudheyer M. 2010. A comparative study of the effects of cellular stresses on 
astrocyte and neuronal cell survival. Master of Pharmacy, Cardiff University. 
Kimball BC, Yule DI & Mulholland MW (1996). Caffeine- and ryanodine-sensitive 
Ca
2+
 stores in cultured guinea pig myenteric neurons. Am. J. Physiol., 270, 
G594 - G603. 
Krebs B, Wiebelitz A, Balitzki-Korte B, Vassallo N, Paluch S, Mitteregger G, et al. 
(2007). Cellular prion protein modulates the intracellular calcium response to 
hydrogen peroxide. J. Neurochem., 100, 358 - 367. 
Kruman, Ii, Pedersen WA, Springer JE & Mattson MP (1999). Als-linked Cu/Zn-SOD 
mutation increases vulnerability of motor neurons to excitotoxicity by a 
mechanism involving increased oxidative stress and perturbed calcium 
homeostasis. Exp. Neurol., 160, 28-39. 
Lafon-Cazal M, Pietri S, Culcasi M & Bockaert J (1993). NMDA-dependent 
superoxide production and neurotoxicity. Nature, 364, 535 - 537. 
Laifenfeld D, Klein E & Ben-Shachar D (2002). Norepinephrine alters the expression 
of genes involved in neuronal sprouting and differentiation: Relevance for 
major depression and antidepressant mechanisms. J. Neurochem., 83, 1054 - 
1064. 
Lal R, Lin H & Quist AP (2007). Amyloid beta ion channel: 3D structure and 
relevance to amyloid channel paradigm. Biochim. Biophys. Acta, 1768, 1966 
- 1975. 
Cellular Basis of Neurodegeneration 
 
 
274 
 
Laver DR (2007). Ca
2+
 stores regulate ryanodine receptor Ca
2+
 release channels via 
luminal and cytosolic Ca
2+
 sites. Clin. Exp. Pharmacol. Physiol., 34, 889 - 896. 
Lee EB, Skovronsky DM, Abtahian F, Doms RW & Lee VM-Y (2003). Secretion and 
intracellular generation of truncated Aβ in β-site amyloid-β precursor protein-
cleaving enzyme expressing human neurons. The Journal of Biological 
Chemistry, 278, 4458 - 4466. 
Lessard CB, Lussier MP, Cayouette S, Bourque G & Boulay G (2005). The 
overexpression of presenilin2 and Alzheimer's-disease-linked presenilin2 
variants influences TRPC6-enhanced Ca
2+
 entry into HEK293 cells. Cell. 
Signal., 17, 437 - 445. 
Liao Y, Kristiansen A-M, Oksvold CP, Tuvnes FA, Gu N, Rundén-Pran E, et al. 
(2010). Neuronal Ca
2+
-activated K
+
 channels limit brain infarction and 
promote survival. PLoS ONE, 5, 1 - 8. 
Lin H, Bhatia R & Lal R (2001). Amyloid β protein forms ion channels: Implications 
for Alzheimer's disease pathophysiology. The FASEB Journal, 15, 2433 - 
2444. 
Lin MT & Beal MF (2006). Mitochondrial dysfunction and oxidative stress in 
neurodegenerative diseases. Nature, 443, 787 - 795. 
Liu D, Lu C, Wan R, Auyeung WW & Mattson MP (2002). Activation of 
mitochondrial ATP-dependent potassium channels protects neurons against 
ischemia-induced death by a mechanism involving suppression of bax 
translocation and cytochrome c release. J. Cereb. Blood Flow Metab., 22, 431 
- 443. 
Liu D, Slevin JR, Lu CB, Chan SL, Hansson M, Elmer E, et al. (2003). Involvement 
of mitochondrial K
+
 release and cellular efflux in ischemic and apoptotic 
neuronal death. J. Neurochem., 86, 966-979. 
Lovat PE, Irving H, Margherita, Annicchiarico-Petruzzelli, Bernassola F, Malcolm AJ, 
et al. (1997). Apoptosis of N-type neuroblastoma cells after differentiation 
with 9-cis-retinoic acid and subsequent washout. Journal of National Cancer 
Institute, 89, 446 - 452. 
Macdonald JF, Xiong ZG & Jackson MF (2006). Paradox of Ca
2+
 signaling, cell death 
and stroke. Trends Neurosci., 29, 75-81. 
Mak DOD, Mcbride S & Foskett JK (1998). Inositol 1,4,5-tris-phosphate activation of 
inositol tris-phosphate receptor Ca
2+
 channel by ligand tuning of Ca
2+
 
inhibition. Proc. Natl. Acad. Sci. U. S. A., 95, 15821-15825. 
Cellular Basis of Neurodegeneration 
 
 
275 
 
Makarewicz D, Ziemińska E & Łazarewicz JW (2003). Dantrolene inhibits nmda-
induced 
45
Ca uptake in cultured cerebellar granule neurons. Neurochem. Int., 
43, 273 - 278. 
Manunta MDI. 2000. Functional properties of RyR3 - Ca
2+
 release channel, of native, 
expressed and tagged isoforms. Doktors der Naturwissenschaften Dissertation, 
Johannes Kepler Universität. 
Mattson MP (1989). Acetylcholine potentiates glutamate-induced neurodegeneration 
incultured hippocampal neurons. Brain Res., 497, 402 - 406. 
Mattson MP (2003). Excitotoxic and excitoprotective mechanisms - abundant targets 
for the prevention and treatment of neurodegenerative disorders. 
Neuromolecular Med., 3, 65-94. 
Mattson MP (2007). Calcium and neurodegeneration. Aging Cell, 6, 337 - 350. 
Mattson MP, Gleichmann M & Cheng A (2008). Mitochondria in neuroplasticity and 
neurological disorders. Neuron, 60, 748-766. 
Mattson MP & Kater SB (1989). Development and selective neurodegeneration in cell 
cultures from different hippocampal regions. Brain Res., 490, 110 - 125. 
Mattson MP & Magnus T (2006). Ageing and neuronal vulnerability. Nature Reviews 
Neuroscience, 7, 278-294. 
Matyash M, Matyash V, Nolte C, Sorrentino V & Kettenmann H (2002). Requirement 
of functional ryanodine receptor type 3 for astrocyte migration. The FASEB 
Journal, 16, 84 - 86. 
Meera P, Wallner M & Toro L (2000). A neuronal β subunit (KCNMB4) makes the 
large conductance, voltage- and Ca
2+
-activated K
+
 channel resistant to 
charybdotoxin and iberiotoxin. PNAS, 97, 5562 - 5567. 
Mori F, Okada M, Tomiyama M, Kaneko S & Wakabayashi K (2005). Effects of 
ryanodine receptor activation on neurotransmitter release and neuronal cell 
death following kainic acid-induced status epilepticus. Epilepsy Res., 65, 59 - 
70. 
Mulder J, Berghuis P, Cate BT & Luiten PGM 2003. Improved method to investigate 
β-amyloid toxicity in rat primary cholinergic culture. In: NEUROSCIENCE, 
S. O. (ed.) 33rd Annual Meeting of the Society of Neuroscience. New Orleans, 
LA, USA: Society for Neuroscience Abstract View and Itinery Planner. 
Nixon RA (2003). The calpains in aging and aging-related diseases. Ageing Research 
Reviews, 2, 407 - 418. 
Obata T & Yamanaka Y (2000). Block of cardiac atp-sensitive K
+
 channels reduces 
Cellular Basis of Neurodegeneration 
 
 
276 
 
hydroxyl radicals in the rat myocardium. Arch. Biochem. Biophys., 378, 195 - 
200. 
Olesen S-P, Munch E, Moldt P & Drejer J (1994). Selective activation of Ca
2+
-
dependent K
+
 channels by novel benzimidazolone. Eur. J. Pharmacol., 251, 53 
- 59. 
Orio P, Rojas P, Ferreira G & Latorre R (2002). New disguises for an old channel: 
Maxik channel β-subunits. News Physiol. Sci., 17, 156 - 161. 
Papassotiriou J, Köhler R, Prenen J, Krause H, Akbar M, Eggermont J, et al. (2000). 
Endothelial K
+
 channel lacks the Ca
2+
 sensitivity-regulating β subunit. The 
FASEB Journal, 14, 885 - 894. 
Parker I, Choi J & Yao Y (1996). Elementary events of InsP(3)-induced Ca
2+
 
liberation in xenopus oocytes: Hot spots, puffs and blips. Cell Calcium, 20, 
105-121. 
Parri HR & Crunelli V (2003). The role of Ca
2+
 in the generation of spontaneous 
astrocytic Ca
2+
 oscillations. Neuroscience, 120, 979 - 992. 
Plant LD, Boyle JP, Smith IF, Peer C & Pearson HA (2003). The production of 
amyloid β peptide is a critical requirement for the viability of central neurons. 
The Journal of Neuroscience, 23, 5531 - 5535. 
Prilipko L 2004. Neurological atlas. Country resources for neurological disorders. 
Geneva: World Health Organisation, World Federation Neurology. 
Pugh N, Mead-Savery FC, Coadwell WJ, Rossi D, Sorrentino V & Williams AJ 
(2005). Probing luminal negative charge in the type 3 ryanodine receptor. 
Biochem. Biophys. Res. Commun., 337, 1072 - 1079. 
Qahwash IM, Boire A, Lanning J, Krausz T, Pytel P & Meredith SC (2007). Site-
specific effects of peptide lipidation on β-amyloid aggregation and 
cytotoxicity. The Journal of Biological Chemistry, 282, 36987 - 36997. 
Reviriego P. 2009. Engineering aequorin as an indicator of calcium signals near the 
BK channel. Philosophiae Doctor, Cardiff University. 
Robitaille R & Charlton MP (1992). Presynaptic calcium signals and transmitter 
release are modulated by calcium-activated potassium channels. The Journal 
of Neuroscience, 12, 297 - 305. 
Rogers EF, Koniuszy FR, Shavel J & Folkers K (1948). Plant insecticides. I. 
Ryanodine, a new alkaloid from ryania speciosa vahl. J. Am. Chem. Soc., 70, 
3086 - 3088. 
Roher AE, Palmer KC, Yurewicz EC, Ball MJ & Greenberg BD (1993). 
Cellular Basis of Neurodegeneration 
 
 
277 
 
Morphological and biochemical analyses of amyloid plaque core proteins 
purified from Alzheimer's dissease brain tissue. J. Neurochem., 61, 1916 - 
1928. 
Rong Y-P, Aromolaran AS, Bultynck G, Zhong F, Li X, Mccoll K, et al. (2008). 
Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of 
apoptotic calcium signals. Mol. Cell, 31, 255 - 265. 
Rootwelt T, Dunn M, Yudkoff M, Itoh T, Almaas R & Pleasure D (1998). Hypoxic 
cell death in human NT2-N neurons: Involvement of nmda and non-NMDA 
glutamate receptors. Joournal of Neurochemistry, 71, 1544 - 1553. 
Rosa R, Sanfeliu C, Rodríguez-Farré E, Frandsen A, Schousboe A & Suñol C (1997). 
Properties of ryanodine receptor in cultured cerebellar granule neurons: 
Effects of hexachlorocyclohexane isomers and calcium. J. Neurosci. Res., 47, 
27 - 33. 
Ross RA, Spengler BA & Biedler JL (1983). Coordinate morphological and 
biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer 
Inst., 71, 741 - 747. 
Rybalchenko V, Hwang S-Y, Rybalchenko N & Koulen P (2008). The cytosolic N-
terminus of presenilin-1 potentiates mouse ryanodine receptro single channel 
activity. The International Journal of Biochemistry & Cell Biology, 40, 84 - 
97. 
Samsó M, Wagenknecht T & Allen PD (2005). Internal structure and visualization of 
transmembrane domains of the RyR1 calcium release channel by cryo-EM. 
Nat. Struct. Mol. Biol., 12, 539 - 544. 
Sharma MR, Jeyakumar LH, Fleischer S & Wagenknecht T (2000). Three-
dimensional structure of ryanodine receptor isoform three in two 
conformational states as visualized by cryo-electron microscopy. The Journal 
of Biological Chemistry, 275, 9485 - 9491. 
Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE & Tuttle JB (1997). 
Altered calcium homeostasis in cells transformed by mitochondria from 
individuals with Parkinson's disease. J. Neurochem., 68, 1221-1233. 
Shoshan-Barmatz V, Orr I, Martin C & Vardi N (2005). Novel ryanodine-binding 
properties in mammalian retina. The International Journal of Biochemistry & 
Cell Biology, 37, 1681 - 1695. 
Silva HaD, Aronson JK, Grahame-Smith DG, Jobst KA & Smith AD (1998). 
Abnormal function of potassium channels in platelets of patients with 
Cellular Basis of Neurodegeneration 
 
 
278 
 
Alzheimer's disease. Lancet, 352. 
Smith IF, Hitt B, Green KN, Oddo S & Laferla FM (2005). Enhanced caffeine-
induced Ca
2+
 release in the 3xTg-AD mouse model of Alzheimer's disease. J. 
Neurochem., 94, 1711 - 1718. 
Sorrentino V (1995). The ryanodine receptor family of intracellular calcium release 
channels. Adv. Pharmacol., 33, 67 - 90. 
Spillantini MG 2011. Inflammation, astrocytes and tau related neurodegeneration. In: 
BRAIN REPAIR CENTRE, U. O. C. (ed.) Cambridge Centre for Brain 
Repair Spring School. Cambridge, UK. 
Stutzmann GE & Mattson MP (2011). Endoplasmic reticulum Ca
2+
 handling in 
excitable cells in health and disease. Pharmacol. Rev., 63, 700 - 727. 
Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM & Parker I (2006a). 
Enhanced ryanodine receptor recruitment contributes to Ca
2+
 disruptions in 
yound, adult, and aged Alzheimer's disease mice. The Journal of Neuroscience, 
26, 5180 - 5189. 
Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I & Laferla F 2006b. Enhanced 
ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's 
mouse models. Meeting on Imaging and the Aging Brain. New York, NY, 
USA: New York Academy of Sciences. 
Sun H-S, Feng Z-P, Miki T, Seino S & French RJ (2006). Enhanced neuronal damage 
after ischemic insults in mice lacking Kir6.2-containing atp-sensitive K
+
 
channels. J. Neurophysiol., 95, 2590 - 2601. 
Supnet C, Grant J, Kong H, Westaway D & Mayne M (2006). Amyloid-β-(1-42) 
increases ryanodine receptor-3 expression and function in neurons of 
TgCRND8 mice. The Journal of Biological Chemistry, 281, 38440 - 38447. 
Szewczyk A, Kajma A, Malinska D, Wrzosek A, Bednarczyk P, Zablocka B, et al. 
(2010). Pharmacology of mitochondrial potassium channels: Dark side of the 
field. FEBS Lett., 584, 2063 - 2069. 
Tieu K, Zuo DM & Yu PH (1999). Differential effects of staurosporine and retinoic 
acid on the vulnerability of the SH-SY5Y neuroblastoma cells: Involvement 
of Bcl-2 and P53 proteins. J. Neurosci. Res., 58, 426 - 435. 
Tilgen N, Zorzato F, Halliger-Keller B, Muntoni F, Sewry C, Palmucci LM, et al. 
(2001). Identification of four novel mutations in the C-terminal membrane 
spanning domain of the ryanodine receptor 1: Association with central core 
disease and alteration of calcium homeostasis. Hum. Mol. Genet., 10, 2879 - 
Cellular Basis of Neurodegeneration 
 
 
279 
 
2887. 
Tokuhiro S, Tomita T, Iwata H, Kosaka T, Saido TC, Maruyama K, et al. (1998). The 
presenilin 1 mutation (M146V) linked to familial Alzheimer's disease 
attenuates the neuronal differentiation of NTERA 2 cells. Biochem. Biophys. 
Res. Commun., 244, 751 - 755. 
Torp R, Head E, Milgram NW, Hahn F, Ottersen OP & Cotman CW (2000). 
Ultrastructural evidence of fibrillar β-amyloid associated with neuronal 
membranes in behaviorally characterized aged dog brains. Neuroscience, 96, 
495 - 506. 
Tu H, Nelson O, Bezproavanny A, Wang Z, Lee S-F, Hao Y-H, et al. (2006). 
Presenilins form ER Ca
2+
 leak channels, a function disrupted by familial 
Alzheimer's disease-linked mutations. Cell, 126, 981 - 993. 
Tweedie D, Brossi A, Chen D, Ge Y-W, Bailey J, Yu Q-S, et al. (2006). Neurien, an 
acetylcholine autolysis product, elevates secreted amyloid-β protein precursor 
and amyloid-β peptide levels, and lowers neuronal cell viability in culture: A 
role in Alzheimer's disease. J. Alzheimer's Dis., 10, 9 - 16. 
Ueda T, Nagata M, Monji A, Yoshida I, Tashiro N & Imoto T (2002). Effect of 
sucrose on formation of the β-amyloid fibrils and D-aspartic acids in Aβ1-42. 
Biol. Pharm. Bull., 25, 375 - 378. 
Usachev Y, Shmigol A, Pronchuk N, Kostyuk P & Verkhratsky A (1993). Caffeine-
induced calcium release from internal stores in cultured rat sensory neurons. 
Neuroscience, 57, 845 - 859. 
Vanterpool CK, Vanterpool EA, Pearce WJ & Buchholz JN (2006). Advancing age 
alters the expression of the ryanodine receptor 3 isoform in adult rat superior 
cervical ganglia. J. Appl. Physiol., 101, 392 - 400. 
Vaucher E, Aumont N, Pearson D, Rowe W, Poirier J & Kar S (2001). Amyloid beta 
peptide levels and its effects on hippocampal acetylcholine release in aged, 
cognitively-impaired and -unimpaired rats. J. Chem. Neuroanat., 21, 323-329. 
Wang G & Lemos JR (1995). Tetrandrine: A new ligand to block voltage-dependent 
Ca
2+
 and Ca
2+
-activated K
+
 channels. Life Sci., 56, 295 - 306. 
Wang G, Lemos JR & Iadecola C (2004). Herbal alkaloid tetrandrine: From an ion 
channel blocker to inhibitor of tumor proliferation. Trends Pharmacol. Sci., 25, 
120 - 123. 
Wang HY, Lee DHS, D'andrea MR, Peterson PA, Shank RP & Reitz AB (2000). Beta-
amyloid(1-42) binds to alpha 7 nicotinic acetylcholine receptor with high 
Cellular Basis of Neurodegeneration 
 
 
280 
 
affinity - implications for Alzheimer's disease pathology. J. Biol. Chem., 275, 
5626-5632. 
Wang Y-H, Zheng H-Y, Qin N-L, Yu S-B & Liu S-Y (2007). Involvement of atp-
sensitive potassium channels in proliferation and differentiation of rat 
preadipocytes. Acta Physiologica Sinica, 59, 8 - 12. 
Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JPA, Nolte D, et al. 
(2006). Mutations in voltage-gated potassium channel KCNC3 cause 
degenerative and developmental central nervous system phenotypes. Nat. 
Genet., 38, 447 - 451. 
Wulff H & Zhorov BS (2008). K
+
 channel modulators for the treatment of 
neurological disorders and autoimmune diseases. Chem. Rev., 108, 1744 - 
1773. 
Xu WH, Liu YG, Wang S, Mcdonald T, Van Eyk JE, Sidor A, et al. (2002). 
Cytoprotective role of Ca
2+
-activated K
+
 channels in the cardiac inner 
mitochondrial membrane. Science, 298, 1029-1033. 
Yamada K & Inagaki N (2005). Neuroprotection by KATP channels. J. Mol. Cell. 
Cardiol., 38, 945 - 949. 
Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, et al. (2001). Protective role of 
ATP-sensitive potassium channels in hypoxia-induced generalized seizure. 
Science, 292, 1543 - 1546. 
Yamaguchi N, Xu L, Evans EE, Pasek DA & Meissner G (2004). Different regions in 
skeletal and cardiac muscle ryanodine receptor are involved in transducting 
the functional effects of calmodulin. The Journal of Biological Chemistry, 279, 
36433 - 36439. 
Yao Z-X, Han Z, Xu J, Greeson J, Lecanu L & Papadopoulos V (2007). 22R-
hydroxycholesterol induces differentiation of human NT2 precursor 
(NTERA2/D1 teratocarcinoma) cells. Neuroscience, 148, 441 - 453. 
Yu SP, Farhangrazi ZS, Ying HS, Yeh C-H & Choi DW (1998). Enhancement of 
outward potassium current may participate in β-amyloid peptide-induced 
cortical neuronal death. Neurobiol. Dis., 5, 81 - 88. 
Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LMT, Farhangrazi ZS, et al. (1997). 
Mediation of neuronal apoptosis by enhancement of outward potassium 
current. Science, 278, 114-117. 
Zahradnίková A & Palade P (1993). Procaine effects on single sarcoplasmic reticulum 
Ca
2+
 release channels. Biophys. J., 64, 991 - 1003. 
Cellular Basis of Neurodegeneration 
 
 
281 
 
Zhang W, Jin H-W & Wang X-L (2004). Effects of presenilins and β-amyloid 
precursor protein on delayed rectifier potassium channels in cultured rat 
hippocampal neurons. Acta Pharmacol. Sin., 25, 181 - 185. 
Zhu X, Zhou W, Cui Y, Zhu L, Li J, Xia Z, et al. (2009). Muscarinic activation 
attenuates abnormal processing of β-amyloid precursor protein induced by 
cobalt chloride-mimetic hypoxia in retinal ganglion cells. Biochem. Biophys. 
Res. Commun., 384, 110 - 113. 
 
 
  
Cellular Basis of Neurodegeneration 
 
 
282 
 
Acknowledgements 
 
By the end of my PhD, it is my pleasure to acknowledge all those people who 
have provided me with support and encouragement during these four years. 
 
Firstly my supervisors. Prof. Kenneth T. Wann has supported me very much on 
my research planning, results analysis, thesis writing and attendance in both 
internal and international conference presentations. And, Prof. Wann always 
encourages me to generate my idea and to try my idea in experiments. That has 
not only improved my understanding of the research topic I am working on, but 
also enhanced my research skills and abilities which I believe will benefit my 
future career a lot. In addition, I very much appreciate the support from Prof. 
Wann, as well as my other supervisor Prof. Gary F. Baxter, the Head of school, 
foy my living costs in my final year and funding applications. 
 
Secondly, I much appreciate the sources of funding. Particularly, my family, 
Prof. Zhang Cheng-Zhi and Prof. Wang Ai-Qin, have supported my tuition fee 
and bench fee for three years, as well as some living costs, which is something 
more than £60,000 in total. I know it is unusual, in acknowledgement, to put 
funding or family before any other help from colleagues, but I believe 
everybody that may have some ideas of the average salary for a Professor in 
China will absolutely acknowledge their unvaluable support and forgive me my 
preference for this acknowledgement priority. That support, as well as all of 
their encouragement, has shown their love for me; I would like to say that 
Cellular Basis of Neurodegeneration 
 
 
283 
 
nothing is possible in this PhD without that. Besides, I also thank the funding 
from Great Britain – China Centre (£4,000) and Henry Lester Trust (£2,500). 
 
Thirdly, I much appreciate all the help from my colleagues in Cardiff 
University. My thanks to Dr. Dwaine Burley, Dr. Neil C. Henney, Dr. Pablo 
Reviriego, Mr. Charles D. Cox and Miss Nassrin Vassel in my lab for their 
demonstration of experimental techniques and suggestions on my research, 
especially when I was sometimes puzzled. I also thank Dr. Bronwen Evans in 
the School of Medicine, Dr. Rhian Thomas and the Tenovas group in School of 
Pharmacy and Pharmaceutical Sciences for their kind offer of their research 
facilities, as well as the discussion of relevant data, to support my research. In 
addition, I thank all the Erasmus students and project students who worked 
with me, including Miss. Elisabetta Asson, Miss Jasmin Nowak, Miss Marwa 
Khudheyer, Miss Emily Knight and Mr. Mohamedameer Pirmohamed, for their 
efforts in research and their ideas which have inspired me several times. I also 
thank all the administrative staff in this school, especially Mrs. Lynne Terrett, 
Mrs. Sarah Davis and Mrs. Wendy Davies, for their kind help which has 
guranteed a good research environment in the school. 
 
Last but not least, I also much appreciate the other colleagues and friends in the 
department, the school and all over the university. I am very glad for having 
shared 4 years of a happy time, which is fortunately not only lab work, and that 
has encouraged me to hold a positive attitude and being sunshine into both my 
research and life. 
